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Summary 
 
Type II DNA topoisomerases catalyze the ATP-dependent passage of a double-stranded DNA 
through a gap in a second duplex by coordinating the sequential opening and closing of three 
dimerization interfaces (gates). Gyrase is a specialized type II topoisomerase possessing a 
spiral domain (GyrA CTD) that wraps DNA for intramolecular strand passage of a Transfer-
segment (T-segment) and thus confers negative supercoiling activity. 
The exact position of the GyrA CTD relative to the catalytic core is not known as no full-
length high-resolution structure of GyrA or gyrase has been solved. To monitor potential 
dynamics of a single GyrA CTD and localize the domain with respect to the core of the 
enzyme, single-molecule FRET (smFRET) experiments were performed. Stable dimeric 
constructs with one wt and one mutant subunit (carrying solvent-accessible cysteine residues 
for fluorescent labeling on the GyrA core and on the CTD) were produced in a hetero-dimeric 
expression system. FRET efficiencies from GyrA constructs labeled at different positions 
were converted to inter-dye distances, allowing the triangulation of the position of the N-
terminal region of the CTD. In absence of DNA and GyrB, the FRET model placed the CTD 
close to the catalytic core domain, indicating a position suitable to contact a DNA bound to 
the DNA-gate. Upon addition of GyrB and supercoiled plasmid, the N-terminal region of the 
CTD is displaced from the core by 2.5 to 2.6 nm (depending on the labeling position of the 
CTD monitored), indicating an extended conformation of the CTD.  
Fluorescence anisotropy titrations suggest that the extended CTD conformation is 
characterized by simultaneous binding of the DNA to the DNA-gate and the CTDs. However, 
in the absence of GyrB the CTDs are the main DNA interaction sites of GyrA. Binding of 
plasmid DNA induces conformational flexibility in the CTDs, which indicates transient 
bridging interaction of the DNA to both the CTDs and the DNA-gate. Binding of GyrB to 
GyrA induces only a small movement of the CTDs, probably by spatial interference, 
indicating that GyrB itself is not responsible for the extended CTD conformation, but rather 
for the stabilization of the enzyme-DNA complex.  
Addition of neg. supercoiled or relaxed plasmid or linear DNAs of 48 to 110 bp to gyrase 
results in an extended CTD conformation; anisotropy measurements clearly showed that the 
linear DNAs bind to both the DNA-gate and the CTDs in presence of GyrB. However, a 37bp 
DNA showed similar KD values for GyrA and GyrA-core in the presence of GyrB. Moreover, 
binding to gyrase did not result in an extended CTD conformation. These findings indicate 
that a small interaction between DNA and CTDs (not more than approx. 5 bp) is sufficient to 
induce the conformational change. Meanwhile, the extended position of the CTD does neither 
   
depend on the topology of the substrate nor extensive wrapping or the presence or absence of 
a T-segment. 
In contrast to previous speculations, binding of ADPNP (a non-hydrolysable ATP-analog) to 
the gyrase-DNA complex did not result in the release of the GyrA CTDs, and no 
conformational change connected to strand passage could be detected. A cleavage-deficient 
GyrA mutant exhibits a 1.5-fold higher DNA affinity but retains wild-type like CTD 
conformations; suggesting that the latter are independent of DNA distortion and cleavage. 
Deletion of a conserved heptapeptide on the CTD (GyrA-box) abolished the supercoiling 
activity, but did not alter the DNA affinity or the conformational behavior of the enzyme. 
Taken together, the present data suggests that the conformational change of the CTDs is 
mediated by simultaneous binding of DNA to the CTDs and the DNA-gate (a complex which 
is stabilized by GyrB) and represents an early event in the supercoiling cycle of gyrase. 
 
Topoisomerase VI possesses only two dimerization interfaces compared to the three in 
conventional type II enzymes, thereby exhibiting less complexity than e.g. gyrase. It catalyzes 
DNA relaxation and decatenation in an ATP-dependent manner. In smFRET experiments, a 
fluorescently labeled 50bp DNA was used as a FRET probe for potential DNA-gate dynamics 
in TopoVI. A reduction in the DNA affinity upon deletion of the active site tyrosine residue 
inducing DNA cleavage indicated the formation of a covalent protein-DNA intermediate in 
wild-type TopoVI, although DNA cleavage could not be demonstrated directly; the 
conformation of the DNA was similar in complexes with wild-type and active-site mutant 
enzyme. No distortion of the DNA or gate opening could be detected upon addition of ATP 
and ADPNP. 
Conformational changes in the ATPase-gate of TopoVI were monitored in smFRET 
measurements, using fluorescently labeled enzyme with one dye attached to each nucleotide-
binding domain. We have observed four different conformational states in the ATPase-gate: 
In absence of nucleotide or DNA substrates the ATPase-gate exhibits conformational 
flexibility, indicating gate opening and closing. Binding of supercoiled plasmid to TopoVI 
forces the ATPase-gate to open up even wider, although considerable flexibility of the 
domains is retained; both these states have been proposed on the basis of two crystal 
structures of intact TopoVI holoenzymes, showing a closed and an open gate conformation.  
Addition of ADPNP to TopoVI induces a well-defined conformation of the ATPase domains 
close to each other, indicating dimerization; this is in agreement with crystal structures from 
isolated TopoVI-B domains which show tight association when bound to ADPNP. Addition 
of both nucleotide and plasmid immobilizes the domains in a conformation different from the 
   
one observed for the closed gate, indicating that the presence of a T-DNA segment in the 
central cavity induces physical strain to the TopoVI complex; this state has not been proposed 
so far. During all these conformational changes of the ATPase-gate, the transducer domain 
linking the two gates barely moves, suggesting that the ATPase domains exhibit a rotational 
flexibility in absence of nucleotide. TopoVI shows a different conformational behavior than 
type II topoisomerases (e.g. gyrase) in that it exhibits dynamic opening and closing of the 
ATPase-gate in absence of ligands. Furthermore it does not show DNA-induced pre-closure, 
but rather opening of the gate in presence of a supercoiled DNA.  
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1. Introduction 
1.1 Topoisomerases: An essential enzyme class to solve topological 
problems in DNA 
Stable storage of genetic information is vital for all organisms, and is achieved in a universal 
manner via the nucleotide sequence in DNA. Its double-helical structure protects the 
nucleobases from the chemistry of the environment, while the complementary nature of the 
two strands enable organisms to repair DNA mismatches and damaged nucleobases, thus 
minimizing the risk of losing information. To fit the long DNA molecules into the restricted 
space of a cell or a sub-cellular compartment, organisms keep the DNA in a compact 
configuration. For example, in case of mesophilic prokaryotes, the DNA is slightly 
underwound, resulting in a compact configuration, while in eukaryotes the DNA is organized 
in a plectonemic structure mediated by scaffolding proteins [1]. While formation of the 
double helix and the packing of the DNA successfully protect the genetic information, it 
counteracts processes, which require access to the genetic information stored in the base-pairs 
and their need to induce strand separation, such as replication and transcription. Besides not 
being favored energetically, the local melting of base-pairs creates strain in the adjacent 
region of the DNA duplex: Progression of a transcription complexes along the DNA induces 
overwinding of the double-helix in the direction of movement, while the DNA behind the 
transcription bubble is underwound [2]. These effects are normally compensated by the 
formation of so-called supercoils, i.e. the coiling of the DNA duplex around itself. DNA 
replication also induces positive supercoiling in front of the replication fork, leaving behind 
intertwined DNA duplexes consisting of mother and daughter strands; in case of a bacterial 
chromosome, the ligation of the two circular daughter chromosomes results in interlocked 
DNA circles, known as catenanes [3, 4]. Negative or positive supercoiles or superstructures 
like catenanes or knots disturb the normal DNA topology of a cell, impairing DNA packing, 
maintenance, and read-out. In order to solve topological problems in DNA cells express a 
very diverse class of enzymes known as topoisomerases. 
The only common property of topoisomerases is the ability to induce topological change into 
DNA: They transiently cleave one or two DNA strands by nucleophilic attack of one or two 
active site tyrosines on the phosphate backbone, respectively, forming a covalent 
phosphotyrosyl intermediate. They allow a second DNA segment (also a single or a double 
strand, respectively) to rearrange, and religate the cleaved phosphate backbone [5-7]. 
Topoisomerases are divided in two structurally and functionally very different families: Type 
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I topoisomerases induce a single-strand DNA break, while the complementary strand is either 
actively transported through the gap, changing the linking number in steps of 1 (type IA) [8, 
9], or allow one double-strand next to the cleavage site to swivel around the non-cleaved 
phosphate backbone (type IB, C) [8, 10-12]. Type I enzymes generally consist of monomeric 
enzymes, with the only known exception being the type IB topoisomerase from L. donovani 
which consists of two subunits [13]. They relax negatively or positively supercoiled DNA or 
disentangle catenated DNAs in a nucleotide-independent manner, using the free energy stored 
in DNA supercoils [14]. The only type I topoisomerase not following this principle is reverse 
gyrase, an enzyme found exclusively in hyperthermophilic bacteria and archaea, which 
combines a topo IA domain with a nucleotide-binding helicase-like domain and catalyzes 
positive supercoiling coupled to ATP-hydrolysis [15, 16]. 
In contrast to type I topoisomerases, the type II topoisomerases are oligomeric protein 
complexes of A2 or A2B2 arrangements normally, and exhibit a two-fold structural symmetry. 
This property enables this class of enzymes to introduce double-strand breaks, forming a 
covalent intermediate between the two DNA phosphate backbones and the active-site 
tyrosines. Through the gap a second DNA duplex is transported, a process which, in case of a 
relaxation reaction, removes two supercoils at a time [17]. Strand passage has been shown to 
require ATP hydrolysis and the presence of Mg2+ cations [18]. Type II topoisomerases are 
divided in two very different sub-families: Type IIA enzymes were found in different variants 
in all three kingdoms of life as well as in viruses and bacteriophages, while type IIB proteins 
have been mainly identified in archaea as well as in plants, some bacteria and algae [19-22]. 
Type IIA topoisomerases are specialized in relaxation of supercoiled DNA (eukaryotic 
topoisomerases II and bacterial topoisomerase IV), decatenation of daughter chromosomes in 
bacteria prior to cell division (bacterial topoisomerase IV), and introduction of negative 
supercoiles into bacterial circular chromosomes (bacterial gyrase), while type IIB 
(topoisomerase VI) enzymes are involved in the removal of supercoils, cantenanes, and DNA 
knots. Structure and function of both the type II topoisomerase subfamilies will be introduced 
in the following paragraphs. 
To manage the topological state of the DNA every organism expresses at least one type I and 
type II topoisomerase each [23]. The thermophilic archaeum S. shibatae for example 
expresses reverse gyrase and topoisomerase VI: The first is required for maintaining the 
characteristic positively supercoiled state of the genomic DNA, while the second relaxes 
negative supercoiles occurring in transcription and decatenates daughter chromosomes prior 
to cell division [24, 25]. E. coli employs four topoisomerases: gyrase and topoisomerase IV 
are resolve supercoils resulting from replication and transcription; the negatively supercoiled 
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state of the genome is regulated in competition between gyrase and topoisomerases IV, I and 
III [23]. 
 
 
 
 
 
Fig. 1.1: Structural organization of gyrase.  
A: Dimer of an E. coli GyrB fragment, encompassing the GHKL and transducer domains, indicated in 
yellow and orange. These two domains form the ATPase-gate, which is closed in this structure due to 
ADPNP (blue) bound to the nucleotide-binding pockets (PDB-entry: 1EI1 [37]).  
B: High-resolution structure of an E. coli GyrBA fusion construct, encompassing the TOPRIM-
domain of GyrB (dark blue) and the GyrA core domain consisting of winged-helix (WHD), tower and 
coiled-coil domains (light blue, dark green and light green, respectively). A domain specific for gram-
negative bacteria (an insert to the TOPRIM fold of 170 amino-acids length) is present in the published 
structure, but was omitted here for clarity (PDB-entry: 3NUH [28]). The DNA-gate is formed by the 
WHD and the TOPRIM fold which contain the active site tyrosines and a Mg2+-binding motif assisting 
in DNA binding, respectively. The C-gate (also termed Exit-gate) is formed by a highly conserved 
region of the coiled-coil structure.  
C: Structure of the GyrA C-terminal domain from X. campestris, the only strucuture showing the 
highly conserved GyrA-box motif (stick representation, blue) (PDB-entry: 3L6V [38]). The domain 
consists of 6 blade-like β-sheets (numbered 1 – 6) assembled in a slightly spiral ring; extended loops at 
the periphery of the domain connect two neighboring blades. The N-terminus of the CTD shown in red 
is the anker for a linker peptide connecting the GyrA tower domain with the CTD.  
D: The CTD as shown in C, but in electrostatic surface representation. Positively and negatively 
charged regions are shown in blue and red, respectively. The rim of the CTD is highly negatively 
charged and supposed to mediate DNA wrapping. 
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1.2 The catalytic core of gyrase is homologous to conventional type IIA 
proteins 
Bacterial gyrase is the only known enzyme catalyzing the negative supercoiling of circular 
DNA. It is responsible to balance the topological state of the DNA of its host in an 
underwound state, rendering the genetic material more compact [18]. Introduction of neg. 
supercoils is the main activity of gyrase and depends on ATP-hydrolysis, while it can also 
relax supercoils in a nucleotide-independent manner [26]. Despite this very unusual activity 
profile – all other type IIA topoisomerases catalyze the relaxation and decatenation of DNA – 
gyrase shares structural and mechanistic similarities with the core domains of the other type 
IIA topoisomerases (with the exception of a 170 amino-acid insert in GyrB of some gram-
negative bacteria involved in DNA binding [27, 28]). 
Eukaryotic topoisomerase II consists of a homo-dimer, while all bacterial type IIA 
topoisomerases (topoisomerase IV, gyrase) form a hetero-tetrameric complex (ParE2ParC2, 
GyrB2GyrA2, respectively). The catalytic core forms three dimerization interfaces 
encompassing two cavities. The main subunit interactions are found at the so-called DNA- 
and C-(or Exit-)gates (Fig. 1.1B), while the latter seems to mediate a stronger interaction [29]. 
The DNA-gate is responsible for binding and cleaving the scissile DNA double-strand 
(termed gate DNA segment or G-segment) and consists of the winged helix (WHD) and the 
TOPRIM domains, which harbor the catalytic tyrosine residue and an essential Mg2+-binding 
motif involved in DNA cleavage/religation, respectively [30, 31]. DNA cleavage results in 
phosphotyrosyl bonds to the 5’-ends of the DNA, creating 4bp-overhangs [6]. In bacterial 
topoisomerase IV and gyrase, the WHD and the TOPRIM domain are located on separate 
subunits. Binding and cleavage of a DNA substrate at the DNA-gate induces strand distortion, 
as shown by crystal structures and in single molecule experiments [31-34]. The DNA binding 
site of the DNA-gate extends to the tower domains located at the sides of the DNA-gate (Fig. 
1.1A). 
The N-terminal part of topoisomerase II and the topoisomerase IV and gyrase subunits ParE 
and GyrB, respectively, consist of a GHKL domain, an ATP-binding and hydrolysis fold 
found in all type II enzymes, and the transducer domain [30, 35]. The name GHKL originates 
from the presence of the domain in gyrase, the molecular chaperone Hsp90, in CheA-type 
histidine kinases, and in the DNA-mismatch repair enzyme MutL. The transducer domain is 
thought to structurally couple ATP hydrolysis to strand passage, involving an invariant lysine 
residue acting as a sensor and for the γ-phosphate of a bound ATP [30]. The ATPase domains 
dimerize upon nucleotide binding, forming an extensive subunit interface comprising an N-
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terminal extension (strap), which interacts with the neighboring subunit and the bound 
nucleotide (Fig. 1.1A). This dimerization interface is also known as ATPase- or N-gate [36].  
The catalytic cycle of the strand passage was proposed to function according to a 2- or 3-gate 
mechanism (depending on counting the dimerization interface of the ATPase domains as a 
gate or not), in which subsequent opening and closing of dimerization interfaces guide a DNA 
double-strand through the gap of a cleaved double helix, initiated by binding of one DNA 
segment (known as gate-DNA or G-DNA segment) to the DNA-gate and formation of the 
complex of the WHDs and TOPRIM domains [39]. A second DNA duplex, known as the 
transfer- or T-DNA segment, inserts into the cavity between DNA- and ATPase-gate; the 
latter dimerizes upon nucleotide binding, resulting in physical strain on the DNA-gate due to 
the restricted space in the cavity, probably inducing cleavage of the G-DNA and opening of 
the DNA-gate, thereby forcing the T-DNA to pass through the second cavity and the C-gate 
[40, 41]. Dynamics of the ATPase-gate of gyrase as well of the DNA-gate of topoisomerase II 
have been observed, while DNA-gate opening could not be detected in the case of gyrase [33, 
42, 43]. On the basis of crystal structures DNA-gate opening is proposed to involve major 
structural rearrangement of the DNA-binding domains [29, 32]. Cross-linking of the C-gate 
was shown to abolish strand passage in gyrase, indicating a transient opening during strand 
passage [44]. A slightly open conformation has been observed in a crystal structure of a 
topoisomerase II fragment bound to DNA [32]. 
The role of ATP hydrolysis has not been fully elucidated. Hydrolysis of the first ATP 
molecule is suggested to induce strand passage, while hydrolysis of the second nucleotide and 
product release would reset the enzyme for another strand passage cycle [45-47]. Somewhat 
contradictory has been the finding that binding of the non-hydrolysable ATP-analog ADPNP 
supports one supercoiling cycle in gyrase, resulting in a stalled enzyme with closed a ATPase-
gate [48]. 
 
 
1.3 The GyrA CTD is indispensable for the supercoiling activity of gyrase 
While the catalytic core of type IIA topoisomerases is structurally and functionally fairly 
invariant, a carboxy-terminal domain in topoisomerase II, ParC and GyrA exhibits differences 
in amino-acid sequences and the three-dimensional structure, which apparantly account for 
the specialized activities. In GyrA, the CTD adopts a β-pinwheel fold with 6 blades exhibiting 
a cylindrical or spiral shape [49, 50] (Fig. 1.1C). The ParC CTDs also consists of blades of β-
structure, but the number of blades is less conserved between different organisms [51]. The 
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CTD of eukaryotic topoisomerase II seems to be unstructured [52], indicating that the CTDs 
from bacterial organisms play a distinct role in the regulation of the enzymatic activity of the 
core. 
Indeed, deletion of the CTD in gyrase abolishes the ATP-dependent supercoiling activity. 
Instead the truncated enzyme behaves similar to a topoisomerase II, relaxing supercoiled 
DNA and decatenating interlocked circular DNA in an ATP-dependent manner [53]. The 
CTD has been known for a long time to bind DNA. It was shown to bend a linear DNA in an 
angle of 180°, thus wrapping the substrate around itself [49]. The DNA is supposed to bind 
around the outer rim of the CTD, judged by the highly positive charge on loops located at the 
periphery of the domain, connecting blades 1, 4, 5, and 6 [49, 50] (Fig. 1.1D). Probably due to 
the spiral arrangment of the DNA-binding site, the isolated CTD stabilizes positive 
supercoiled DNA (an exception being the CTD of GyrA from B. burgdorferi, which adopts a 
cylindrical shape). All these data suggest that the GyrA CTD binds the DNA segment 
extending from the DNA-gate, wraps it around itself and delivers the double-strand back to 
the enzymatic core where it is supposed to function as the T-DNA segment. This hypothesis is 
supported by eletron microscopy and single-molecule FRET data [42, 54]. A highly 
conserved hepta-peptide located on the loop connecting blades 1 and 6, termed the GyrA-box, 
is indispensable for the supercoiling activity of gyrase and is absent in ParC CTDs (Fig. 
1.1C). Deletion or substitution of the consensus amino-acid sequence QRRGGKG (E. coli) 
almost abolishes the supercoiling activity, but does not influence the nucleotide-independent 
DNA relaxation activity [55]. The molecular mechanism for this finding is unclear, but the 
inability of GyrA-box mutants to induce positive supercoiles into DNA suggests that 
wrapping and delivery of the T-segment is impeded. Sequence alignments indicate the 
presence of GyrA-box like motifs in every blade, suggesting a role in DNA binding. 
Mutations of a single arginine in blade 5 abolishes DNA binding, supercoiling, and relaxation, 
indicating a role of the CTD in both the supercoiling and the relaxation reactions of gyrase 
[56]. 
While the importance of the CTDs in the supercoiling reaction has been elucidated, the 
arrangement of the domains with respect to the enzymatic core is not known, as a high-
resolution structure of the full-length gyrase complex is lacking. A SAXS study determined 
the position of the CTDs in the non-complexed GyrA ab initio, placing them close to the C-
gate. The domain is thought to complex the DNA bound to the DNA gate, suggesting a 
conformational change of the CTDs with respect to the catalytic core during the catalytic 
cycle [57]. Surprisingly, a recent SAXS model of gyrase in presence of a 140bp DNA placed 
the CTDs even further away from the DNA-gate, almost on the opposite side of the C-gate, 
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not supporting a CTD position close to the catalytic center [58]. DNA footprinting 
experiments with gyrase and an electron microscopy study of DNA bound to gyrase suggest a 
loss of DNA wrapping upon binding of ADPNP, indicating a movement of the CTDs during 
strand transfer [48, 54]. Taken together, available information about the location and potential 
dynamics of the CTD is scarce and somewhat contradictory. 
 
1.4 Gate dynamics in topoisomerase VI 
The only family member of the type IIB topoisomerases, the topoisomerase VI [19],  is in 
many ways similar to the type IIA superfamily. It cleaves a double stranded DNA by active 
site tyrosines, forming 5’-phosphotyrosyl bridges and 2-bp overhangs [59]. In a reaction 
dependent on ATP and Mg2+, the enzyme catalyzes the passage of a second duplex through 
the gap, exhibiting activities similar to the eukaryotic topoisomerase II or bacterial 
topoisomerase IV, namely the relaxation of negative or positive supercoiles and decatenation 
of circular DNAs [25, 58, 60].  
Topoisomerase VI consists of a two-fold symmetric, heterotetrameric A2B2 complex [61] 
(Fig. 1.2A, B). Namely the B subunit is very similar to the one found in type IIA 
topoisomerase (e.g. GyrB and ParE): It consists of a GHKL fold, responsible for ATP binding 
and hydrolysis; a transducer domain that links the ATPase domain and the part of the enzyme 
which is involved in DNA binding, cleavage and religation; and a small helix-2-turn-helix 
domain (H2TH) which is inserted between the two classical domains, probably involved in 
stabilization of the ATPase-domain interface [62] (Fig. 1.2A – C). The H2TH domain is not 
present in type IIA topoisomerases. The TopoVI-A subunit dimer forms the DNA-gate, 
indicated by its ability to bind a DNA double-strand [63]. The TopoVI-A subunits consist of 
two domains, sharing similarities with the domains forming the DNA-gate in type IIA 
topoisomerases: A WHD and a TOPRIM domain, harboring the catalytic tyrosine residue and 
an acidic cluster binding Mg2+, which assists in DNA binding. A and B subunits interact via a 
four-helix bundle, forming a hydrophobic interface [61]. In some archaea (e.g. M. mazei), the 
TopoVI-B subunit exhibits a small C-terminal domain of unknown function. Structural 
similarity with the immunoglobulin fold suggests a protein-protein interaction site. 
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Fig. 1.2: Structural organization of topoisomerase VI and different conformations of the ATPase 
domain. 
A: X-ray structure of the hetero-tetrameric topoisomerase VI holoenzyme from M. mazei (PDB-entry: 
2Q2E [61]). It consists of 2 TopoVI-A and 2 TopoVI-B subunits, forming the DNA- and the ATPase-
gate, respectively. The A subunits encompass the winged-helix domains (WHD, light blue) and the 
TOPRIM-domains (dark blue), containing the active site tyrosines and a Mg2+-binding motif. The B 
subunits consist of the ATP-binding fold (GHKL), the Helix-2-Turns-Helix and the transducer domain 
(in yellow, dark red and orange, respectively); the ATPase-gate adopts a half-closed conformation in 
this structure. The latter links the ATPase- and the DNA-gates, forming a 4-helix bundle with the 
WHD. A small C-terminal domain (CTD, green) is present in M. mazei TopoVI-B.  
B: X-ray structure of the hetero-tetrameric topoisomerase VI holoenzyme from S. shibatae (PDB-
entry: 2ZBK [64]). The domain organization corresponds to the one in topoisomerase VI from M. 
mazei as depicted in A; the same color code is used in A and B. In contrast to A, the ATPase-gate 
adopts a wide-open conformation, indicating significant conformational flexibility of the ATPase-
domains. 
C: Alignment of TopoVI-B domains from S. shibatae, in the apo form (yellow) and bound to ADPNP 
(grey) (PDB-entries: 1MU5 and 1MX0, respectively [62]. The TopoVI-B domains are aligned by the 
GHKL domain, showing conformational differences in the transducer domains. Binding of ADPNP 
(blue) induces the rotation of the conserved lysine-427 from an outward  orientation (red; apo) to 
complex the nucleotide (black; ADPNP-bound form), resulting in the rotation of the transducer 
domain relative to the ATPase-domain. 
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Two crystal structures of the full-length enzyme from S. shibatae and M. mazei show a two-
gate complex with a wide-open and a half closed ATPase-gate, respectively, indicating 
conformational dynamics of the ATPase-domains [61, 64] (Fig. 1.2A, B). Several high-
resolution structures of the isolated ATPase- and transducer domains in absence and presence 
of different nucleotides suggest dimerization of the domains upon ADPNP binding [62] (Fig. 
1.2C). Very similar to type IIA topoisomerases, an invariant lysine residue, located on a loop 
in the transducer domains, acts as a phosphate sensor and mediates rotation of the transducer 
relative to the ATPase-domain. Upon binding of ATP to TopoVI-B, the lysine residue rotates 
towards the nucleotide binding site, inducing the conformational change of the transducer 
domains, and switches back in an outward conformation hydrolysis [65] (Fig. 1.2C). 
Eventually, as shown by SAXS studies, dimerization of the ATPase-domains and signal 
transduction by the transducer domain seems to alter the conformation of the DNA-gate [61]. 
Together, this information suggests that DNA relaxation is mediated by a two-gate 
mechanism: One DNA duplex binds to the DNA-gate, and a second one (the T-DNA 
segment), is accommodated in the central cavity; this arrangement should be the case in strand 
crossings in supercoiled or catenated DNA. ATP-binding induces dimerization of the ATPase 
domains, and rotation of the transducer might induce physical strain on the enzyme-DNA 
complex, forcing the G-DNA segment to be cleaved, the DNA-gate to open and the T-
segment to be released. Due to the structural similarities of the ATPase-domains in type IIA 
and IIB topoisomerases, the role of ATP hydrolysis has been suggested to be the same; the 
first ATP is supposed to drive strand passage, while hydrolysis of the second could reset the 
enzyme [65].  
 
1.5 Aim of this work 
The goal of this work was to characterize potential conformational changes in the C-terminal 
domain of B. subtilis GyrA and in the dimerization interfaces of M. mazei topoisomerase VI. 
The conformational change should be monitored using single-molecule fluorescence 
resonance energy transfer (FRET), requiring the coupling of fluorescent dyes to appropriate 
locations on the surface of the proteins. This can be achieved for example by labeling solvent-
exposed cysteine residues introduced by site-specific mutagenesis, using dyes with a 
maleimide linker. In DNA supercoiling and relaxation assays, the enzymatic activities after 
the modification procedures needs to be quantified in order to validate the link between 
smFRET data and the enzymatic activities. 
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The first project addressed the potential conformational change in the GyrA CTD. For the 
lack of a full-length structure of the gyrase complex, the GyrA CTDs should be localized 
relative to the enzymatic core, using combinations of dye pairs coupled to multiple sites on 
the GyrA subunit. It has been shown that inter-dye distances can be extracted from smFRET 
data and used to triangulate reference points [66], as planned for the localization of the GyrA 
CTD. To quantify a potential conformational change of the CTDs upon formation of the 
GyrA2B2-DNA complex, the localization procedure should be applied to the situation of the 
ligand-free GyrA and the gyrase-DNA complex.  
A further goal was to link conformational changes of the CTDs to the presence of the 
individual binding partners of GyrA. SmFRET experiments and complementary binding 
studies can provide evidence on the influence of complex formation with DNA and GyrB on 
the position of the CTDs. The conformational change should be linked to the supercoiling 
cycle by characterizing the influence of DNA substrates of different topology and length and 
by the introduction of functional mutations to the enzymatic core. In order to establish the 
relation of conformational changes to individual steps in the supercoiling cycle, we aimed on 
characterizing the influence of functional mutations (e.g. cleavage-deficiency) on the 
conformational behavior of the CTD. Ultimately, the mechanistics of strand passage and its 
manifestation in a potential switch of the CTD conformation should be addressed in smFRET 
experiments in the presence of nucleotide. 
A second project aimed on characterizing gate dynamics in topoisomerase VI. To observe 
conformational change in the DNA-gate, a fluorescently labeled DNA should be devised as a 
FRET probe. The binding and cleavage properties of the substrate DNA to topoisomerase VI 
can be addressed in anisotropy titrations and DNA cleavage assays, while the a potential 
distortion of the DNA upon complex formation, cleavage and opening of the DNA-gate might 
be monitored in smFRET experiments. To achieve site-specific fluorescent labeling of the 
protein, native cysteines need to be removed and topoisomerase VI mutants tested for 
remaining DNA relaxation and ATPase hydrolysis activity. Coupling of fluorescent dyes to 
the cysteine residues introduced at the ATPase-gate should yield a system appropriate for 
smFRET studies. To complement structural data, the gate dynamics might be determined in 
the presence of DNA ligands and nucleotides. 
 
SmFRET studies of the conformational dynamics in GyrA CTD and of the gates in 
topoisomerase VI should give valuable insight to the enzymatic behavior of the proteins, 
linking structural changes to complex formation and the supercoiling and relaxation activities 
observed for gyrase and topoisomerase VI, respectively. 
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2. Materials and Methods 
2.1 Chemicals 
Applichem (Darmstadt, D) glycerol, anhydrous, p.A. 
Carl Roth (Karlsruhe, D) chloramphenicol, ≥ 98 %; kanamycin sulfate, ≥ 750 I.E. / mg; 
peptone; yeast extract, pouder 
Fermentas (St. Leon-Rot, D) PageRuler Plus protein ladder 
Fluka (Buchs, CH) activated charcoal, purum; ciprofloxacine, ≥ 98 % (HPLC); L-glutamic 
acid monopotassium salt monohydrate, p.A.; methanol, p.A.; oxolinic acid, ≥ 97 % 
GERBU Biochemicals (Gaiberg, D) ampicillin sodium salt 
Invitrogen (Eugene, USA) Alexa Fluor 488 C5-maleimide; Alexa Fluor 546 C5-maleimide; 
TMR C5-maleimide 
Merck (Darmstadt, D) Calf thymus DNA, sodium salt (Calbiochem); ethanol, absolute; 2-
propanol, p.A. 
New England BioLabs (Ipswich, USA) DNA ladder, 1 kb, 100 bp 
Pharma Waldhof (Düsseldorf, D) ATP disodium salt; ADP disodium salt 
Radiant Dyes Laser Acc. (Wermelskirchen, D) fluorescein (Uranin) 
Reuss-Chemie (Tägerig, CH) 2-propanol, tech. 
Roche Diagnostics (Mannheim, D) Complete EDTA-free Protease Inhibitor Cocktail Tablets; 
NADH disodium salt; PEP 
Sigma Aldrich (St. Louis, USA) ADPNP tetralithium salt hydrate, ~ 95 % (HPLC); Bis-Tris 
propane, ≥ 99.0 %; deoxynucleotide set (dATP, dCTP, dGTP, dTTP; as sodium salts); 
DMSO, ≥ 99.9 %; ethanol, purum; etoposide, ≥ 98 % 
 
Chemicals not listed above were purchased from Carl Roth (Karlsruhe, D), in either p.A. or 
puriss. quality. 
 
Stock solutions were prepared using ultrapure water purified with Barnstead Nanopure 
Diamond Lab Water System (by Thermo Fisher Scientific, Rockford, USA) and sterilized 
using membrane filters (Durapore 0.22 µm Millipore, Billerica, USA). 
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2.2 Enzymes 
GoTaq DNA Polymerase (Promega, Madison, Wisconsin): 5 U/µl  
GyrB wt from B. subtilis (home purified as described [46]): approx. 200 µM . 
L-Lactate Dehydrogenase (LDH) (Roche Diagnostics GmbH, Mannheim, Germany):              
5 mg/ml, from rabbit muscle, suspension in 3.2 M ammonium sulfate solution 
Pfu DNA Polymerase (Promega, Madison, Wisconsin): 2 - 3 U/µl, 10 x Pfu DNA Polymerase 
reaction buffer 
Phusion High Fidelity DNA Polymerase (Fynnzymes Oy, Espoo, Finland):                                
2 U/µl, 5 x Phusion HF Buffer 
Proteinase K, recombinant, PCR Grade (Roche Diagnostics GmbH, Mannheim, Germany): 
lyophilized  
Pyruvate Kinase (Roche Diagnostics GmbH, Mannheim, Germany): 10 mg/ml, from rabbit 
muscle, suspension in 3.2 M ammonium sulfate solution 
Ristriction Endonucleases (New England BioLabs, Ipswich, Massachusetts): BamHI, DpnI, 
HindIII, XhoI: 20000 U/ml; NcoI: 10000 U/ml; 10 x NEB buffers 2; supplied with 100 
x BSA 
Shrimp Alkaline Phosphatase (SAP) (Promega, Madison, Wisconsin): 1 U/µl, 10 x SAP 
reaction buffer 
T4 DNA Ligase (New England BioLabs, Ipswich, Massachusetts): 400'000 cohesive end 
units/ml, 10 x T4 DNA Ligase reaction buffer  
T4 Polynucleotide kinase (PNK) (New England BioLabs, Ipswich, Massachusetts): 10000 
U/ml, 10 x T4 PNK reaction buffer 
Tobacco Edge Virus protease (TEV) (home purified after [67]): 30 µM  
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2.3 DNA oligonucleotides 
Primers for PCR, mutagenesis and sequencing reactions were order from Microsynth AG 
(Balgach, Switzerland) or Sigma-Aldrich Co. (St. Louis, Missouri). Non-modified and 
fluorescently labeled DNA substrates for B. subtilis gyrase or M. mazei topoisomerase VI 
were synthesized by Purimex (Grebenstein, Germany). 
2.3.1 PCR primers 
gyrA_Bs_DuetBamHI_for: CCA AGG ATC CGA TGA GTG AAC AAA ACA CAC CAC  
gyrA_Bs_DuetHindIII_rev: CCT TAA GCT TTC ACA CTT CTT CTT GTT CTT CTT C 
gyrA_Bs_XhoI_rev: GCG CTC GAG TCA CAC TTC TTC TTG TTC TTC TTC 
pUC18_110_for: GGG TTT TCC CAG TCA CGA CGT TG 
pUC18_110_rev: ACA TGA TTA CGA ATT CGA GCT CGG 
T7 promotor: TAA TAC GAC TCA CTA TAG GG 
2.3.2 Mutagenesis primers 
Mutagenesis primers for the substitution and deletion of the GyrA-box (AboxA, delAbox), the 
removal of an internal NcoI binding and cleavage site (NcoI_remove; silent mutation), and 
the introduction of a sequence coding for a TEV-protease cleavage site (NHis-TEV) (all for B. 
subtilis GyrA).  
 
gyrA_Bs_AboxA_5: GCA TCA ACT TAC CGC AGT GCA GCA GCG GCC GCA GCA GCT GTA 
CAA GGT ATG GG 
gyrA_Bs_AboxA_3: CCC ATA CCT TGT ACA GCT GCT GCG GCC GCT GCT GCA CTG CGG 
TAA GTT GAT GC 
gyrA_Bs_delAbox_5: CGT CTT CCT GCA TCA ACT TAC CGC AGT GTA CAA GGT ATG GGA 
ACA AAC G 
gyrA_Bs_delAbox_3: CGT TTG TTC CCA TAC CTT GTA CAC TGC GGT AAG TTG ATG CAG GAA 
GAC G 
gyrA_Bs_NcoI_remove_5: CGG TAT ATG AAT CTA TGG TCA GAA TGG 
gyrA_Bs_NcoI_remove_3: CCA TTC TGA CCA TAG ATT CAT ATA CCG 
gyrA_Bs_NHis_TEV_5: CCA CAG CCA GGA TCC GGA AAA CCT GTA CTT CCA AAG TGA ACA 
AAA CAC ACC 
gyrA_Bs_NHis_TEV_3: GGT GTG TTT TGT TCA CTT TGG AAG TAC AGG TTT TCC GGA TCC TGG 
CTG TGG 
 
The following mutagenesis primers were used for single amino acid substitution in GyrA 
(single letter amino acid code) as well as for screening purposes (analytical PCR reactions)  
 
gyrA_Bs_Y123F_5: GCG GCG GCC ATG CGT TTT ACA GAA GCA CGA ATG 
gyrA_Bs_Y123F_3: CAT TCG TGC TTC TGT AAA ACG CAT GGC CGC CGC 
gyrA_Bs_T140C_5: GGA GAT TCT TCG CGA CAT CTG CAA AGA CAC AAT CGA TTA CCA GG 
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gyrA_Bs_T140C_3: CCT GGT AAT CGA TTG TGT CTT TGC AGA TGT CGC GAA GAA TCT CC 
gyrA_Bs_E211C_5: CCA GAG CTT ATG TGT GTC ATT CCA GGG C 
gyrA_Bs_E211C_3: GCC CTG GAA TGA CAC ACA TAA GCT CTG G 
gyrA_Bs_E250C_5: GCA AAA GCT GAG ATC TGC CAA ACA TCT TCG 
gyrA_Bs_E250C_3: CGA AGA TGT TTG GCA GAT CTC AGC TTT TGC 
gyrA_Bs_N314C_5: CGA TGC CAA TGC GTG CGT TAT CTT AAA CAA TC 
gyrA_Bs_N314C_3: GATTGTTTAAGATAACGCACGCATTGGCATCG 
gyrA_Bs_C350L_5: CGA AAG TTT TAA CTC TTA AGC AAC TGC TGG AGC ATT ACC 
gyrA_Bs_C350L_3: GGT AAT AGCT CCA GCA GTT GCT TAA GAG TTA AAA CTT TCG 
gyrA_Bs_N399C_5: GCA GTT ATC TCC CTT ATC CGT TGT TCT CAA ACG GCT GAA ATT GCG 
gyrA_Bs_N399C_3: CGC AAT TTC AGC CGT TTG AGA ACG GAT AAG GGA GAT AAC TGC 
gyrA_Bs_T408C_5: CGG CTG AAA TTG CGA GAT GTG GTT TAA TTG AAC AAT TCT C 
gyrA_Bs_T408C_3: GAG AAT TGT TCA ATT AAA CCA CAT CTC GCA ATT TCA GCC G 
gyrA_Bs_S490stop_5: GAG ATC GTC ACT TAA GGA CTG GAG AC 
gyrA_Bs_S490stop_3: GTC TCC AGT CCT TAA GTG ACG ATC TC 
gyrA_Bs_K570C_5: GTG TAT CGT GCA TGC GGG TAT GAA ATC 
gyrA_Bs_K570C_3: GAT TTC ATA CCC GCA TGC ACG ATA CAC 
gyrA_Bs_D695C_5: CAC CCT GAC GTG TGA CGA CGT TG 
gyrA_Bs_D695C_3: CAA CGT CGT CAC ACG TCA GGG TG 
gyrA_Bs_E726C_5: CGA ACT CCT GCT TGT GAG TAC AGA ACC 
gyrA_Bs_E726C_3: GGT TCT GTA CTC ACA AGC AGG AGT TCG 
gyrA_Bs_K594C_5: GCT GGA GGT AGA ATG TGG TGA GTG GAT CAA CG 
gyrA_Bs_K594C_3: CGT TGA TCC ACT CAC CAC ATT CTA CCT CCA GC 
 
The following mutagenesis primers were used for single amino acid substitution in M. mazei 
topoisomerase VI A or B (single letter amino acid code) as well as for screening purposes 
(analytical PCR reactions).  
 
TopoVIA_Y106F_for: CGA GAA CTT TAT TTC ATT TCC GAA GGC 
TopoVIA_Y106F_rev: GCC TTC GGA AAT GAA ATA AAG TTC TCG 
TopoVIB_R87C_for: CCG GGA ATT GTA TGC GAG CAG ATC CCC 
TopoVIB_R87C_rev: GGG GAT CTG CTC GCA TAC AAT TCC CGG 
TopoVIB_D159C_for: GCA CAA ATG AAC CTT GCA TCC TTG TAG ACG AGG 
TopoVIB_D159C_rev: CCT CGT CTA CAA GGA TGC AAG GTT CAT TTG TGC 
TopoVIB_E164C_for: GAT ATC CTT GTA GAC TGC GTC AGG GAC TGG 
TopoVIB_E164C_rev: GTC CCT GAC GCA GTC TAC AAG GAT ATC AGG 
TopoVIB_C267S_for: GCG TTA CTC TTT TTC TAA AAT AGG GC 
TopoVIB_C267S_rev: GCC CTA TTT TAG AAA AAG AGT AAC GC 
TopoVIB_C278A_for: GGA GGA AAT CGC TAA AGC CGC AG 
TopoVIB_C278A_rev: CTG CGG CTT TAG CGA TTT CCT CC 
TopoVIB_C316A_for: GAC GGA CGC GCT TTC TCC TAT CGG 
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TopoVIB_C316G_for: CGA CGG ACG GTC TTT CTC C 
TopoVIB_C316S_for: CGA CGG ACT CTC TTT CTC C 
TopoVIB_C316A_rev: GGA GAA AGC GCG TCC GTC GGA G 
TopoVIB_C316G_rev: GGA GAA AGA CCG TCC GTC G 
TopoVIB_C316S_rev: GGA GAA AGA GAG TCC GTC G 
TopoVIB_P408C_for: GGC TTA AAC CAG TGC GGA GGG GGA ATT C 
TopoVIB_P408C_rev: GAA TTC CCC CTC CGC ACT GGT TTA AGC C 
TopoVIB_C550A_for: CGA AAT GCT CCC CGC TAA AGT TAG CGG 
TopoVIB_C550A_rev: CCG CTA ACT TTA GCG GGG AGC ATT TCG 
 
2.3.3 DNA substrate for B. subtilis gyrase or M. mazei topoisomerase VI 
Positions indicated by X stand for fluorescently labeled thymine nucleotides. The dye is 
covalently attached to an amino linker on C6 of the base. 
 
Gyr_37bp_1bs_for: GTG CCA AGC TAT GCA TGA TCA TAC GTC GAC TCT AGA G 
Gyr_37bp_1bs_rev: CTC TAG AGT CGA CGT ATG ATC ATG CAT AGC TTG GCA C 
Gyr_37bp_1bs_rev_A546: CTC TAG AGT CGA CGT ATG ATC ATG CAX AGC TTG GCA C                      
(X = T labeled with Alexa546) 
Gyr_48bp_1bs_for: CTC GCA GTG CCA AGC TAT GCA TGA TCA TAC GTC GAC TCT AGA 
GTC TCG 
Gyr_48bp_1bs_rev: CGA GAC TCT AGA GTC GAC GTA TGA TCA TGC ATA GCT TGG CAC 
TGC GAG 
Gyr_48bp_1bs_rev_A546: CGA GAC TCT AGA GTC GAC GTA TGA TCA TGC AXA GCT TGG CAC 
TGC GAG (X = T labeled with A546) 
Gyr_60bp_1bs_for: GTC TCG CAG TGC CAA GCT ATG CAT GAT CAT ACG TCG ACT CTA 
GAG TCT CGC AGT GTA CCG 
Gyr_60bp_1bs_rev: CGG TAC ACT GCG AGA CTC TAG AGT CGA CGT ATG ATC ATG CAT 
AGC TTG GCA CTG CGA GAC 
Gyr_60bp_1bs_rev_A546: CGG TAC ACT GCG AGA CTC TAG AGT CGA CGT ATG ATC ATG CAX 
AGC TTG GCA CTG CGA GAC (X = T labeled with Alexa546) 
Gyr_90bp_2bs_for: AGT CAC GAC GTT GTA AAA CGA CGG CCA GTG CCA AGC TAT GCA 
TGA TCA TAC GTC GAC TCT AGA GGA TCC CCG GGT ACC GAG CTC 
GAA TTC 
Gyr_90bp_2bs_rev: GAA TTC GAG CTC GGT ACC CGG GGA TCC TCT AGA GTC GAC GTA 
TGA TCA TGC ATA GCT TGG CAC TGG CCG TCG TTT TAC AAC GTC GTG 
ACT 
TopoVI_51_f: TCA ATA ATA TTG AAA AAG GAA GAG TAT GAG TAT TCA ACA TTT 
CCG TGT CGC 
TopoVI_51_f_fl: XCA ATA ATA TTG AAA AAG GAA GAG TAT GAG TAT TCA ACA TTT 
CCG TGT CGC (X = T labeled with fluorescein) 
TopoVI_50_f_546: CAA TAA TAT TGA AAA AGG AAG AGT ATG AGT ATX CAA CAT TTC 
CGT GTC GC (X = T labeled with A546) 
TopoVI_51_r: GCG ACA CGG AAA TGT TGA ATA CTC ATA CTC TTC CTT TTT CAA TAT 
TAT TGA 
TopoVI_50_r_488: GCG ACA CGG AAA TGT TGA ATA CTC ATA CTC TXC CTT TTT CAA TAT 
TAT TG (X = T labeled with Alexa488) 
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2.3.4 Sequencing primers  
gyrA_Bs_mid1: CCA GGA TAA CTA TGA CGG G 
gyrA_Bs_mid2: CGA TGC CAA TGC GAA TGT TAT C 
pETDuet_DuetDOWN1: GAT TAT GCG GCC GTG TAC AAT AC 
pETDuet_DuetUP1: ATG CGT CCG GCG TAG A  
T7 promotor: TAA TAC GAC TCA CTA TAG GG 
T7 terminator: TGC TAG TTA TTG CTC AGC GG 
TopoVI_mid1: CCC TTG GTC TTA CAG GAT CTA TGC 
TopoVI_mid2: CCG TAC TGC TTC CAC TTA ATG TCC 
 
 
2.4 Consumables 
BD (Franklin Lakes, USA) 50 ml conical tubes, PP; Microlance-3 needles, 0.90 x 40 mm 
Bio-Rad Laboratories (Hercules, USA) Econo-Pac Columns, Micro Bio-Spin 30 columns, 
RNase-free 
Brand (Wertheim, D) UV-cuvettes PLASTIBRAND micro, z = 8.5 mm, 2 x 3.5 mm 
CODAN Medical (Rødby, DK) ONCE inject syringes, 2, 10, 20 ml 
GE Healthcare (Chalfont, St. Giles, UK) illustra Microspin G-25 column 
Eppendorf (Hamburg, D) Safe-lock tubes amber, 1.5 ml; Safe-lock tubes 2.0 ml 
G. Kisker (Steinfurt, D) Quali-‚Low Retention’ tubes, 1.7 ml 
Promega (Madison, USA) PureYield Plasmid Midiprep System; Wizard SV Gel and PCR 
Clean-Up system 
Qiagen (Hilden, D) QIAGEN Plasmid Midi Kit; QIAprep Spin Miniprep Kit; QIAquick 
Nucleotide Removal Kit; QIAquick PCR purification kit 
Sarstedt (Nürnbrecht, D) 15 ml conical tubes, PP; cuvettes 10 x 4 x 45 mm; Filtropur S 0.20 
µm; Micro Tube 1.5 ml, PP; Multiply-Pro cup, 0.2 ml, PP 
Sartorius Stedim Biotech (Aubagne, F) Midisart 2000 filter; Vivaspin 20 concentrator 
10,000 MWCO PES; Vivaspin 6 concentrator 10,000 MWCO PES 
Spectrum Laboratories (Rancho Dominguez, USA) Spectra/Por dialysis membranes,           
12 – 14,000 MWCO 
Starlab (Ahrensburg, D) TipOne Tips 10, 200, 1000 µl 
Thermo Fisher Scientific (Rockford, USA) Lab-Tek chamber slides, 8 chambers, glass slide 
Treff AG (Degersheim, CH) Microtubes ClickFit, 1.5 ml 
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2.5 Instrumentation 
Centrifugation Beckmann Coulter Allegra 21R Centrifuge, rotor S4180 (Brea, USA); 
Heraeus Biofuge pico, rotor 33258; Sorvall RC 5C plus, rotors SS34 and SLA3000 
(Kendro Laboratory Products, Langenselbold, D); Eppendorf centrifuge 5402, rotor F-
45-18-11 (Hamburg, D) 
Electrophoresis Home-built agarose gel caster and gel-electrophoresis unit; Hoefer multiple 
gel caster; gel electrophoresis unit Mighty Small II (8 x 7 cm); power supply EPS 300, 
301, 1001 (Amersham Biosciences Europe, Freiburg, D); gel documentation system 
EDAS 290 (Kodak, Stuttgart, D); transilluminator FT-20/254/365 (Herolab, Wiesloch, 
D) 
Thermocycler GeneAmp PCR System 9600 (Perkin Elmer Inc., MA, USA); Mastercycler 
gradient (Eppendorf, Hamburg, D); Techne TC-3000 Thermal Cycler (Bibby Scientific 
Limited, Staffordshire, UK) 
Incubator Minitron (Infors, Bottmingen, CH) 
Microfluidizer M-110L (Microfluidics, Newton, USA) 
Preparative HPLC ÄKTAprime plus (GE Healthcare, Chalfont, St. Giles, UK); HiLoadTM 
16/60 Superdex 200 pg SEC column; resins: chelating sepharose, SP sepharose, Q 
sepharose, Heparin sepharose (all Fast Flow); LC column XK 16; Superloop 50 ml (all 
Amersham Biosciences, Freiburg, D) 
Absorption measurements Ultrospec 2100 pro (Amersham Biosciences Europe, Freiburg, 
D); precision cuvettes from Quartz SUPRASIL for absorption measurements, no. 
105.202, path 10 mm (Hellma, Müllheim, D); UV/Vis Biophotometer (Eppendorf, 
Hamburg, D) 
Fluorescence measurements FluoroMax-3 (HORIBA JOBIN YVON, Stanmore, UK); 
precision cuvettes from Quartz SUPRASIL for absorption measurements, no. 105.250, 
path 10 x 2 mm (Hellma, Müllheim, D) 
Thermostat ThermoStat plus (Eppendorf, Hamburg, D)  
Confocal fluorescence microscope for single-molecule FRET experiments 
Fluorescence from freely diffusing single molecules was detected on a home-built confocal 
microscope. The excitation light was generated by a modelocked solid-state Ti:sapphire laser 
(Tsunami, Specta-Physics, Mountain View, USA), which was pumped by a countinuous-wave 
Nd:VO4 diode laser (Millenia pro, Spectra-Physics), emitting light of 951 nm pulsed at an 
interval of 40 ns and a pulse-width of 2.5 ps. The beam was frequency-doubled (to 475 nm; 
Model GWU, Spectra-Physics), directed into an inverted microscope (IX71, Olympus, Tokyo, 
J) and focused into the sample volume by a water-immersion objective with a high numerical 
 22 
aperture (NA = 1.2; UPlanApo, Olympus). Fluorescence from single molecules was collected 
by the same objective and directed to the detection part by a dichroic beam splitter (DM505, 
Olympus). Detection of light emitted exclusively from molecules in the excitation volume 
was achieved by focusing the photons on a 100 µm pinhole. Donor and acceptor fluorescence 
was split by a second dichroic mirror and separately detected by avalanche photo diodes 
(APD). The signal transmitted to a single photon counting card (SPC-630, Becker & Hickl, 
Berlin, D) and processed in silico. 
 
2.6 DNA plasmids 
pET-27b(+)_gyrA: Ahead of this work wild-type B. subtilis gyrA has been ligated into pET-
27b(+) vector (Novagen by Merck, Darmstadt, Germany) using NdeI and XhoI 
restriction sites. The vector confers kanamycin resistance. 
 
pETDuet-1 (Novagen by Merck, Darmstadt, Germany) contains two multiple cloning sites 
(MCS) and encodes beta-lactamase (mediating ampicillin resistence). It was used for 
sub-cloning of B. subtilis gyrA from pET-27b(+). The gyrA ORF was fused in frame to 
a His6-tag sequence using BamHI and HindIII restriction sites. 
 
pACYCDuet-1 (Novagen by Merck, Darmstadt, Germany) contains the same MCS as 
pETDuet-1 but comes with a different origin of replication and confers kanamycin 
resistance. his6_gyrA was sub-cloned from pETDuet-1 using NcoI and XhoI restriction 
sites. The construct was co-transformed with pET-27b(+)_gyrA for co-production of 
two GyrA protein versions. 
 
pDEST_topoVIA_B was a gift by Prof. J. M. Berger (University of California, Berkeley, 
California). The ORFs of the topoisomerase VI subunits from M. mazei are cloned in a 
bi-cistronic operon with one T7 promotor sequence. topoVIB is positioned 5’ to 
topoVIA and fused to a N-terminal His6-tag cleavable by TEV protease. 
 
pUC18 (Fermentas by Thermo Fisher Scientific, Waltham, Massachusetts) is a small 
expression vector (2686 bp). It was used as a substrate in DNA supercoiling and 
relaxation assays. pUC18 confers ampicillin resistance. A modified pUC18 vector 
containing a preferred binding/cleavage site for gyrase is used as a template for the 
PCR based production of the gyr_110bp DNA substrate as described [42]. 
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2.7 Bacterial strains 
All strains used in this work were derived from E . coli B which is deficient for Lon protease.  
 
E. coli XL1-Blue (Stratagene, La Jolla, California): recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F ́ proAB lacIqZ∆M15 Tn10 (Tetr)] 
Xl1-Blue was used as host strain for routine cloning (transformation of ligation and 
mutagenesis products) and plasmid DNA propagation. Plasmid DNA extracted from E. coli is 
methylated on N6 positions of adenine bases in the palindromic nucleotide sequence GATC 
due to the presence of DNA adenine methyltransferase [68]. 
 
E. coli BL21(DE3) (Stratagene, La Jolla, California): F– dcm ompT hsdS(rB– m B–) gal λ(DE3) 
The strain was used for the expression of B. subtilis GyrA from pACYCDuet-1 vector alone 
or in combination with pET-27b(+) vector. 
 
E. coli BL21-CodonPlus(DE3)-RP (Stratagene, La Jolla, California): F– ompT hsdS(r B– m B–) 
dcm+ Tetr gal λ(DE3) endA Hte [argU proL; Camr] 
In this strain we expressed His6-tagged or non-tagged B. subtilis GyrA from pETDuet-1 or 
pET-27b(+) vectors. 
 
E. coli Rosetta(DE3) (Merck, Darmstadt, Germany): F– ompT hsdSB(rB– mB–) gal dcm (DE3) 
pRARE (argU, argW, argX, glyT, ileX, leuW, metT, proL, thrT, thrU, tyrU; Camr) 
Rosetta(DE3) was used as an expression host for the co-production of M. mazei TopoVIA and 
TopoVIB proteins. 
 
Culturing Media for E. coli 
Luria Broth (LB) (after [69], containing 10g/l tryptone, 5 g/l yeast extract, and 10 g/l NaCl 
was used to culture E. coli for plasmid DNA production or expression (inoculation culture). 
Single clone propagation was performed on LB agar plates (containing 19 g/l agar). 
Autoinducing medium (AIM) (after [70]) was used for large-scale recombinant expression in 
E. coli.  
Appropriate antibiotics (ampicillin: 100 µg/ml; kanamycin: 20 µg/ml; chloramphenicol: 10 
µg/ml) were added to media and agar plates to select for bacterial strains and vectors. 
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2.8 General Methods 
2.8.1 Transformation of E. coli cells 
50 – 100 µl of chemically competent E. coli cells suspended in 100 mM CaCl2 were mixed 
with 20 – 50 ng purified plasmid DNA or 10 µl ligation or mutagenesis product and incubated 
on ice for 5 min before being subjected to heat treatment (42°C, 90 s). The cells were cooled 
on ice for a 2 – 3 minutes, then mixed with 1 ml of LB medium and incubated at 37°C for 1 h. 
Cells were pelleted gently (Eppendorf table-top centrifuge, 3000 rpm, 2 min), resuspended in 
200 µl supernatant and plated on LB agar containing appropriate antibiotics for strain and 
plasmid selection. 
 
2.8.2 Agarose gel electrophoresis 
• 0.5 x TBE buffer: 5.5 g/l Tris, 2.75 g/l boric acid, 2 g/l EDTA sodium salt 
• 6 x loading buffer: 10 mM Tris/HCl pH 7.6, 60 mM EDTA, 60 % glycerol, 0.03 % (w/v) bromphenol blue, 
0.03 % (w/v) xylene cyanol 
• Staining solution: approx. 1 µg/ml ethidium bromide in MQ-H2O 
 
Agarose gel electrophoresis is a simple method to analyze and separate DNA fragments (PCR 
products, plasmid DNA, restriction fragments, etc.). 0.8 to 2.0 % (w/v) agarose were 
suspended in 0.5 x TBE buffer, boiled, volume adjusted and poured in a gel caster for 
solidification. DNA samples were mixed with 6 x loading buffer and applied to the gel. DNAs 
were separated in an electric field of 11 – 16 V/cm. After electrophoresis gels were incubated 
in staining solution for 15 – 30 min and visualized by a UV transilluminator. 
 
2.8.3 Discontinuous polyacrylamide gel electrophoresis (SDS-PAGE) 
• Stacking gel: 125 mM Tris/HCl pH 6.8 (25°C), 0.06 % (w/v) SDS, 4.5 % (v/v) acrylamide, 0.1 % (v/v) 
bisacrylamide, 0.1 % (w/v) APS, 0.1 % (v/v) TEMED 
• Separating gels: A: 375 mM Tris/HCl pH 8.8 (25°C), 0.1 % (w/v) SDS, 10 % (v/v) acrylamide, 0.26 (v/v) 
bisacrylamide, 0.086 % (w/v) APS, 0.057 % (v/v) TEMED 
B: 375 mM Tris/HCl pH 8.8 (25°C), 0.1 % (w/v) SDS, 15 % (v/v) acrylamide, 0.39 % (v/v) bisacrylamide, 
0.086 % (w/v) APS, 0.057 % (v/v) TEMED 
• Running buffer: 24 mM Tris, 200 mM glycine, 0.1 (w/v) SDS 
• 4 x loading buffer: 130 mM Tris/HCl pH 6.8 (25°C), 200 mM DTT, 20 % (v/v) glycerol, 4 (w/v) SDS, 
approx. 0.01 % (w/v) bromophenol blue 
• Staining solution: 50 % (v/v) methanol, 10 % (v/v) acetic acid, 0.1 % (w/v) Coomassie Brilliant Blue R-250 
• Destaining solution: 20 % (v/v) ethanol, 10 % (v/v) acetic acid 
 
Proteins were analyzed under denaturating conditions by SDS-PAGE introduced by Laemmli 
[71]. Protein samples (expression cultures, purified or chemically modified protein) were 
mixed with loading buffer, heated to 95°C for approx. 5 min, and applied to a gel consisting 
of 2 cm of stacking and 5 cm of separating gel approx. Electrophoresis was performed at an 
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electric current of 30 mA for 25 – 40 min using bromphenol blue as a tracking dye. 
Fluorescently labeled samples were made visible by UV illumination. Non-labeled protein 
was stained with Brilliant Blue by incubating the gel in staining and destaining solution for at 
least 15 and 30 min respectively; over-night incubation in Millipore water was performed for 
increased contrast. 
Non-labeled GyrA and GyrB proteins from B. subtilis were generally analyzed on gels 
containing 10% acrylamide (A) M. mazei topoisomerase VI and fluorescently labeled protein 
on 15% acrylamide (B) gels. 
 
 
2.8.4 Concentration determination 
The concentration of proteins, DNAs, nucleotides and fluorescent labels in solution were 
determined spectrophotometrically. Absorption spectra were recorded on Ultrospec 2100 pro 
photometer using quartz cuvettes and single wave-length absorption on an Eppendorf 
Biophotometer. According to the Beer-Lambert law (eq. 2.1) the absorption scales with the 
concentration of the absorbing species: 
 dcA !!= "" #  (2.1) 
  
Aλ denominates the absorption, ελ the molar extinction coefficient at a given wavelength, c the 
concentration of the solute, and d the path length (given by the cuvette: 1 cm). 
 
Extinction coefficients ε of proteins at 280 nm were calculated with Protparam [72]: 
B. subtilis GyrA wild-type and mutants: 42750 M-1cm-1 
B. subtilis GyrA Y123F: 41260 M-1cm-1 
B. subtilis GyrA ΔCTD: 25330 M-1cm-1 
B. subtilis GyrB wild-type: 52720 M-1cm-1 
M. mazei TopoVIA wild-type: 47330 M-1cm-1 
M. mazei TopoVIA Y106F: 45840 M-1cm-1 
M. mazei TopoVIB wild-type and mutants: 46300 M-1cm-1 
According to the only available crystal structure for M. mazei topoisomerase VI [61], no 
cysteine residue formed disulfide bonds: For the calculation of extinction coefficients the 
number of disulfide bonds (cystines) was assumed to be 0. 
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The concentration of co-expressed and co-purified TopoVIAB proteins was estimated by 
assuming equimolarity. As extinction coefficient for TopoVIAB the sum of the individual 
coefficients was used: 
M. mazei TopoVIA (wild-type) B (wild-type and mutants): 93630 M-1cm-1 
M. mazei TopoVIA (Y123F) B (wild-type): 92140 M-1cm-1 
 
Extinction coefficients for single-stranded DNAs were estimated with the nearest-neighbor 
model [73]: 
Gyr_90bp_for: 871700 M-1cm-1 
Gyr_90bp_rev: 851300 M-1cm-1 
Gyr_60bp_for: 569000 M-1cm-1 
Gyr_60bp_rev: 580000 M-1cm-1 
Gyr_48bp_for: 453800 M-1cm-1 
Gyr_48bp_rev: 467000 M-1cm-1 
Gyr_37bp_for: 360600 M-1cm-1 
Gyr_37bp_rev: 355500 M-1cm-1 
TopoVI_51bp_for: 520200 M-1cm-1 
TopoVI_51bp_rev: 492100 M-1cm-1 
The concentration of double stranded DNAs (Gyr_110bp, plasmid DNA) was estimated by: 
1 A260 = 50 ng/ml  
 
Extinction coefficients for nucleotides and analogs: 
ATP, ADPNP, ADP: ε260 = 15400 M-1cm-1 
NADH: ε340 = 6300 M-1cm-1 [74] 
 
Extinction coefficients of fluorescent dyes (provided by the manufacturer and in [75]): 
Alexa Fluor488 C5 maleimide (A488): ε493 = 72000 M-1cm-1 (ε280 = 72000 M-1cm-1) 
Alexa Fluor546 C5 maleimide (A546): ε554 = 93000 M-1cm-1 (ε280 = 10538 M-1cm-1, ε493 = 
7025 M-1cm-1) 
TMR maleimide (TMR): ε550 = 95000 M-1cm-1 (ε280 = 18531 M-1cm-1, ε493 = 11259 M-1cm-1) 
Uranine (fluorescein): ε490 = 93000 M-1cm-1  
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2.9 DNA manipulation methods 
2.9.1 Cloning: PCR amplification of linear DNA, restriction enzyme digestion and 
ligation into target vector DNA 
The polymerase chain reaction (PCR) [76] was used to preparatively amplify target gene open 
reading frames (ORF) on an Eppendorf Mastercycler gradient. A DNA primer pair 
complementary to the 3’ ends of sense and antisense strands of the gene was used for the 
amplification of a target gene contained in plasmid DNA serving as a template. PCR reactions 
generally contained 1 ng/µl template DNA, 0.5 µM forward and reverse primer each, 0.2 mM 
deoxynucleotide triphosphates (dATP, dGTP, dCTP, dTTP) each, 0.02 U/ µl Phusion 
Polymerase in 1x Phusion HF Buffer. The PCR was performed according to the 
manufacturers instructions, typically applying annealing temperatures between 58 and 70°C 
and elongation times of 20 – 30 s / kb. 
PCR products were purified with PCR clean-up kit (Sigma) and cut with appropriate 
restriction endonucleases in the appropriate buffers alongside with target cloning vectors. Cut 
vectors were dephosphorylated with Shrimp Alkaline Phosphatase (SAP) according to 
instructions by the manufacturer. Restriction fragments were purified with QIAquick 
nucleotide removal kit (Qiagen) and ligated over-night at 16°C using T4 ligase with the 
appropriate buffer and insert:vector ratios varying between 3:1 and 6:1; the concentration 
vector DNA was set to approx. 2.5 ng/µl. For transformation of the ligation product, 50 µl of 
E. coli XL1-Blue cells were mixed with 10 µl of ligation reaction and grown on agar plates 
containing antibiotics to select for the plasmid to yield single clone colonies. 
 
2.9.2 Site-directed mutagenesis 
Mutagenesis was performed according to the QuikChange site-directed mutagenesis protocol 
(Stratagene, La Jolla, USA) [77] and used for nucleotide base substitution, insertion or 
deletion on a given template (usually a vector containing an ORF of a gene of interest). The 
latter is amplified in a PCR reaction using a pair of complementary DNA primers containing 
the mutant nucleotide sequence. Mutagenesis reactions generally contained 1 ng/µl template 
DNA, 0.25 µM primers each, 0.2 mM deoxynucleotide triphosphates (dATP, dGTP, dCTP, 
dTTP) each, 0.02 U/ µl Phusion Polymerase in 1x µM Phusion HF Buffer. The reaction mix 
was split in 5 aliquots for parallel annealing temperature screening. The mutagenesis was 
performed like usual PCR reactions (section 2.9.1) 
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10 µl of reaction mix containing PCR product was cut with DpnI (1.8 U/µl, 37°C, 2 h) for 
template DNA degradation and transformed into E. coli XL1-Blue cells. Transformed cells 
were grown on agar plates containing antibiotics to select for the plasmid to yield single clone 
colonies. 
 
2.9.3 Analytical DNA amplification by PCR: Selection of correct DNA constructs 
• Buffer Y: 20 mM Tris/HCl (pH 8.6), 16 mM (NH4)2SO4, 0.01 % Tween20, 2 mM MgCl2 
 
E. coli XL1-Blue cells transformed with ligation or mutagenesis constructs were screened for 
correct insert orientation (ligation) and insertions (mutagenesis) by PCR-amplification of 200 
– 600 nucleotides encompassing the sequence of interest. Primers used were often not fully 
complementary to the template (mutagenesis primers), but annealing conditions were not 
stringent to compensate. 
PCR reactions contained 1 µM forward and reverse primers, 0.2 µM dNTPs each, 0.025 U/µl 
GoTaq polymerase, and 1x buffer Y. A minimal amount of cell material containing the test 
plasmid was added to 8.5 µl reaction mix. The PCR was performed using a standard 
annealing temperature of 52°C and elongation times of approx. 60 s / kb. 
Plasmid DNA of positive clones was propagated in E. coli, purified with Miniprep Kit 
(Qiagen), and sequenced (Microsynth AG, Balgach, CH). 
  
2.9.4 Cloning and mutagenesis of B. subtilis gyrA constructs 
pET-27b(+)_gyrA and mutants 
Ahead of this work the gyrA ORF had been amplified by PCR and cloned into pET-27b (+) 
vector using restriction endonuclease cleavage sites NdeI and XhoI, yielding a non-tagged 
GyrA when expressed [46]. Moreover, several cysteine mutants (all in combination with 
C350L: T140C, E211C, N399C, T408C, K594C, and E726C) as well as the active site mutant 
Y123F were constructed previously. Further single cysteine mutants were produced by quick-
change mutagenesis [77] using respective mutagenesis primers: E250C, N314C, K570C, 
D695C (all mutations in combination with C350L). Double cysteine mutants with one mutant 
residue in the GyrA body and one in the CTD were constructed from single cysteine mutants. 
Functional mutants were produced on the basis of the wild-type or C350L_T140C_K594C 
double cysteine mutant templates, using corresponding primers. GyrA-box mutants with 
residues deleted (ΔAbox) and exchanged to alanines (AboxA) were both constructed using 
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the wt template, while a cleavage-deficient Y123F and a ΔAbox were constructed on the basis 
of the double-cysteine mutant template. 
A C-terminal domain deletion mutant was constructed from the wild-type template by 
mutation of the S490 codon to a translation stop codon (TAA). 
 
pETDuet-1_His6_gyrA 
gyrA C350L was amplified by PCR from pET-27b(+)_gyrA with primers 
gyrA_Bs_DuetBamHI_for and gyrA_Bs_DuetHindIII_rev, cut with BamHI and HindIII 
endonucleases (using NEB buffer 2) and ligated by T4 DNA ligase (in T4 DNA ligase buffer) 
into multiple cloning site 1 (MCS1) of pETDuet-1 vector, in frame with a sequence coding for 
an N-terminal His6-tag.  
 
pETDuet-1_His6_TEV_gyrA and _gyrA_ΔCTD 
The nucleotide sequence for a TEV protease (TEVp) cleavage site was introduced to the 
pETDuet-1_His6_gyrA construct by mutagenesis (section 2.9.2). Primers used were 
gyrA_Bs_NHis_TEV_5 and _3 comprising an insertion of 18 nucleotides. Expression of the 
construct yielded a protein with the amino acid sequence H6-P-E-N-L-Y-F-Q|-S-GyrA, 
underlined letters denoting the recognition sequence of TEVp with the cleavage site indicated 
by the vertical line. 
A construct lacking the nucleotide sequence for the CTD was produced by introducing the 
S490stop mutation. 
 
pACYCDuet-1_His6_TEV_gyrA and mutants Y123F and ΔAbox 
For these constructs pETDuet-1_His6TEV_gyrA served as a template: An internal sequence 
for the restriction endonuclease NcoI was mutated with primers gyrA_Bs_NcoI_remove_5 
and _3 and the construct encompassing the fused ORF His6_TEV_gyrA was amplified by 
PCR (section 2.9.1) with the primers T7 promotor and gyra_rev (containing the gyrA stop 
codon and an XhoI restriction site). Enzymatic cleavage and subsequent ligation of the PCR 
product using NcoI and XhoI restriction sites of pACYCDuet-1 vector resulted in a sequence 
encoding the same expression product as the pETDuet-1 construct. 
Functional mutants Y123F and ΔAbox were produced following the same protocol as for 
gyrA constructs in pET-27b(+). 
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2.9.5 Mutagenesis of pDEST_topoisomerase VI construct 
The plasmid encoding M. mazei topoisomerase VI subunits A and B was a gift from Prof. 
James Berger (University of California, Berkeley, California, USA). The vector was derived 
from a common pET vector (Prof. Berger: personal communication) confering kanamycin 
resistance. The ORFs coding for topoisomerase VI were cloned in a bi-cistronic operon with 
the ORF of topoVIA arranged 5’ to the one of topoVIB. TopoVIB was fused to an N-terminal 
His6-tag cleavable with TEV protease. 
All mutagenesis reactions were performed on the pDEST construct as a template (section 
2.9.2) using appropriate primers. 
 
2.9.6 DNA sequence verification 
Plasmid DNA was sequenced at Microsynth AG (Balgach, Switzerland) applying the chain 
termination method [78], using primers listed in section 2.3.4. Correct sequences were 
confirmed for all DNA constructs and corresponding proteins described in this work. 
 
2.10 Protein preparation and purification 
Proteins purified ahead of this work were wild-type B. subtilis GyrA and GyrB and the GyrA 
mutants Y123F, T140C, E211C, T408C, K594C, and E726C. All mutants with the exception 
of Y123F contained the mutation C350L. 
Ines Hertel (Group Klostermeier, Biozentrum, University of Basel) assisted in the production 
and purification of hetero-dimeric GyrA proteins (section 2.10.2). 
 
2.10.1 Fermentation 
All proteins purified in course of this work were recombinantly over-produced using E. coli 
(individual fermentation protocols below). A single colony of expression strains transformed 
with the appropriate vector(s) (section 2.8.1) were pre-cultured in LB medium (section 2.7) at 
37°C over night and used to inoculate auto-induction medium in a 1:100 (v/v) ratio. If not 
indicated otherwise expression cultures were shaken at 37°C for approx. 24 h. Cells were 
pelleted by centrifugation (SLA3000 rotor, 5000 rpm, 10 min, 4°C) and stored at -20°C. 
 
Non-tagged GyrA mutant proteins with corresponding open reading frames inserted into pET-
27b(+) were produced in E. coli BL21(DE3)RP cells as described before [46]. 
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Full-length and CTD deletion mutant GyrA His6-tag fusion constructs cloned into pETDuet-1 
vector were expressed in E. coli BL21(DE3)RP. GyrA expressed from pACYCDuet-1 vector 
were produced in E. coli BL21(DE3).  
Hetero-dimeric GyrA were expressed in E. coli BL21(DE3) strain transformed with pET27b 
and pACYCDuet-1, each containing a copy of gyrA open reading frame. Selection was done 
for both plasmids by using kanamycin and chloramphenicol. For enhanced protein production 
and solubility co-transformed cells were cultured at 30°C for 24 h. 
Wild-type and mutant M. mazei Topoisomerase VI A and B were co-expressed in E. coli 
Rosetta(DE3) cells as described before [61] at 37°C for 24 h. 
 
2.10.2 Purification of GyrA constructs 
All protein purification steps involving chromatography were performed on the liquid 
chromatography system ÄKTAprime plus. The flow rate was generally set to 1 ml/min. 
Dialysis of protein solutions was performed in tubular cellulose membranes (Dialysis 
Membrane Spectra/Por 4) with a molecular cut-off of 12 to 14 kDa. Protein was concentrated 
by ultrafiltration using Vivaspin concentrators on a Beckmann Allegra 21R Centrifuge 
(S4180 rotor, 4800 rpm, 4°C). 
 
Purification of  full-length GyrA mutants and GyrA ΔCTD 
• GyrA purification buffer: 50 mM Tris/HCl pH 7.5 (4°C), 10 mM MgCl2, 2 mM β-mercaptoethanol; 
concentrations of NaCl and imidazole as indicated. 
• GyrA storage buffer: 50 mM Tris/HCl pH 7.5 (4°C), 300 mM NaCl, 10 mM MgCl2, 2 mM                             
β-mercaptoethanol 
 
Cells from 1.5 – 2.0 l culture were thawed, resuspended in approx. 25 ml purification buffer 
containing 1 M NaCl and protease inhibitor cocktail (Complete EDTA-free), and disrupted in 
a micro-fluidic cell. Cell debris was removed by centrifugation (SS-34 rotor, 14’000 rpm, 60 
min, 4°C), and the supernatant was dialyzed over night against 2 x 1l purification buffer 
containing 200 mM NaCl. The protein solution was cleared by centrifugation and loaded onto 
a heparin sepharose column (1 ml/min). GyrA was eluted in a gradient of 0.2 – 1 M NaCl. 
Fractions containing GyrA with UV absorption ratio A280/A260 higher than 1.4 were pooled, 
concentrated by ultrafiltration and further purified on a Superdex S200 size exclusion column 
equilibrated in GyrA storage buffer. Protein eluted after approx. 55 ml were concentrated, 
shock-frozen, and stored at -80°C. 
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Purification of GyrA His6-tag fusion protein (His6-GyrA) 
Cells were disrupted and the protein purified on a heparin Sepharose column as described 
above. It was further purified by IMAC using a Ni2+-NTA column equilibrated in purification 
buffer containing 200 mM NaCl and 20 mM imidazole. The protein was eluted with 500 mM 
imidazole and dialyzed over night against 2 x 1l purification buffer containing 200 mM NaCl. 
Precipitate was removed by centrifugation, the supernatant adjusted to 300 mM NaCl and 
concentrated by ultrafiltration. The protein was further purified by SEC using a Superdex 
S200 column equilibrated in storage buffer containing 400 mM NaCl, concentrated and stored 
at -80°C. 
Purification of homo- and hetero-dimeric GyrA His6-tag fusion proteins with TEV cleavage 
site (His6-TEV-GyrA) 
Cell containing recombinant proteins were disrupted and the debris removed as described 
above. The purification buffer containing 1 M NaCl was adjusted to 20 mM imidazole and the 
protein was loaded onto a Ni2+-NTA column. Adsorbed protein was eluted with 500 mM 
imidazole, mixed with 0.5 – 1 ml TEV protease (self-purified; 30 µM) to cleave the His6-tag, 
and dialyzed over night against buffer containing 500 mM NaCl. Dialyzed GyrA was adjusted 
to 20 mM imidazole and loaded onto a Ni2+-NTA column for separation from non-cleaved 
protein and the tag peptide. The flow-through was dialyzed for 2 h against 0.5 l of GyrA 
storage buffer, concentrated by ultrafiltration and passed over a Superdex S200 size exclusion 
column equilibrated in the same buffer. Fractions containing GyrA were concentrated by 
ultrafiltration, shock-frozen and stored at -80°C. 
 
2.10.3 Co-purification of M. mazei Topoisomerase VI A and B subunits 
• T6 purification buffer: 20 mM Tris/HCl pH 7.5 (4°C), 10% (v/v) glycerol, 2 mM β-mercaptoethanol; 
concentrations of NaCl and imidazole as indicated. 
• T6 storage buffer: 20 mM Tris/HCl pH 7.5 (4°C), 150 mM NaCl, 10% (v/v) glycerol, 2 mM β-
mercaptoethanol 
 
The purification protocol for TopoVI was derived from [61]. Cell containing recombinant 
protein were disrupted and the debris removed as described for GyrA (section 2.10.2); the 
buffer used was T6 purification buffer containing 800 mM NaCl. The protein solution was 
adjusted to 20 mM imidazole and applied to a Ni2+-NTA column equilibrated with the same 
buffer (flow rate: 0.5 – 1 ml/min). TopoVI A + B bound to the resin, the non-tagged A 
subunits being pulled down by His6-TopoVIB subunits, and was eluted with 500 mM 
imidazole. The eluate was mixed with 0.5 – 1 ml of TEV protease (self-purified; 30 µM) and 
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dialyzed over night against 2 x 1l of buffer containing 150 mM NaCl. Precipitate was 
removed by centrifugation and cleaved protein separated from non-cleaved, tag peptide and 
TEV protease in a second IMAC run. The protein found in the flow-through was dialyzed 
again (0.5 l, 2 h, 150 mM NaCl) and passed over a SP sepharose cation exchange column 
equilibrated with the same buffer thus separating the TopoVI complex from proteolyzed 
TopoVIB proteins [61]. The flow-through was applied to a Q sepharose anion exchange 
column equilibrated with the same buffer and eluted in gradient of 150 – 1000 mM NaCl and 
a length of 50 ml, separating the protein from co-purified nucleic acids. Fractions containing 
TopoVI were concentrated by ultrafiltration and purified on a Superdex S200 size exclusion 
column equilibrated with T6 storage buffer. Proteins were concentrated by ultrafiltration, 
flash-frozen, and stored at -80°C. 
 
 
 
 
2.11 DNA substrate preparation and purification 
2.11.1 Plasmid DNA production and purification 
E. coli XL1-Blue cells transformed with a target plasmid were cultured in LB medium (37°C, 
over night). Plasmid DNA was extracted and purified with Plasmid Miniprep Kit or Plasmid 
Midiprep Kit (both Qiagen N. V., Netherlands) for small (5 – 10 ml) and large culture volume 
(50 – 100 ml), respectively. Purified DNA were stored in sterile H2O at -20°C. 
pUC18 (negatively supercoiled as extracted from E. coli) used as a substrate for B. subtilis 
gyrase or M. mazei topoisomerase VI was further purified by ethanol precipitation (section 
2.11.3). 
 
2.11.2 Preparative relaxation of pUC18 plasmid DNA 
• Gyrase activity buffer: 50 mM Tris/HCl (pH 7.5 at 25°C), 100 mM KCl, 10 mM MgCl2 
 
Negatively supercoiled pUC18 plasmid was mixed with B. subtilis gyrase in absence of 
nucleotide. The relaxation reaction containing 200 nM wild-type GyrA , 800 nM wild-type 
GyrB and 100 nM pUC18 in gyrase activity buffer was incubated at 37°C for 2 to 3 h. The 
DNA was sequentially purified with Enzyme Removal Kit (Qiagen N. V., Netherlands) and 
ethanol precipitation (described below).  
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2.11.3 Ethanol precipitation 
To remove residual salt and fluorescent background from DNA substrates used for smFRET 
measurements they were precipitated by sequentially mixing with 0.1 volume of 3 M KOAc 
(used instead of NaOAc due to a preference for K+ ions of both gyrase and topoisomerase VI) 
and 2.5 volumes of ethanol p.a. Precipitated nucleic acids were pelleted by centrifugation 
(Eppendorf Centrifuge 5402, F 45-18-11 rotor, 13’000 rpm, 30 min, 4°C). The supernatant 
was decanted and the pellet carefully washed twice with ice-cold 70% ethanol, dried under 
vacuum (Eppendorf Concentrator 5301, 45°C, approx. 30 min) and re-dissolved in charcoal 
treated H2O or appropriate buffer. 
 
2.11.4 Linear double-stranded DNA substrates 
Non-modified or fluorescently labeled linear DNA substrates for B. subtilis gyrase (A; 37bp, 
48bp, 60bp, 90bp) and for topoisomerase VI (B; 50bp, 51bp) were assembled from 
complementary single-stranded DNA oligomers (section 2.3.3). DNAs were denaturated 
(95°C, 5 min) and annealed (A: 95 – 4°C gradient, 36 min; B: 95 – 20°C gradient, 60 min) on 
a thermocycler (GeneAmp PCR System 9600, Perkin Elmer Inc., MA, USA) and stored at -
20°C. 
The 110bp DNA substrate for gyrase was produced by PCR (section 2.9.1) using primers 
pUC18_110bp_for pUC18_110bp_rev and pUC18 containing a preferred binding / cleavage 
site for gyrase as a template. The PCR product was separated from enzymes and residual 
nucleotides and primer DNA by using the PCR clean-up kit (Promega). The theoretical 
nucleotide sequence of the 110bp DNA forward strand is: 
 
5’-GGGTTTTCCCAGTCACGACGTTGTAAAACGTCTCGCAGTGCCAAGCTATGCATGATCATACGT 
CGACTCTAGAGTCTCGCAGTGTACCGAGCTCGAATTCGTAATCATGT-3’ 
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2.12 Topoisomerase assays 
2.12.1 DNA supercoiling and relaxation assays with B. subtilis gyrase 
• Gyrase activity buffer: 50 mM Tris/HCl (pH 7.5 at 25°C), 100 mM KCl, 10 mM MgCl2 
• 5x quenching solution: 50 mM EDTA, 5% (v/v) SDS, 50% glycerol, 0.05% (w/v) bromphenol blue 
 
The DNA supercoiling and relaxation assays are used to report on the overall activity of 
mutant and / or chemically modified enzyme compared to the wt. Proteins were generally 
diluted from storage or labeling buffer. 
DNA relaxation experiments were typically performed using 200 nM GyrA, 800 nM wt 
GyrB, and 15 nM neg. supercoiled pUC18 plasmid, in gyrase activity buffer, with a reaction 
volume was 10 - 16 µl. The reaction mix was incubated at 37°C for 30 min (Eppendorf 
ThermoStat plus). 
The DNA supercoiling assays typically used 50 or 200 nM GyrA, 800 nM wt GyrB, 50 nM 
relaxed pUC18 plasmid, and 2 mM ATP, in gyrase activity buffer, with a reaction volume of 
10 µl. The reaction being very fast, it was kept on ice before incubation at 37°C for 2 min. 
Both relaxation and supercoiling reactions were quenched by adding 5x quenching solution 
(0.25 x the reaction volume) and flash-frozen in liquid N2. The reaction mix containing 300 
ng of plasmid DNA was applied to a 1.2% agarose gel and topoisomers were separated by 
electrophoresis and visualized by ethidium bromide staining and UV illumination (section 
2.8.2). 
 
2.12.2 DNA relaxation assay with M. mazei topoisomerase VI 
• T6 activity buffer: 40 mM Bis-Tris propane/HCl (pH 6.5 at 25°C), 150 mM potassium glutamate, 20 mM 
MgCl2, 1 mM DTT 
• 5x quenching solution: 50 mM EDTA, 5% (v/v) SDS, 50% glycerol, 0.05% (w/v) bromphenol blue 
 
DNA relaxation reactions typically contained approx. equimolar concentrations of TopoVIA 
and B proteins, 15 nM of neg. supercoiled pUC18 plasmid, and 2 mM ATP in T6 activity 
buffer. 16 µl reaction mix were incubated at 30°C for 30 min (Eppendorf ThermoStat plus) 
and subsequently stopped by the addition of quenching solution and flash-freezing in liquid 
N2. The stopped reactions containing 400 ng plasmid DNA were analyzed by agarose gel 
electrophoresis as described above (section 2.8.2). 
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2.13 TopoisomeraseVI DNA cleavage assay 
1 µM single stand DNA TopVI_51_f was radioactively labeled on the 5’ end using 10 µCy 
[γ-32P]ATP (corresponding to approx. 0.3 m) and Polynucleotide kinase (PNK) (1 U/µl) in 
PNK buffer (supplied by the manufacturer). The reaction mix was incubated at 37°C for 60 
min and the enzyme was inactivated by incubating the reaction at 65°C for 20 min. The DNA 
was separated from nucleotides and proteins by size exclusion chromatography (illustra 
Microspin G-25 column) according to the manufacturer’s protocol. Approx. 25 nM labeled 
oligonucleotide was annealed with 25 nM of its complementary DNA TopVI_51_r by heating 
to 95°C for 5 min and cooling to room temperature in 90 min. 
The DNA cleavage reaction was performed with approx. 12.5 nM [32P]DNA and 5 µM 
topoisomerase VI in T6 activtiy buffer (see above). Nucleotides (ATP, ADPNP) were added 
at concentrations of 2 mM. The reaction mix was incubated at 37°C for 2 h, the enzyme 
degraded for 20 min by the addition of 0.1 µg/µl proteinase K, and the reactions stopped with 
quenching solution (see 2.12.2) and heating to 95°C for 5 min. 
The DNA products were applied to a 15 % polyacrylamide gel and separated by 
electrophoresis using 1 x TBE as buffer (150V, 2.5 h). The gel was exposed to a storage 
phosphor screen over night and the bands were visualized by a Storm 820 phosphor imager 
(GE Healthcare). 
 
2.14 Steady-state ATP hydrolysis assay for M. mazei topoisomerase VI 
• T6 ATPase buffer: T6 activity buffer (see above), containing 1 mM PEP, 0.2 mM NADH, 13 µg/ml pyruvate 
kinase, 23 µg/ml lactate dehydrogenase. 
 
The steady-state ATP hydrolysis rate of topoisomerase VI was monitored in a coupled 
enzymatic assay [79]: ATP hydrolysed by the enzyme is regenerated from ADP by pyruvate 
kinase in a phosphotransfer reaction driven by the dephosphorylation of PEP. The product 
pyruvate is reduced to lactate by lactate dehydrogenase in a reaction coupled to the oxidation 
of NADH to NAD+, which can be monitored spectrophotometrically by the decrease in 
absorption by NADH at 340 nm. The method was used to assay the basic (i. e. non-
stimulated) topoisomerase VI ATP hydrolysis activity.  
8 hydrolysis reactions were performed in parallel on a Ultrospec 2100 photometer. Quartz 
cuvettes containing ATPase buffer and varying concentrations of ATP were incubated at 37°C 
until reaching equilibrium (after approx. 30 min). Then 4 µM topoisomerase VI was added 
(by direct dilution from storage buffer conditions) with incubation continuing for at least 30 
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min. The absorption at 340 nm was monitored for both part of the experiment as a function of 
time at an interval of 16 s. 
The concentration of NADH can be calculated from the NADH absorption at 340 nm by 
using the Beer-Lambert law (Eq. 2.1) and the extinction coefficient of NADH (6300 M-1cm-1 
at 340 nm) [74]. ATP hydrolysis is correlated in a 1 : 1 stoichiometry to the decrease in 
NADH concentration over time; thus the velocity of ATP hydrolysis can be expressed as the 
absolute value of the time derivative of NADH concentration (Eq. 2.2): 
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v being the velocity of ATP consumption, [ATP] the nucleotide concentration, A340nm the 
absorption at 340 nm, and d the pathlength given by the cuvette (1 cm). The velocity was 
corrected with the apparent ATP consumption in absence of topoisomerase VI.  
The velocity of ATP consumption was plotted against the ATP concentration and analyzed 
according to the Michaelis-Menten formalism, calculating the maximal velocity of ATP 
consumption vmax, the Michaelis-Menten constant KM, and the ATP turnover number kcat 
(Eqns. 2.3 and 2.4): 
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[TopoVI] denominates the concentration of topoisomerase VI. 
 
 
2.15 Fluorescence anisotropy titrations 
Fluorescence from dyes excited with linearly polarized light can be split in parallel and 
perpendicular contributions relative to the polarization of the incoming beam; in case these 
contributions differ the fluorescence is called anisotropic. Fluorescence anisotropy r is defined 
as (Eq. 2.5): 
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where I|| and I ! are the measured fluorescence intensities parallel and perpendicular to the 
excitation polarization. The fluorescence anisotropy reports on the rotational mobility of a 
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fluorescently labeled molecule and can therefore be used to describe association of 
fluorescently labeled species with other molecules. Affinities of B. subtilis gyrase and M. 
mazei topoisomerase VI for DNA substrates were determined on a fluorimeter (Jobin Yvon 
FluoroMax 3) by titration of fluorescently labeled DNAs. 
 
2.15.1 Titrations with GyrA and GyrB 
• Gyrase activity buffer: 50 mM Tris/HCl (pH 7.5 at 25°C), 100 mM KCl, 10 mM MgCl2,                                 
2 mM β-mercaptoethanol 
 
10 nM linear double-stranded DNA substrates internally labeled with Alexa546 were titrated 
with GyrA or GyrB proteins in absence of the other and with GyrA in presence of 4 µM wt 
GyrB, using gyrase activity buffer containing 2 mM β-mercaptoethanol. Proteins were diluted 
from stock solutions (section 2.10). Displacement titrations with negatively supercoiled 
pUC18 were performed with 100 nM fluorescently labeled DNA and 1 µM GyrA in the 
absence, or with 10 nM labeled DNA and 250 µM GyrA in the presence of 4 µM GyrB. 
Measurements were performed at 37°C with equilibration time of 1 min. Alexa546 was 
excited at 555 nm (slit: 3 nm) and fluorescence detected at 571 nm (slit: 6 nm).  
 
2.15.2 Titrations with topoisomerase VI 
• T6 activity buffer: 40 mM Bis-Tris propane/HCl (pH 6.5 at 25°C), 150 mM potassium glutamate,                  
20 mM MgCl2, 1 mM DTT 
 
50 nM linear double-stranded DNA substrates single labeled with fluorescein (end), Alexa488 
(A488; internal), or Alexa546 (A546; internal) or double-labeled with Alexa488 and 546 were 
titrated with topoisomerase VI complex in T6 activity buffer. Proteins were diluted from 
respective stock solutions (section 2.10). 
Measurements were performed at 37°C with equilibration time of 1 min. Excitation and 
emission detection wavelengths were 496, 493, 554 nm and 520, 515, 569 nm for substrates 
labeled with fluorescein, A488 and A546, respectively. Slit widths for the excitation and 
emission were 4 and 10 nm for fluorescein and 3 and 6 nm for A488 and A546. For titrations 
of a double-labeled DNA (A488, A546) the same parameters were used as for a substrate 
labeled with A546 only. 
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2.15.3 Data evaluation 
Titrations with GyrA and topoisomerase VI were analyzed under the assumption of a 1:1 
complex formation with DNA. The dissociation constant for the enzyme-DNA complex can 
be expressed as in equation 2.6: 
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 Kd is the dissociation constant, [E] the free enzyme concentration, [DNA] the free DNA 
concentration, and [EDNA] the concentration of the enzyme-DNA complex.  
The detected fluorescence anisotropy r is a function of the initial anisotropy and the maximal 
anisotropy amplitude scaled with the saturation degree of the labeled DNA (Eq. 2.7): 
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r0 is the anisotropy of the free DNA, [DNA]tot the total DNA concentration, and Δr the 
maximal anisotropy difference at saturation enzyme concentration. [E·DNA] can be 
substituted by a quadratic equation applying the principle of mass conservation; r can be 
rewritten as follows (Eq. 3.8): 
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Equilibrium titrations of DNA with GyrA in presence of 4 µM GyrB were evaluated as in eq. 
2.8. We assume, that the affinity of one species for another is much lower than for the 
complex of the two others [46], leading to a preferred population of the tripartite complex. 
The binding of GyrB to GyrA or DNA alone is neglected. 
 
Anisotropy data from titration of a DNA substrate with GyrB was analyzed with the Hill 
equation, assuming high co-operativity of binding (eq. 2.9).  
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v is the degree of occupancy of DNA, n is the Hill coefficient, [GyrB]tot is the total 
concentration of GyrB, and Kd is the dissociation constant for the DNA-GyrBn complex. 
Following eq. 3.8, the anisotropy can be expressed as in eq. 2.10: 
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To determine binding of non-labeled plasmid DNA to GyrA or gyrase we performed 
displacement titrations on the enzyme bound to linear labeled DNA were performed. 1 µM 
GyrA and 100 nM fluorescently labeled DNA were titrated with negatively supercoiled 
pUC18 in the absence, 10 nM labeled DNA and 250 µM GyrA in the presence of 4 µM GyrB. 
As no binding model was found that could describe the data sufficiently well, no dissociation 
constants for supercoiled plasmid were obtained. 
 
2.16 Fluorescent labeling of proteins 
Mutant proteins constructed for FRET experiments were fluorescently labeled using 
maleimide-linked dyes for the coupling to free thiol groups. Purified protein was transferred 
to labeling buffer by size-exclusion chromatography (Micro Bio-Spin 30 columns) according 
to the manufacturer’s protocol, mixed with fluorescent dyes, and incubated at 25°C. 
Fluorescent dyes (Alexa Fluor 488 C5-maleimide, Alexa Fluor 546 C5-maleimide, TMR C5-
maleimide) were directly diluted into labeling reactions from stock solutions (20 mM in 
DMSO). Non-reacted dye molecules were efficiently removed by SEC in two steps reusing 
the same micro-spin columns. 
Labeled proteins were stored at 4°C and reused for experiments up to 3 days. 
 
2.16.1 Fluorescent labeling of B. subtilis GyrA 
• GyrA labeling buffer: 50 mM Tris/HCl (pH 7.5 at 25°C), 200 mM NaCl, 10 mM MgCl2, 1 mM TCEP 
 
GyrA mutants for single molecule (sm) and ensemble FRET experiments or activity assays 
were diluted to 50 - 80 µM and the buffer exchanged to buffer A. Proteins were diluted to 30 
µM and simultaneously (i.e. statistically) labeled with 90 – 120 µM Alexa488 and / or 120 
µM Alexa546 for smFRET and 120 µM Alexa488 and 150 µM TMR for denaturation 
experiments. Fluorescent dyes were premixed before addition to protein solutions for fully 
statistical labeling. Chemical modification was done at 25°C for 1 h. 
Proteins used for correction parameter determination were labeled with one dye only. 
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2.16.2 Fluorescent labeling of TopoVIB 
• T6 labeling buffer: 20 mM Tris/HCl (pH 8.0 at 25°C), 300 mM NaCl, 10 % glycerol, 1 mM TCEP 
 
Co-purified TopoVIA and B proteins were subject to labeling as a complex. Initial labeling 
experiments to identify accessible native cysteines were performed with 30 µM proteins and 
150 – 300 µM A546 in T6 labeling buffer, with incubation at 25°C for 2 h. 
Mutant proteins for FRET experiments were labeled at a concentration of 30 µM using 24 µM 
A488 and 36 µM A546 with dyes being premixed prior to addition. The labeling reaction mix 
was incubated at 25°C for 10 min. Non-reacted dyes were removed as described above.  
 
2.16.3 Determination of labeling degrees 
Fluorescently labeled proteins were probed for free dye by SDS-PAGE, and protein and dye 
concentrations were determined with absorption measurements, employing the Beer-Lambert 
law (eq. 2.1) and correcting for dye absorption at 280 nm and (in case of simultaneous 
labeling with donor and acceptor dye) acceptor contribution at 493 nm as well as buffer 
contributions (eqns. 2.11 – 2.13). 
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Aλ is the absorption at wavelength λ, ελ,x the molar extinction coefficient of species x at 
wavelength λ, cx the concentration of species x, and d the path-length (1 cm). Values are listed 
in section 2.8.4. If the concentration of free dye could be neglected the degree of labeling is 
given by the ratio cdye/cprot. 
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2.17 Guanidinium chloride induced GyrA dimer dissociation monitored by 
ensemble FRET 
• Buffer G: 50 mM Tris/HCl (pH 7.5 at 25°C), 200 mM NaCl, 10 mM MgCl2 
 
Guanidinium chloride is a powerful denaturant inducing protein unfolding and complex 
dissociation [80]. We tried to separate GyrA dimer by addition of GuHCl. Ensemble FRET 
between GyrA monomers labeled with donor and acceptor dyes at the dimerization interfaces 
was measured to monitor intramolecular proximity [81]. 
GyrA mutants T140C or T408C were labeled with A488 as donor and TMR as acceptor and 
labeling efficiencies determined as described above (sections 2.16.1 / 2.16.3). The protein was 
diluted into buffer G to a final donor label concentration of 10 nm. Fluorescence 
measurements of individually mixed samples containing varying concentrations (0 – 5 M) of 
GuHCl were recorded on a fluorimeter (Jobin Yvon FluoroMax 3) with a low excitation 
wavelength of 460 nm (slit: 5 nm) to avoid direct excitation of the acceptor. Fluorescence 
emission spectra were recorded in a range from 500 – 650 nm (slit: 10 nm) and corrected for 
buffer contributions. Incubation temperature was 37°C; samples were equilibrated for 1 min 
prior to spectra recording. From individual fluorescence spectra an apparent FRET efficiency 
(EFRET,app) was calculated (Eq. 2.14):  
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I519nm and I574nm denominate single-wavelength fluorescence intensities. 
 
 
2.18 Single molecule experiments 
• Gyrase FRET buffer: 50 mM Tris/HCl (pH 7.5 at 25°C), 100 mM KCl, 10 mM MgCl2; treated with active 
charcoal 
• T6 FRET buffer: 40 mM Bis-Tris propane/HCl (pH 6.5 at 25°C), 150 mM potassium glutamate, 20 mM 
MgCl2; treated with active charcoal. 
 
Single molecule experiments were performed on a home-built confocal microscope. 
Chambered coverglass cuvettes were passivated with 0.1 mg/ml BSA in the appropriate 
buffer for at least 1 h. Measurements were performed in gyrase or T6 buffer (depending on 
the enzyme involved) at 37°C, with fluorescently labeled protein (section 2.16) or DNA at 50 
– 75 pM concentration with respect to donor label. If not indicated otherwise, substrate 
concentrations used were 8 µM, 25 nM, and 2 mM for GyrB, plasmid DNA, and nucleotides. 
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Fluorescence was excited with monochromatic pulsed light of 475 nm from a mode-locked, 
wavelength doubled Ti:sapphire laser. The intensity of the excitation beam was set to 75 µW, 
the pulse width to 2.5 ps at an interval of 40 ns. Fluorescence from freely diffusing molecules 
passing the confocal volume was collected by an objective with high numerical aperture and 
split onto two avalanche photo diodes to be detected as donor or acceptor signals. 
Fluorescence was recorded for 20 to 30 min. 
 
2.18.1 Data processing 
Labeled molecules passing through the confocal volume emit a large number of photons 
yielding a fluorescence burst. Background fluorescence (from impurities) is removed by an 
algorithm described by [82]. Bursts with more than 100 photons above background were 
considered significant and the transfer efficiency calculated from fluorescence intensities (eq. 
2.15): 
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EFRET is the transfer efficiency, IA and ID are the fluorescence intensities of the acceptor and 
the donor fluorophors respectively. 
Autocorrelation of the donor fluorescence signal can be used to calculate a diffusion time of 
the detected fluorescent species [83]. Visual inspection of the curvature of the autocorrelation 
curve in the range between 10-4  and 10-2 s was used to follow complex formation of GyrA or 
gyrase with plasmid DNA:  an inflection point at < 10-3 s was indicative of a MW complex 
corresponding to GyrA or gyrase, while one at ≥ 10-2 s was characteristic for complexes 
containing plasmid DNA. 
 
2.18.2 Correction of single molecule fluorescence intensities 
Fluorescence intensities are affected by spectral over-lap of donor and acceptor absorption 
and fluorescence and non-ideal physical properties of the fluorescence detection set-up [82]. 
These effects have to be corrected for when calculating FRET efficiencies [84]. Correction 
parameters are presented in the following paragraphs. 
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Measurements for the determination of correction parameters for GyrA mutants 
• Gyrase FRET buffer: 50 mM Tris/HCl (pH 7.5 at 25°C), 100 mM KCl, 10 mM MgCl2; treated with active 
charcoal 
 
GyrA mutants were labeled with A488 or A546 as described above (section 2.16). A fraction 
of labeled protein was digested with proteinase K (0.2 mg/ml, 37°C, 30 min), and complete 
proteolytic degradation of GyrA was confirmed by SDS-PAGE. The fluorophore 
concentration was determined from absorption spectra using extinction coefficients listed in 
section 2.8.4. Absorption spectra of approximately 5 µM labeled GyrA protein were recorded 
in absence and presence of 6 µM wt GyrB and 0.3 µg/µl calf thymus DNA (assuming 
saturation of GyrA) in gyrase FRET buffer containing 1 mM TCEP. Absorption spectra were 
corrected for buffer contributions. 
Fluorescence excitation spectra of labeled protein were recorded in absence and presence of 
20 nM supercoiled pUC18 plasmid and 8 µM GyrB in gyrase FRET buffer at 37°C, with label 
concentration of 10 nM. Fluorescence was excited in a range between 350 and 520 nm in case 
of A488 and between 400 and 580 nm in case of A546; emission was detected at 530 and 590 
nm (slits: 5 nm). Fluorescence emission spectra of protein labeled with A488 were recorded 
between 470 and 700 nm with excitation set at 460 nm (slits: 5 nm). Fluorescence spectra 
were corrected for buffer contributions. 
Fluorophore extinction coefficients at 475 nm were not calculated directly from absorption 
spectra, but from fluorescence excitation spectra fitted to the corresponding absorption 
spectra, assuming that the spectral shapes were the same. This was done due to the higher 
sensitivity of the fluorescence measurement. 
For the correction of detection-related problems counting rates of single dye labeled proteins 
were recorded on the single-molecule confocal microscope with the dye concentration set to 
50 nM. Measurements were performed in gyrase FRET buffer, in absence and presence 20 
nM supercoiled pUC18 plasmid (section 2.11) and 8 µM GyrB. A neutral filter (OD = 0.5) 
was used to decrease fluorescence intensity. 
 
Measurements for the determination of correction parameters for a 50bp DNA 
• T6 FRET buffer: 40 mM Bis-Tris propane/HCl (pH 6.5 at 25°C), 150 mM potassium glutamate, 20 mM 
MgCl2; treated with active charcoal. 
 
50bp DNAs labeled with A488 or 546 were annealed from complementary single-stranded 
DNA pairs TopoVI_51_f / TopoVI_50_r_488 and TopoVI_50_f_546 / TopoVI_51_r, 
respectively. Absorption spectra were recorded at 25°C in the absence and presence of 12 µM 
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TopoVI A+B, using T6 FRET buffer. The concentration of the fluorescent labels was set to 4 
µM  (using extinction coefficients given by the manufacturer: εA488, 493 nm = 78'000 M-1·cm-1 
and εA546, 554 nm = 112'000 M-1·cm-1 for A488 and A546, respectively). The direct excitation δ 
was calculated from absorption values at 475 nm. 
Counting rates of single-dye labeled 50bp DNAs were recorded on the single-molecule 
confocal microscope with the dye concentration set to 100 nM. Measurements were 
performed at room temperature in T6 FRET buffer in absence and presence of 12 µM TopoVI 
A+B. Counting rates were corrected for buffer contributions. 
Correction for direct excitation of the acceptor: δ 
Significant over-lap in the absorption spectra of donor and acceptor fluorophores impedes 
exclusive excitation of the donor. The acceptor dye is directly excited by light of the 
excitation wavelength of 475 nm following a non-zero extinction coefficient ε475 nm. The 
correction for direct excitation is given by the ratio of the extinction coefficients of acceptor 
and donor dyes (eq. 2.16): 
 nmDo
nmAcc
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 (2.16) 
εAcc,475nm and εDo,475nm are the extinction coefficients of the fluorophores calculated from 
absorption and fluorescence excitation spectra. 
 
Correction for fluorescence cross detection:  α and β 
Photons emitted from fluorophores and collected by the objective are separated by a beam 
splitter (dichroic) onto two detection units (APDs), thus being detected either as donor or 
acceptor fluorescence. The discrimination is not perfect due to overlap in the emission spectra 
of the two dyes and non-ideal separation of emitted photons into the detection channels by the 
beam splitter, leading to photons emitted by the donor to be detected in the acceptor channel 
and vice versa. Parameters correcting for cross detection are α and β, describing leakage of 
donor photons into acceptor channel and vice versa, respectively (eqns. 2.17, 18).  
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ID and IA are fluorescence intensities detected in donor and acceptor channels, exponents 
indicate measurements of protein labeled with the denominated fluorophore or of the 
background (buffer).  
 
Correction for unequal detection efficiency: γ 
The parameter γ corrects for different quantum efficiencies of donor and acceptor 
fluorophores and different detection efficiencies of emitted fluorescence (eq. 2.19): 
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ID and IA are fluorescence intensities detected in donor and acceptor channels, exponents 
indicate measurements of protein labeled with the denominated fluorophore or of the 
background (buffer). 
 
Corrected FRET efficiencies 
The corrected FRET efficiency is described by eq. 2.15 with incorporated correction 
parameters α, β, γ, and δ. Correction parameters with direct excitation taken into account 
write as (eqns. 2.20 – 2.22): 
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Using modified correction parameters α’, β’, and γ’,  eq. 2.15 transforms to (eq. 2.23): 
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2.18.3 Determination of Förster distance (R0) 
The Förster distance for a given pair of fluorescent dyes is the distance at which the transfer 
efficiency (EFRET) is 0.5 [85]. It is an essential factor for the conversion of a given FRET 
efficiency to the corresponding distance (eq. 2.24): 
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R0 is the Förster distance of two fluorophores, r the distance between them. The Förster 
distance is described by eq. 2.25: 
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NA is the Avogadro number, φD the donor quantum yield, κ2 the dipole orientation factor, n 
the refractive index of the medium between the fluorophores, and J the overlap integral of the 
fluorescence and absorption spectra of donor and acceptor dyes respectively. The dipole 
orientation factor was assumed to be 2/3, equivalent to freely rotating fluorophores [86]. The 
refractive index was set to 1.33, the one of water at 25°C [87]. 
The overlap integral and the donor quantum yield were determined individually for each 
FRET pair (cysteine positions, donor and acceptor dyes) as described below. 
 
The overlap integral: J 
The overlap integral is the degree of overlap between the normalized donor fluorescence and 
acceptor absorption spectra according to equation 2.26 [86]: 
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J is the overlap integral, FD the donor fluorescence and εA the absorption coefficient for the 
acceptor at a certain wavelength λ. The spectra were recorded as described above. The 
fluorescence emission spectrum of the donor was normalized by its integral, the absorption 
spectrum by the dye concentration (equaling the extinction coefficients for each wavelength). 
For practical reasons the integrals are substituted by sums of overlap values at a given 
wavelength with a λ step size of 1 nm. 
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The fluorescence quantum yield φD 
The fluorescence quantum yield of A488 bound to protein was determined relative to the one 
of uranine (fluorescein) in solution [88] using corresponding absorption and fluorescence 
emission spectra (eq. 2.27): 
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φD is the quantum yield of A488, φU the one of uranine, εD and εD are the extinction 
coefficients at 460 nm as determined from absorption spectra (A488) or given in section 2.8.4 
(uranine). The quantum yield of uranine in aqueous solutions is 0.93 [89]. Absorption and 
fluorescence emission spectra of uranine were recorded in 0.1 NaOH and corrected for buffer 
contributions. Fluorescence measurements of uranine and A488 were performed using 10 nM 
fluorophore with identical parameters (λex of 460 nm, λem from 470 to 700 nm, slits: 5 nm). 
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3. Results 
3.1 Part I: CTD from B. subtilis GyrA 
  
Gyrase is a heterotetrameric complex consisting of two GyrA and two GyrB subunits. Both 
proteins were produced individually and purified in their wild-type forms by ion-exchange 
(IEX) and size-exclusion chromatography (SEC). Protein yields were high, but overlapping 
elution profiles of protein and nucleic acids on the IEX column lead to selecting of only a 
restricted elution fraction, resulting in a significant loss of protein. This work reports 
purification protocols for B. subtilis GyrA His6-fusion proteins, using immobilized metal 
affinity chromatography (IMAC). 
 
3.1.1 Production and purification of His6-tagged GyrA 
B. subtilis gyrA_C350L (cysteine-free mutant: hereafter abbreviated gyrA*) open reading 
frame was subcloned from pET-27b(+) into a pETDuet-1 vector (section 2.9.4), resulting in a 
DNA sequence coding for an N-terminal His6-tagged fusion protein (His6-GyrA*) with a 
length of 835 amino acids and a calculated molecular weight (MW) of 93.7 kDa [72]. His6-
GyrA* was recombinantly expressed in E. coli BL21 CodonPlus(DE3)RP cells, yielding a 
high amount of protein visible as the main band with the expected MW on a denaturating 
acrylamide gel (Fig. 3.1 E). 
His6-GyrA* was purified as described in section 2.10.2. Dialysis of the crude extract against 
200 mM NaCl resulted in protein precipitation; this effect was known from the purification of 
non-tagged GyrA, albeit to a lower degree [36]. His6-GyrA* was adsorbed to a heparin 
column and eluted in a NaCl gradient with an elution maximum at approx. 400 mM NaCl, 
similar to the non-tagged protein. Judged from absorption spectra (ratio of the absorption at 
wavelengths of 280 nm versus 260 nm) the tagged protein co-eluted with a similar amount of 
nucleic acids as the wild-type protein. Several protein impurities were visible on SDS 
polyacrylamide gel (Fig. 3.1 E). 
To test His6-GyrA* for accessibility of the His6-tag, the protein was applied to Ni2+-NTA 
column. His6-GyrA* was eluted with 500 mM imidazol, but not by washing with 20 mM 
imidazole, indicating specific binding of the N-terminal His6-tag to the immobilized metal 
ions as shown by the UV chromatogram and SDS-PAGE (Fig. 3.1 A and E).  
Protein precipitation was high during a second dialysis against a buffer containing 200 mM 
NaCl, but could be avoided by increasing the salt concentration to 300 mM. In the subsequent 
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size-exclusion chromatography step most of the protein eluted in the exclusion volume as a 
high-MW species, probably due to aggregation (Fig. 3.1 B and E). A small fraction of His6-
GyrA* eluted at a retention volume of 55 ml corresponding to an apparent MW of 270 kDa, 
which was the same for the non-tagged protein [36]. This fraction was pure as judged by 
SDS-PAGE (coommassie staining) (Fig. 3.1 G) and UV absorption. It was pooled and stored 
in 400 mM NaCl. The protein yield was 1.7 mg per liter culture, which is very low compared 
to the one of non-tagged protein (10 – 15 mg/l) [36].  
 
3.1.2 Introduction of a TEV protease cleavage site to the GyrA His6 fusion protein 
Due to the low solubility of the His6-tagged GyrA protein, a version with a cleavable His6-tag 
was devised: The nucleotide sequence encoding a TEV-protease cleavage site was inserted 
between the tag and the GyrA ORF by site-specific mutagenesis on the template vector 
pETDuet-1_ His6-gyrA* (section 2.9.4), allowing for the selection of the tagged proteins from 
the crude extract and subsequent removal of the tag. The tagged protein has a length of 840 
amino acids and an MW of 94.4 kDa. Removal of the tag should yield a wild-type like protein 
GyrA* lacking the N-terminal Met residue with a reduced length of 820 amino acids and a 
MW of 92.0 kDa. 
Like His6-GyrA*, the cleavable GyrA His6-tag fusion protein (His6-TEV-GyrA*) was 
produced in E. coli BL21 CodonPlus(DE3)RP cells (section 2.10.1) exhibiting a comparable 
expression level (Fig. 3.1 F). Most of the protein was found in the soluble fraction after cell 
disruption. The protein was efficiently adsorbed to a Ni2+-NTA column in a 1 M NaCl buffer 
containing 20 mM imidazole and eluted with 500 mM imidazole (Fig. 3.1 F). The protein was 
incubated with TEV protease at 4°C during dialysis against a buffer only 300 mM NaCl to 
facilitate protease cleavage. Subsequently the protein was passed over a Ni2+-NTA column 
where it could be found in the flow-through indicating a successful separation of GyrA from 
the His6-tag (Fig. 3.1 C and F). 
The cleaved protein was further purified by size-exclusion chromatography where most of it 
eluted as a dimer at a retention volume of 55 ml approx. (Fig. 3.1 D), similar to the non-
tagged protein and His6-GyrA* (section 3.1.1). Contamination by other proteins or nucleic 
acids was very low as judged by SDS-PAGE (Fig. 3.1 G) and UV absorption (the ratio 
A280/A260 being 2.0, which was similar to the value observed for GyrA purified by IEX [46]). 
21 mg of protein were obtained per liter of culture, which marks a 2-fold increase compared 
to the yields of non-tagged GyrA [36]. 
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Fig. 3.1: Production and purification of N-terminal His6-tagged full-length GyrA* (C, D). 
A – D: Chromatograms of selected purification steps for His6-GyrA* (A, B) and His6-TEV-GyrA*, 
monitored by absorption at 280 nm. Horizontal bars denominate protein fractions used for subsequent 
steps. 
A: Ni2+-IMAC of His6-GyrA* pre-purified by IEX; the protein bound to the resin at 20 mM imidazol 
and eluted with 500 mM. 
B: SEC of His6-GyrA* using a Superdex S200 column: GyrA predominantly eluted in the exclusion 
volume as a high MW species (45 ml). Only a small fraction of GyrA eluted as an apparent dimer (55 
ml). 
C: Second Ni2+-IMAC of His6-TEV-GyrA* cleaved with TEV protease (GyrA*): The protein does 
not bind to the resin and is found in the flow-through. 
D: SEC of cleaved His6-TEV-GyrA* using an Superdex S200: Most of the protein is eluted as a 
dimer at 55 ml retention volume. 
E – G: SDS polyacrylamide gels of different purification stages with protein marker (M) and 
corresponding MW indicated in kDa. 
E: Purification of His6-GyrA* (◄). 1: Expression from BL21(DE3). 2: Crude extract. 3: GyrA 
purified by IEX chromatography (Heparin). 4 and 5: Flow-through and elution from Ni2+-NTA column 
(see A). 6 His6-GyrA* eluted in the exclusion volume (46 ml; see B). 
Continued on following page. 
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F: Purification of His6-TEV-GyrA* (►). 1: Expression from BL21(DE3). 2: Crude extract. 3 and 4: 
Flow-through and elution from the first Ni2+-NTA column. 5: His6-TEV-GyrA* cleaved with TEV 
protease. 6 and 7: Flow-through and elution from the second Ni2+-NTA column (see C). TEV protease 
is visible as a faint band with an apparent MW of 30 kDa approx. (lanes 5 and 7); the cleaved His6-tag 
is missing due to its low MW of 2.4 kDa. 
G: Purified proteins as eluted from the Superdex S200 column (see B and C: collected fractions 
assigned with horizontal bars) in comparison with non-tagged GyrA wt purified by IEX 
chromatography and SEC. 1: His6-GyrA*. 2: GyrA* (NHT) (cleaved His6-TEV-GyrA*). 3: GyrA 
wt. All preparations are of similar purity. 
 
 
3.1.3 Affinity-purified GyrA proteins exhibit wild-type like activity 
His6-GyrA* and cleaved His6-TEV-GyrA* (hereafter abbreviated GyrA* NHT) were assayed 
for their relaxation and supercoiling activities in topoisomerase assays (section 2.12.1). 
DNA relaxation by His6-GyrA* was performed with 200 nM GyrA, 800 nM GyrB and 15 nM 
supercoiled pUC18 plasmid substrate. After 120 min incubation time at 37°C, half of the 
relaxation reaction was supplied with 2 mM ATP to induce supercoiling activity and 
incubated for further 2 min. Tagged GyrA and the wild-type control showed comparable 
relaxation and supercoiling activities under these experimental conditions (Fig. 3.2 A) 
indicating that neither the introduction of an N-terminal His6-tag nor the modification of the 
purification protocol significantly influenced the overall enzymatic activity of GyrA. 
The DNA relaxation and supercoiling activity tests of GyrA* NHT were performed in 
separate reactions. Both experiments were done under conditions described above. GyrA* 
NHT showed the same topoisomer distributions as wild-type GyrA in both relaxation and 
supercoiling tests (Fig. 3.2 B).  
 
 
 
Fig. 3.2: Plasmid DNA relaxation and ATP-dependent supercoiling activities of GyrA proteins 
purified as His6-tag fusions using 200 nM GyrA, 800 nM GyrB and 15 nM pUC18 in gyrase activity 
buffer (section 2.12.1). Incubation times were 30 and 2 min for DNA relaxation and ATP-dependent 
supercoiling reactions, respectively. 
A: 1 and 2: Relaxation and supercoiling reaction products for His6-GyrA*. 3 and 4: Relaxation and 
supercoiling reaction products for GyrA wt. 5: Control DNA (neg. supercoiled pUC18). 
B: 1 and 2: Control DNAs (neg. supercoiled and relaxed pUC18). 3 and 4: Relaxation and 
supercoiling reaction products for GyrA* NHT. 5 and 6: Relaxation and supercoiling reaction products 
for GyrA wt. 
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3.1.4 Purification of GyrA lacking the C-terminal domain 
A simple approach towards understanding the role of the C-terminal domain (CTD) in GyrA 
is the characterization of a CTD deletion mutant (ΔCTD). We produced two versions of 
GyrA_ΔCTD, both truncated after Thr489: A translational stop codon was introduced to the 
constructs pET-27b(+)_gyrA* and pETDuet-1_ His6-TEV-gyrA* by site-specific mutagenesis 
yielding a truncated wild-type GyrA body (MW: 55.3 kDa) and an N-terminal His6-tag fusion 
protein (MW: 57.6 kDa), respectively. Both constructs were expressed in E. coli BL21 
CodonPlus(DE3)RP cells, showing high expression levels of the respective proteins. 
The clarified crude extract containing non-tagged GyrA*_ΔCTD was applied to a heparin 
column in 200 mM NaCl. Under these conditions most of the protein was adsorbed and 
subsequently eluted in an NaCl gradient, achieving separation from the majority of E. coli 
proteins. However, the fractions containing the target protein still contained undesirable 
protein and nucleic acid. GyrA*_ΔCTD was further purified by size-exclusion 
chromatography using a Superdex S200 column: The protein eluted at a retention volume of 
64 ml (Fig. 3.3 A). Nucleic acid contaminations were efficiently removed as judged from the 
absorption ratio A280/A260 of 2.2, but the purified protein still contained minor protein 
impurities (Fig. 3.3 B and C). The yield was exceptionally high compared to full-length GyrA 
(45 mg compared to 10 – 20 mg per liter of bacterial culture). 
The tagged protein His6-TEV-GyrA*_ΔCTD was purified on a Ni2+-NTA column as 
described for the full-length enzyme His6-TEV-GyrA* (section 3.1.2): Most of the protein 
was adsorbed to the resin and eluted with 500 mM imidazole in a pure form. During over-
night dialysis against a buffer containing 500 mM NaCl the protein was cleaved from the N-
terminal His6-tag by TEV protease (GyrA*_ΔCTD NHT). After a second IMAC step most of 
the protein was found in the flow-through indicating efficient proteolytic removal of the tag. 
Further purification on a Superdex S200 size-exclusion column showed the same elution 
profile peaks observed for GyrA*_ΔCTD at retention volumes of 64 ml with a minor shoulder 
at approx. 67.5 ml (Fig. 3.3 A) corresponding to apparent MW of 120 and 88 kDa 
respectively, both containing pure truncated GyrA (Fig. 3.3 C). Fractions from the first peak 
reflecting the expected size of the dimeric protein were pooled and concentrated. 
GyrA*_ΔCTD was free from protein or nucleic acid contamination (absorption ratio A280/A260 
of 2.45; Fig. 3.3 B). The protein yield was similar as the one for the non-tagged construct (42 
mg per liter of bacterial culture). 
Both proteins could be concentrated to 1.1 mM without showing precipitation. 
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Fig. 3.3: Purification by SEC of GyrA*_ΔCTD pre-purified by IEX chromatography (non-tagged, I) 
and IMAC (N-terminal His6-tag, cleaved with TEV protease, II). 
A: Chromatograms of SEC purification of GyrA*_ΔCTD I (black line) and II (red line) with elution 
volumes of 64 ml. Horizontal bars denominate protein fractions pooled and concentrated for further 
use. Different contaminations could be eliminated successfully (I: nucleic acids eluting at 50 ml; II: 
GyrA*_ΔCTD with anomalous behavior eluting at 67.5 ml). 
B: UV absorption spectra for GyrA*_ΔCTD preparations I (black) and II (red) in storage buffer. 
Protein concentrations were 15 µM. Absorption maxima are found at 278 nm, the A280/A260 ratio is 
2.2 and 2.45 for preparations I and II, respectively. 
C: SDS polyacrylamide gels of purified GyrA*_ΔCTD (◄, 55 kDa) compared to wild-type GyrA ( , 
92 kDa). 1: GyrA wt. 2: Preparation I. 3: Preparation II. M: Protein marker with corresponding MW 
indicated in kDa. GyrA*_ΔCTD purified as a His6-tag fusion protein (preparation II) is of superior 
purity compared to protein from preparation I. 
 
 
3.1.5 GyrA_ΔCTD is supercoiling deficient 
The truncated GyrA proteins were tested for their remaining DNA relaxation and supercoiling 
activity. 200 nM GyrA proteins (ΔCTD and wild-type control) were incubated with 800 nM 
GyrB and 15 nM neg. supercoiled or relaxed pUC18, in the absence or presence of ATP at 
37°C. Both GyrA*_ΔCTD proteins showed a significantly decreased ATP-independent DNA 
relaxation activity compared to the wt control. In the presence of 2 mM ATP the relaxation of 
supercoiled plasmid DNA was dramatically enhanced (Fig. 3.4 A and B). The truncated GyrA 
proteins showed the same behavior, further indicating that the different purification protocols 
do not influence the enzymatic activities (Fig. 3.4 B). 
The protein purified by affinity chromatography showed complete substrate relaxation under 
the applied conditions after 5 min of incubation time with no visible change of product DNA 
topology after 25 or 80 min (Fig. 3.4 A). Incubation with relaxed plasmid DNA in the 
presence of 2 mM ATP did not yield supercoiled, but even further relaxed plasmid (Fig. 3.4 
B), indicating the complete loss of DNA supercoiling activity in the CTD deletion mutants. 
These results are in agreement with previous findings for E. coli gyrase [53], showing that the 
deletion of the GyrA CTDs converts gyrase to a conventional type II topoisomerase. 
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Fig. 3.4: DNA relaxation by GyrA CTD-deletion mutants. Reactions were performed using 200 nM 
GyrA proteins, 800 nM GyrB, and 15 nM plasmid substrates and gyrase activity buffer (section 
2.12.1). 2 mM ATP were added as indicated. Incubation times specified below. 
A: Plasmid DNA relaxation by GyrA*_ΔCTD NHT. 1 and 2: Relaxed and neg. supercoiled plasmid 
controls (pUC18). 3: Product of relaxation reaction by GyrA wt. 4 and 5: Relaxation by GyrA*_ΔCTD 
NHT after 25 and 80 min of incubation. 6 – 9: Relaxation by GyrA*_ΔCTD NHT after 1, 5, 25, and 
80 min of incubation in the presence of 2 mM ATP. 
B: Plasmid DNA relaxation by GyrA*_ΔCTD (lanes 1 – 4) and GyrA*_ΔCTD NHT (lanes 5 – 8). 1 
and 5: Relaxation after 30 min of incubation. 2 and 6: Relaxation after 5 min incubation. 3 and 7: 
Relaxation after 5 min of incubation in the presence of 2 mM ATP. 4 and 8: Product of truncated 
GyrA proteins acting on relaxed plasmid in the presence of 2 mM ATP (2 min incubation). 
In contrast to GyrA wt, GyrA*_ΔCTD-catalyzed plasmid DNA relaxation is ATP-dependent. The 
truncated protein is therefore deficient in plasmid DNA supercoiling. GyrA*_ΔCTD proteins from 
different preparations exhibit the same relaxation activities. 
 
3.1.6 DNA affinity of GyrA 
GyrA binds DNA at the DNA gate and the CTDs [90, 91]. In fluorescence anisotropy 
titrations DNA affinity for the wild-type GyrA and the CTD deletion mutant GyrA*_ΔCTD 
NHT (hereafter denominated GyrA_ΔCTD) were determined in the absence of GyrB. The 
60bp DNA used as a substrate containing one binding site (bs) for B. subtilis gyrase [33] was 
annealed from complementary strands, i.e. Gyr_60bp_1bs_for and fluorescently labeled 
Gyr_60bp_1bs_rev_A546. The anisotropy signal of Alexa546 linked to the 60bp DNA varied 
from 0.055 to 0.075 between different experiments (Fig. 3.5 A). 
The substrate DNA was titrated with GyrA up to a concentration of 10 µM, causing an 
increase of the anisotropy to approx. 0.2. The data were analyzed according to a 1 : 1 binding 
model and yielded a Kd of 2.3 ± 0.2 µM for the DNA enzyme complex. The maximal 
anisotropy was calculated as 0.225, indicating a 84 % saturation of the 60bp DNA at 10 µM 
enzyme concentration (Fig. 3.5 A). 
Titration of the substrate with GyrA_ΔCTD showed a much lower anisotropy increase than 
with GyrA wt. Enzyme was added up to a final concentration of 20 µM. The calculated Kd 
was 73 ± 64 µM. However, the curvature of the fit was not well defined due to incomplete 
saturation of the substrate, resulting in a standard error in the range of the Kd and a very 
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unlikely calculated maximal anisotropy of 0.39 (which is very high compared to the one for 
the DNA-GyrA wt complex). Fixing the maximal anisotropy to 0.225 as for GyrA wt leads to 
a lower calculated Kd of 43 ± 2 µM (Fig. 3.5 A). 
The deletion of the C-terminal domains leads to an approx. 20- to 50-fold decrease of affinity 
for the 60bp DNA. This clearly shows a high DNA affinity for the CTDs. Due to the lack of 
prominent DNA binding sites other than the DNA gate and on the CTDs, suggesting that the 
CTDs constitute the main DNA-binding site in GyrA. 
 
3.1.7 DNA affinity of GyrB 
The DNA affinity of GyrB was determined using the 60bp DNA. 10 nM DNA was titrated 
with B. subtilis wild-type GyrB to reach a final concentration of 20 µM. The anisotropy of the 
dye increased from a starting value of 0.070 up to approx. 0.20, showing a sigmoidal behavior 
(Fig. 3.5 B). The data could be described with the Hill equation and the following parameters: 
Kd was calculated as 17.1 ± 6.6 µM and the anisotropy under saturating conditions as 0.21 
approx. The Hill coefficient was determined as 1.99 ± 0.28, clearly indicating positive 
cooperative binding of more than one GyrB subunit to one molecule of DNA. 
 
 
 
 
 
Fig. 3.5: Anisotropy titrations with linear double stranded 60bp DNA containing one gyrase binding 
site (annealed from Gyr_60bp_1bs_for and Gyr_60bp_1bs_rev_A546) and GyrA, GyrA_ΔCTD and 
GyrB. 
A: Titrations with GyrA wt (black) and GyrA_ΔCTD (red) yield Kd values of 2.3 ± 0.2 and 43 ± 2 
µM, respectively. The latter is poorly defined due to non-sufficient saturation of the DNA substrate. 
B: Titration with GyrB wt. The fit employing the Hill equation yields a Kd value of 17.1 ± 6.6 µM and 
a Hill coefficient of 1.99 ± 0.28 indicating cooperative binding of at least two GyrB molecules to the 
60bp DNA. 
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3.1.8 The presence of GyrB increases GyrA affinity for DNA 
Next, the influence of GyrB on the GyrA affinity for DNA was determined. GyrA wt and 
GyrA_ΔCTD were titrated with 60bp DNA to a final concentration of 10 nM in the presence 
of 4 µM GyrB. This concentration of GyrB was by far not enough to saturate the DNA 
substrate in the absence of GyrA as the Kd is approx. 17 µM (Fig. 3.5B), but should saturate 
the GyrA2-60bp complex (personal communication by A. Gubaev). Most importantly, using 4 
µM of GyrB guaranteed for a medium initial anisotropy value and thus for a significant signal 
change upon addition of GyrA. As the anisotropy in this concentration range is very sensitive 
to small changes in concentration of GyrB, the start value ranged from 0.9 to 1.2 in different 
experiments.  
Measured Kd values for GyrA wt and GyrA_ΔCTD for the 60bp DNA in the presence of 
GyrB were 63 ± 5 nM and 299 ± 20 nM, respectively. This finding marks a 5-fold decrease of 
affinity for the substrate upon deletion of the CTD, which provided evidence of the high DNA 
affinity of the CTDs as already shown with titrations in the absence of GyrB (Fig. 3.6 A and 
B).   
The affinity constants also showed a sharp increase of affinity of 35-fold for GyrA wt and 15- 
to 25-fold for GyrA_ΔCTD due to the presence of GyrB (Fig. 3.6 A and B). As GyrA and 
GyrB mainly interact at the DNA gate, embracing the gate DNA segment, the increase in 
affinity of GyrA for DNA could be attributed to this interface. 
The calculated maximum anisotropies were 0.27 and 0.30 for wt GyrA and ΔCTD in complex 
with GyrB and 60bp DNA, respectively (Fig. 3.6 A and B), which is significantly higher than 
0.225 for the GyrA wt-60bp complex (Fig. 3.5 A).  
 
 
Fig. 3.6: Anisotropy titrations of 60bp DNA substrate with GyrA and GyrA_ΔCTD in the presence of 
4 µM GyrB. 
A: Titration with GyrA (black). The Kd value is 63 ± 5 nM in the presence of GyrB, which marks a 
35-fold increase in affinity over GyrA in the absence of GyrB (grey). 
B: Titration with GyrA_ΔCTD (black). The measured Kd is 299 ± 20 nM, which is approx. 25-fold 
lower than in the absence of GyrB (grey). 
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3.1.9 DNA affinity of GyrA decreases strongly with DNA substrate length  
From the 60bp substrate DNA two shorter DNAs of 48 and 37 base-pair length were derived, 
both containing the preferred binding site in the center of the sequence [92] and an A546 label 
at the same position (Fig. 3.7). The affinities of GyrA wt and GyrA_ΔCTD for the DNA 
fragments were measured in fluorescence anisotropy titrations, using 10 nM DNA and 4 µM 
GyrB. The anisotropy value in the absence of GyrA was 0.085 – 0.095 for both DNAs (Fig. 
3.8 A and B). 
 
 
 
Fig. 3.7: DNA substrates used in anisotropy titrations. From top to bottom: nucleotide sequences of 
Gyr_37bp_1bs_rev, Gyr_48bp_1bs_rev, and Gyr_60bp_1bs_rev DNAs. Sequences of the 
complementary strands are listed in section 2.3.3. The preferred gyrase binding site is highlighted in 
red. Cleavage sites on the depicted and complementary strands are marked with black and white 
arrows, respectively. The thymines highlighted in blue carry the A546 lable. 
 
 
Titrations with wt GyrA yielded Kd values of 189 ± 13 nM and 654 ± 88 nM for 48bp and 
37bp substrates, respectively. Compared to the affinity of 63 nM for the 60bp DNA, the one 
for the shorter substrates drops approx. 3- and 10-fold, indicating a non-proportional 
correlation between GyrA affinity and substrate length (Fig. 3.8 A).  
The same experiments were performed with GyrA_ΔCTD yielding Kd values for the 48bp and 
37bp substrates of 378 ± 27 nM and 462 ± 46 nM, respectively. This corresponds to a 1.3- and 
1.5-fold decrease in affinity compared to Kd values of 299 nM measured for the 60bp DNA. 
These data indicate a linear relation between Kd values and the substrate length (Fig. 3.8 B). 
The Kd values for the 60bp and 48bp substrates are 5- and 2-fold lower in wt GyrA than in 
GyrA_ΔCTD, suggesting that the gain of affinity in the presence of the CTD decreases with 
DNA chain length. This interpretation is supported by the Kd value for the 37bp DNA which 
is even 1.4-fold higher in wt GyrA than in GyrA_ΔCTD. The findings suggest that the 60bp 
and 48bp DNA substrates contact the CTDs, whereas this interaction seems to be lost in case 
of the 37bp DNA. Thus, the minimal length of a DNA substrate that bridges the DNA-gate 
and the CTDs should be between 37 and 48 bp. 
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Fig. 3.8: Anisotropy titrations of linear double stranded DNAs with GyrA wt and GyrA_ΔCTD in the 
presence of 4 µM GyrB. 
A: Titrations of linear double-stranded DNAs with GyrA wt. Kd values are 63 ± 5 nM (60bp), 189 ± 
13 nM (48bp) and 654 ± 88 nM (37bp). 
B: Titrations of linear double stranded DNAs with GyrA_ΔCTD. Kd values are 299 ± 20 nM (60bp), 
378 ± 27 nM (48bp) and 462 ± 46  nM (37bp). 
 
 
3.1.10 Construction of GyrA for single molecule experiments 
It was shown that the C-terminal domain of GyrA is indispensable for the DNA supercoiling 
activity of gyrase from E. coli [53] and B. subtilis (section 3.1.5). The CTD was proposed to 
undergo conformational changes when binding and releasing DNA during the supercoiling 
cycle. In order to elucidate potential movement we performed single-molecule FRET 
measurements, for which two GyrA systems were constructed: A set of homo-dimeric GyrA 
mutants for fluorescent labeling at one position in both CTDs, and hetero-dimeric GyrA with 
one subunit bearing two labeling sites, one on the GyrA body (the so-called cleavage and 
religation domain) and another on the CTD. 
 
3.1.11 Homo-dimeric constructs with dyes on both CTDs 
B. subtilis GyrA CTD was modeled using the structure of the E. coli GyrA CTD (PDB entry: 
1ZI0, chain B [50]) employing the SWISS-MODEL structure homology-modeling server 
[93]. Four presumably solvent exposed and non-conserved amino-acid residues as judged 
from alignments of homologous protein sequences were selected for the mutation to cysteine 
residues: K570 and K594 on opposite faces of blade 2 close to the amino terminus, and D695 
and E726 on blades 4 and 5 respectively, both located on the distant end of the β-pinwheel 
fold (Fig. 3.9A). 
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Fig. 3.9: Sites for cysteine introduction on GyrA CTD 
A: Front (left) and side (right) views of a structural model of B. subtilis GyrA CTD in cartoon 
representation. The CTD exhibits a β-pinwheel fold with a pseudo 6-fold symmetry, consisting of 6 
sectors (blades) of antiparallel β-sheet structure [50]. N (blue): Amino terminus and the attachment 
point to the N-terminal domain of GyrA. Residues depicted as yellow (K570, E726) and red spheres 
(K594, D695) were selected for individual mutation to Cys. 
B: SDS-polyacrylamide gel of GyrA*_D695C labeled with A488 (1, 3) or A546 (2, 4) in fluorescence 
view (right) and after coommassie staining (left). Non-reacted dye is annotated D. The protein size 
marker is denominated M, and corresponding MW are indicated in kDa. Labeling efficiencies were 87 
and 92 % for A488 and A546, respectively. 
 
Production, fluorescent labeling, and activity of single Cys FRET mutants 
All of the four GyrA Cys mutants lacked the only native cysteine located in the GyrA body 
[33]. The proteins were produced and purified as described (section 2.10.2). The mutants 
GyrA*_K594C and E726C had been produced ahead of this work [36]. Mutants K570C and 
D695C were purified to similar yields (11 – 13 mg/l bacterial culture) and purity (very low 
protein and nucleic acid contamination) as described for the wild-type. 
For single-molecule experiments the proteins were statistically labeled with fluorescent dyes 
as described in section 2.16.1, using a 3- and 4-fold excess of Alexa488 (A488) and Alexa546 
(A 546) maleimide dyes over protein, respectively. The total labeling degree (i.e. the sum of 
the individual labeling degrees of the dyes) for each of the Cys mutants was up to 100% with 
respect to available Cys residues, demonstrating good solvent accessibility of the selected 
positions (e.g. labeling of GyrA*_D695C with either A488 or A546: Fig. 3.9B) 
It is of utmost importance that proteins modified for single-molecule experiments retain 
enzymatic activity. Ahead of this work GyrA*_K594C and _E726C mutants were shown to 
possess wild-type like supercoiling activity even when labeled with Alexa488 and Alexa546 
dyes [36]. Also the newly constructed mutants GyrA*_K570C and _D695C exhibited 
unchanged DNA supercoiling and relaxation activities, suggesting that neither the mutation of 
above mentioned residues to cysteine nor the chemical modification altered the enzymatic 
behavior (Fig. 3.10 A – C). 
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Fig. 3.10: DNA relaxation and ATP-dependent supercoiling activity of GyrA single Cys mutants 
using 200 nM GyrA, 800 nM GyrB, and 15 nM pUC18. Supercoiling reactions used relaxation 
reactions as starting points and were supplied with 2 mM ATP. Incubation times were 30 and 2 min 
for the relaxation and supercoiling reactions, respectively. Reactions were performed in gyrase activity 
buffer (section 2.12.1). 
A: Plasmid DNA relaxation and supercoiling activity of non-labeled GyrA mutants K570C and 
D695C compared to wild-type GyrA. 1 and 2: Relaxation and supercoiling by GyrA wt. 3: 
Supercoiled pUC18 plasmid. 4 and 5: Relaxation and supercoiling by GyrA*_D695C. 6 and 7: 
Relaxation and supercoiling by GyrA*_K570C. Both mutant proteins exhibited wild-type like 
relaxation and supercoiling activities. 
B: Plasmid DNA relaxation and supercoiling activity tests of non-labeled and double labeled 
GyrA*_K570C. 1 and 2: Relaxation and supercoiling by the non-labeled mutant. 3 and 4: Relaxation 
and supercoiling by the mutant labeled with A488 and A546 (total labeling degree: 75 %). The double 
labeled protein showed a slightly increased relaxation but similar supercoiling activity compared to the 
non-labeled enzyme.  
C: Plasmid DNA relaxation and supercoiling activity tests of non-labeled and labeled GyrA*_D695C. 
1 and 2: Relaxation and supercoiling by the non-labeled mutant. 3 and 4: Relaxation and supercoiling 
by the mutant labeled with A488  (labeling degree: 95 %).  5 and 6: Relaxation and supercoiling by the 
mutant labeled with A546 (labeling degree: 100 %). Labeled proteins exhibited the same activities as 
the non-labeled enzyme. 
 
3.1.12 Hetero-dimeric GyrA FRET constructs 
Parallel to the construction of single-cysteine mutants, the formation of hetero-dimeric GyrA 
constructs was attempted: The main objective was to create a FRET mutant composed of one 
wild-type subunit and one mutant subunit with two labeling sites, one each on the GyrA body 
and on the CTD. Such a construct has several advantages over the homo-dimeric GyrA FRET 
mutants: (I) It would allow to observe conformational changes of an individual CTD with 
respect to the GyrA body. (II) At the same time the degrees of freedom between the domains 
labeled with fluorescent dyes would be reduced. (III) Very importantly, the number of 
possible arrangements of the two dyes would be increased: Given the dimensions of the GyrA 
body dimer of roughly 9 nm in diameter, the distance between the CTDs should be at least in 
the same range, limiting the applicability of FRET measurements with homo-dimeric 
constructs. In a hetero-dimeric construct the inter-dye distance could be adjusted to values 
within the sensitive range of FRET signals (i.e. 3 to 8 nm). 
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GyrA subunit separation under denaturating conditions 
One possibility to construct GyrA hetero-dimers would be the separation and subsequent 
reconstitution of different GyrA homo-dimers. The chaotropic denaturant GuHCl was used to 
explore subunit separation by denaturation. GyrA mutants labeled with donor (Alexa488) and 
acceptor dyes (TMR) at the DNA gate (T140C) or at the C-gate (T408C), both known for 
small inter-dye distance and FRET efficiencies higher than 0.8 [33], were incubated with 
varying concentrations of GuHCl. The separation of the dimer interfaces was monitored in 
ensemble FRET experiments, calculating a apparent FRET efficiency from fluorescence 
spectra corrected for buffer contributions as described in section 2.17. In the absence of 
GuHCl, both double-labeled GyrA mutants showed strong acceptor fluorescence emission 
upon excitation of the donor dye, showing efficient energy transfer between donor and 
acceptor dyes as expected (Fig. 3.10 A). 
GyrA*_T140C exhibited a total loss (as judged from the spectra) of acceptor signal with 
concomitant increase in donor fluorescence intensity in a GuHCl concentration range between 
0.5 and 1.75 M, indicating a structural rearrangement of the DNA-gate with a melting point at 
approx. 1.25 M GuHCl (visual inspection). At higher GuHCl concentration no further change 
in fluorescence intensities could be detected apart from a continuous red-shift of fluorescence 
maxima (from 516 to 521 nm and from 571 to 577 nm for donor and acceptor, respectively) 
(Fig. 3.11 C). 
Incubation of GyrA*_T408C with up to 5 M GuHCl did not strongly influence donor and 
acceptor fluorescence intensities, apart from shifting the fluorescence maxima to slightly 
higher wavelengths. This finding indicates that the dimer interface of the C-gate is not 
disrupted even at high denaturant concentration (3.10 B). This is in contrast to the data for the 
DNA-gate, indicating much stronger dimer stability at the C-gate. 
The two experiments clearly demonstrated that separation of the GyrA dimer at low 
concentrations of GuHCl is not possible; thus subunit exchange cannot be achieved by this 
method. 
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Fig. 3.11: Disruption of intersubunit contacts in GyrA mutants in the presence of GuHCl. 
A and B: Fluorescence emission spectra of GyrA*_T140C and _T408C labeled with A488 and TMR 
in the presence of different concentrations of GuHCl (0 – 5 M). Spectra are normalized with an 
apparent FRET efficiency (eq. 2.14). Donor and acceptor fluorescence exhibit a slight red-shift of 
approx. 5 nm with increasing GuHCl concentration. 
A: For GyrA*_T140C a sharp decrease of the acceptor flurescence (574 nm) and a concomitant 
increase of the donor signal (approx. 519 nm) was observed in the range of  0.75 to 1.75 M GuHCl. 
Labeling efficiencies were 35 and 58 % for A488 and TMR, respectively. 
B: Normalized fluorescence spectra of GyrA*_T408C labeled with A488 and TMR remain constant 
across the tested GuHCl concentration range. Labeling efficiencies were 26 and 44 % for A488 and 
TMR, respectively. 
C: Apparent FRET efficiencies calculated from fluorescence emission spectra were plotted against the 
GuHCl concentration for both mutants. GyrA*_T140C (red) exhibited two distinct crude FRET 
efficiencies (initial: 0.38; final: 0.2) with a transition at approx. 1.25 M GuHCl. The apparent FRET 
efficiency in GyrA*_T408C (blue) remained constant around a value of 0.32 in the tested GuHCl 
concentration range. 
 
Co-production of two GyrA proteins 
As the separation of the GyrA dimer by denaturation with GuHCl could not be achieved (see 
section above) the formation of hetero-dimeric GyrA was performed by co-production in E. 
coli. Two plasmids encoding different versions of GyrA and conferring different antibiotic 
resistance were co-transformed into E. coli expression strains. Initial transformation of 
cloning vectors pET-27b(+)_gyrA_mut and pETDuet-1_His6-TEV-gyrA* resulted in cell 
proliferation stop, probably following concomitant loss of one plasmid and the antibiotic 
resistance due to identical replication origins of the two plasmids. However, co-
transformation of the vectors pACYCDuet and pET-27b(+) encoding His6-TEV-GyrA* 
_ΔCTD and full-length GyrA*_ T140C_K594C, respectively, resulted in stable protein co-
production (Fig. 3.12 A).   
Numerous double cysteine GyrA mutants were co-produced with His6-tagged wild-type GyrA 
and purified as described in section 2.10.2. The single or double tagged GyrA dimers were 
separated from host protein and non-tagged homo-dimeric GyrA by adsorption to a Ni2+-NTA 
column (Fig. 3.12 B). The amount of GyrA protein found in the flow-through was high for all 
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co-expression products, but varied significantly between single purifications, probably 
depending on the production ratio and differences in solubility of the tagged and non-tagged 
proteins. The fully purified proteins were of similar purity as the GyrA* NHT purified by 
IMAC (section 3.1.2) with only low protein or DNA contaminations detectable. The yields 
were generally lower, ranging from 3 to 6 mg/l bacterial culture for most co-expressed and 
co-purified GyrA proteins. An exception was GyrA* / GyrA*_N314C_K594C which yielded 
only 0.5 mg/l culture due to a low expression level and slight solubility problems. 
The production and purification of hetero-dimeric GyrA proteins was performed with the help 
of Ines Hertel (group Klostermeier, Biozentrum, University of Basel). 
 
 
 
Fig. 3.12: Co-expression  and co-purification of two GyrA proteins. 
A: SDS polyacrylamide gel of co-expressed His6-TEV-GyrA*_ΔCTD (◄) and 
GyrA*_T140C_K594C ( ) from E. coli BL21(DE3) cells (CE). Cloning vectors used were 
pACYCDuet-1 and pET-27b(+) for the CTD-deletion mutant and the full-length enzyme respectively. 
M: Protein standard with corresponding MW indicated in kDa. 
B: SDS polyacrylamide gel of early purification steps of co-expressed His6-TEV-GyrA* / GyrA* 
double Cys mutants E211C_K570C and E250C_K594C. L: Crude cell extracts as loaded to the first 
Ni2+-NTA column. FT and E: Flow-throughs and elutions from the Ni2+-NTA column (at 20 and 500 
mM imdazol, respectively). A large fraction of GyrA protein was not adsorbed to the resin indicating 
the lack of His6-tags in the protein complex.  
C: Magnified view of GyrA bands of E250C_K594C constructs eluted from the Ni2+-NTA column 
(lane E). GyrA, which eluted at high imidazol concentrations, consisted of two different species with a 
small but visible difference in MW as expected for co-expressed tagged and non-tagged GyrA 
proteins. This is a strong indication that a large fraction of purified GyrA is indeed hetero-dimeric. 
 
Cysteine positions in double mutants 
In order to detect conformational change between the GyrA body and the CTD, double 
cysteine mutants with one Cys on the CTD and one on the body domain were constructed. 
Positions on the CTD were equivalent to those described in section 3.1.11. Cysteine mutations 
on the body were introduced at the DNA gate (T140C), C-gate (N399C, T408C), and on the 
tower domain (E211C, E250C, T299C, N314C). B. subtilis GyrA body was modeled using E. 
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coli GyrA body as a template (PDB entry 2Y3P [94]), and mutagenesis sites were chosen on 
the basis of this homology model. The locations of mutated residues are depicted in Fig. 
3.13A. 
 
 
 
Fig. 3.13: Sites for cysteine introduction on the GyrA body; fluorescent labeling of homo-dimeric 
single-cysteine mutant E250C and hetero-dimeric GyrA containing one double-cysteine mutant 
subunit (E250C_K570C). 
A: Side (left) and front view (right) of a structural model of B. subtilis GyrA body in cartoon 
representation (using E. coli GyrA as a template: PDB entry 2Y3P [94]). C (black): Carboxy terminus 
of GyrA and the attachment point of the linker peptide to the CTD. Residues depicted as spheres were 
selected for mutation to cysteine: T140 at the DNA gate (red); E211, E250, T299, and N314 in the 
tower domain (blue); N399 and T408 at the C-gate (green). 
B: SDS-polyacrylamide gel of GyrA*_E250C labeled with A488 (1, 3) and A546 (2, 4) in 
fluorescence view (right) and after coommassie staining (left). No non-reacted dye is visible (D). The 
protein size marker is denominated M, and corresponding MW are indicated in kDa. Labeling 
efficiencies were 85 and 97 % for A488 and A546, respectively. 
C: Absorption spectrum of hetero-dimeric GyrA* / GyrA*_E250C_K570C labeled with A488 and 
A546. Contributions of the protein, A488 and A546 are denominated P, D, and A. Labeling degrees 
were calculated from absorption maxima at 280, 493 and 555 nm as described (section 2.16.3). Values 
were approx. 35 and 55 % for A488 and A546, respectively, relative to available cysteines (assuming 
pure hetero-dimeric protein without contaminations by homo-dimeric GyrA wt). 
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Fluorescent labeling of hetero-dimeric GyrA 
Single cysteine mutants GyrA*_T140C, _E211C and E250C were labeled under conditions 
described in section 2.16.1. Modification degrees were 85 to 100 % for all positions using 
dyes Alexa488 and Alexa546, indicating good solvent accessibility for the introduced 
cysteine residues and a sufficiently high accuracy of the structural model of the GyrA body 
(e.g. labeling of GyrA*_E250C: Fig. 3.13 B). The mutants GyrA*_T140C, _N399C and 
_T408C were labeled to similar degrees as shown in experiments performed ahead of this 
work [33, 36].  
With the knowledge that individually introduced cysteines could be fully labeled several co-
produced GyrA* / GyrA*_double Cys mutants were fluorescently labeled using the same 
dyes and procedure as for the homo-dimeric single Cys mutants (sections 2.16.1 and 3.1.11). 
For all the proteins both labeling with one or two dyes resulted in labeling degrees of 80 – 
100% with respect to the concentration of GyrA monomers (e.g. absorption spectrum of 
GyrA* / GyrA*_E250C_K570C: Fig. 3.13 C). This was also the case for double Cys mutants 
T299C_K594C and N314C_K570C which had not been tested in single Cys mutants, 
suggesting full solvent accessibility for the positions T299C and N314C. 
Hetero-dimeric  GyrA contains two cysteine residues (located both on the same subunit while 
the other is cysteine-free). Assuming pure hetero-dimeric protein (without contaminations by 
homo-dimeric GyrA wt) the concentration of subunits should be equal to the one for available 
cysteine residues. Thus, labeling degrees of close to 100 % (total dye concentration relative to 
total GyrA concentration) indicated that most of the GyrA dimers actually consisted of two 
different monomers (Fig. 3.13 C). 
 
Activity of hetero-dimeric GyrA proteins 
GyrA*_T140C, _E211C, _N399C, and _T408C were shown to retain wild-type like DNA 
relaxation and supercoiling activity in their purified and fluorescently labeled states [33, 36]. 
Hence, it was assumed that hetero-dimeric protein containing a GyrA subunit with combined 
Cys mutations would also exhibit unaltered activity. This hypothesis was validated in DNA 
supercoiling assays by gyrase containing the hetero-dimeric GyrA proteins most often used in 
single molecule experiments (sections 3.1.16, 17). Of all the proteins tested only GyrA* / 
GyrA*_E211C_K594C showed a slightly reduced activity. Generally labeling of hetero-
dimeric GyrA did not result in loss of activity (Fig. 3.14 A and B). 
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Fig. 3.14: DNA supercoiling by non-labeled and fluorescently labeled GyrA dimers containing one 
GyrA* and one GyrA* Cys double mutant subunit (GyrA2*_double mutant). Reactions were 
performed using 50 nM GyrA, 800 nM GyrB, 50 nM pUC18 –sc, and 2 mM ATP, in gyrase activity 
buffer (section 2.12.1). Incubation time was 2 min. Lanes marked D and A contain protein labeled 
with donor (A488) or acceptor dye (A546), respectively. 
A: 1 and 2: Negatively supercoiled and relaxed pUC18 plasmid. 3: Plasmid supercoiled by wild-type 
gyrase. 4 – 6: Supercoiling by gyrase containing GyrA2*_T140C_K570C. 7 – 9: Supercoiling by 
gyrase containing GyrA2*_T140C_K594C. 
B: 1 and 2: Negatively supercoiled and relaxed pUC18 plasmid. 3: Plasmid supercoiled by wild-type 
gyrase. 4 – 6: Supercoiling by gyrase containing GyrA2*_E211C_K570C. 7 – 9: 
Supercoiling by gyrase containing GyrA2*_E211C_K594C. 10 – 12: Supercoiling by gyrase 
containing GyrA2*_E250C_K570C. 13 – 15: Supercoiling by GyrA2*_E250C_K594C. 
 
 
3.1.13 Correction parameters for single-molecule measurements 
To correctly interpret a FRET efficiency of a donor- and acceptor-labeled molecule and to 
subsequently extract distance information, the fluorescence signal has to be corrected for 
photophysical properties of the dyes and contributions of the measurement conditions (e.g. the 
single-molecule confocal microscope).  
The correction parameters α, β, γ and δ for single-cysteine GyrA mutants K570C, K594C, 
D695C and E726C were determined for the non-complexed GyrA, while parameters for the 
hetero-dimeric GyrA constructs with two different labeling sites were determined in the 
absence and presence of GyrB and DNA and for combinations of labeling positions on the 
GyrA body (T140C, E211C, E250C) and on the CTD (K570C and K594C). Measurements 
and calculations were done as described (section 2.18.2), and values for correction parameters 
are listed in tables 3.1 – 3.3. Parameter α correcting for detection of donor fluorescence in the 
acceptor channel did not deviate more than 10 % between different FRET pairs, with an 
average value of 0. 35, indicating low change of donor fluorescence signal due to different 
environment. Parameters β and γ, correcting for acceptor cross-detection and difference in 
quantum yield and detection efficiencies of donor and acceptor fluorescence, respectively, 
exhibited higher differences between FRET pairs, suggesting increased acceptor fluorescence 
intensity changes depending on the attachment site of the dye in GyrA (Tables 3.1 – 3.3). The 
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parameter δ also showed values of 0.09 to 0.17 with an average of approx. 0.12, indicating 
significant direct excitation of the acceptor dye (approx. 10 - 17 % of the excitation of the 
donor dye); variation of approx. 50 % indicate that the local environment of the dyes 
influence absorption significantly. The correction parameters α’, β’ and γ’ were calculated 
from the parameters α, β, γ and δ as described (section 2.18.2). 
The average correction parameters α’, β’ and γ’ determined from data recorded at 37°C in the 
absence of DNA and GyrB were calculated as 0.67, 0.0104 and 3.08, respectively (Table 3.2). 
They were used to correct single-molecule data recorded at 37°C involving labeled GyrA 
mutants for which site-specific correction parameters had not been determined. 
 
 
 
Table 3.1: Photophysical correction parameters and Förster distances for homo-dimeric single 
cysteine GyrA mutants labeled at two equivalent positions, acquired at 25°C for labeled GyrA in the 
absence of ligands. α, β, γ, and δ denominate correction parameters, α', β' and γ' the ones corrected 
with δ. R0 is the Förster distance, calculated with the donor fluorescence quantum yield ФD and the 
overlap integral J(λ). The orientation factor κ2 and the refractive index n were set to listed values. 
 
Mutant K570C K594C D695C E726C 
α 0.33 0.32 0.32 0.33 
β 0.0067 0.0077 0.0073 0.0127 
γ 2.5 3.11 2.85 2.33 
δ 0.12 0.1 0.09 0.09 
α' 0.63 0.63 0.58 0.54 
β' 0.0067 0.0077 0.0073 0.0127 
γ' 2.79 3.41 3.1 2.53 
ФD 0.366 0.373 0.427 0.606 
J(λ) (*1015) 3.32 2.62 3.26 2.70 
κ2 0.667 
n 1.33 
R0 (nm) 5.32 5.13 5.45 5.59 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tables 3.2 (top) and 3.3 (bottom): Photophysical correction parameters and Förster distances for hetero-dimeric GyrA proteins labeled at two non-equivalent 
positions (double cysteine mutant) for the correction of single-molecule FRET data obtained at 37°C in the absence (Tab. 3.2) and in the presence (Tab. 3.3) 
of DNA and GyrB. α, β, γ, and δ denominate correction parameters, α', β' and γ' the ones corrected with δ. R0 is the Förster distance, calculated with the donor 
fluorescence quantum yield ФD and the overlap integral J(λ). The orientation factor κ2 and the refractive index n were set to listed values. 
Donor T140C K570C T140C K594C E211C K570C E211C K594C E250C K570C E250C K594C 
Acceptor K570C T140C K594C T140C K570C E211C K594C E211C K570C E250C K594C E250C 
average 
α 0.35 0.34 0.35 0.34 0.33 0.34 0.33 0.34 0.36 0.35 0.36 0.36 0.35 
β 0.0076 0.0015 0.0089 0.0149 0.0076 0.0126 0.0089 0.0126 0.0042 0.0122 0.0078 0.0122 0.0092 
γ 4.25 2.40 3.68 3.12 2.84 2.55 2.46 3.10 1.94 2.14 1.70 2.94 2.76 
δ 0.10 0.15 0.11 0.12 0.10 0.14 0.11 0.12 0.11 0.15 0.12 0.12 0.12 
α' 0.77 0.70 0.75 0.71 0.61 0.69 0.60 0.71 0.57 0.67 0.56 0.71 0.67 
β' 0.0076 0.0149 0.0089 0.0149 0.0076 0.0126 0.0089 0.0126 0.0042 0.0122 0.0078 0.0122 0.0104 
γ' 4.66 2.75 4.07 3.48 3.12 2.89 2.72 3.46 2.15 2.45 1.90 3.28 3.08 
ФD 0.48 0.37 0.48 0.41 0.45 0.37 0.45 0.41 0.58 0.37 0.58 0.41 0.45 
J(λ) (*1015) 3.18 3.43 3.32 3.29 3.21 3.36 3.35 3.22 3.20 3.47 3.33 3.33 3.31 
κ2 0.667 
n 1.33 
R0 (nm) 5.53 5.37 5.56 5.42 5.49 5.35 5.52 5.40 5.71 5.38 5.75 5.43 5.49 
Donor T140C K570C T140C K594C E211C K570C E211C K594C E250C K570C E250C K594C 
Acceptor K570C T140C K594C T140C K570C E211C K594C E211C K570C E250C K594C E250C 
α 0.37 0.36 0.37 0.36 0.34 0.36 0.34 0.36 0.39 0.38 0.39 0.37 
β 0.0177 0.0184 0.0184 0.0184 0.0177 0.0178 0.0184 0.0178 0.0109 0.0115 0.0111 0.0115 
γ 4.76 2.83 4.10 3.20 4.25 3.29 3.64 3.77 3.09 3.24 2.68 3.80 
δ 0.11 0.15 0.12 0.13 0.10 0.14 0.11 0.12 0.12 0.14 0.13 0.12 
α' 0.89 0.78 0.85 0.77 0.76 0.81 0.73 0.81 0.76 0.83 0.74 0.82 
β' 0.0177 0.0184 0.0184 0.0184 0.0177 0.0178 0.0184 0.0178 0.0109 0.0115 0.0111 0.0115 
γ' 5.24 3.23 4.55 3.59 4.64 3.72 4.01 4.19 3.45 3.67 3.02 4.23 
ФD 0.48 0.51 0.48 0.40 0.56 0.51 0.56 0.40 0.56 0.51 0.56 0.40 
J(λ) (*1015) 3.31 3.47 3.50 3.44 3.33 3.22 3.52 3.20 3.34 3.37 3.53 3.34 
κ2 0.667 
n 1.33 
R0 (nm) 5.57 5.66 5.62 5.44 5.72 5.60 5.77 5.37 5.72 5.64 5.77 5.41 
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3.1.14 Determination of Förster distances for GyrA constructs 
Distance information for a given pair of fluorescent dyes can be calculated from 
corresponding FRET efficiencies according to eq. 2.24., employing the Förster distance for 
this specific dye pair. Förster distances were determined as described (section 2.18.3) for the 
following dye arrangements: For single-cysteine GyrA mutants K570C, K594C, D695C and 
E726C in the non-complexed state; and  for hetero-dimeric constructs with two fluorescent 
labels, one on the GyrA body (T140C, E211C, or E250C) and one on the CTD (K570C or 
K594C) (Tables 3.1 – 3.3).  
The donor quantum yield and the overlap integral of donor fluorescence emission and 
acceptor absorption were determined, but the orientation factor κ2 and the refraction index of 
the medium between the dyes in a given FRET system were assumed as 2/3 and 1.33, 
respectively [86, 87]. The quantum yields of A488 coupled to GyrA mutants were determined 
from absorption data and fluorescence emission spectra as described (section 2.18.3). 
Corresponding fluorescence measurements were performed at 25°C or 37°C for the correction 
of measurements involving homo-dimeric single cysteine mutant proteins and hetero-dimeric 
mutants with non-equivalent labeling positions (double cysteine mutants), respectively. 
Quantum yields for A488 attached to different location showed values between 0.37 and 0.61 
with an average of 0.44 for measurements at 37°C (Tables 3.2 – 3.3). The overlap integral 
J(λ) was calculated as described (section 2.18.3). J(λ) values ranged from 2.62 to 3.52 * 1015, 
scattering not more than 10% for the hetero-dimeric proteins (Tables 3.2 – 3.3). The resulting 
Förster distances R0 for the dye pair used (A488, A546) were close to the values of approx. 
5.5 nm determined before [33, 84], the lowest and highest being 5.13 and 5.57 nm, 
respectively. 
The average Förster distance determined from data recorded at 37°C in the absence of DNA 
and GyrB was calculated as 5.49 nm (Table 3.2). It was used to derive FRET distances from 
measurements involving GyrA mutants for which R0 had not been determined. 
 
 
3.1.15 Determination of the CTD position with smFRET data from labeled single-
cysteine GyrA mutants 
To characterize the position of the C-terminal domains of GyrA, the FRET efficiency of 
protein with two fluorescence labels, one on each CTD, was measured on a single-molecule 
confocal microscope. GyrA*_K570C, _K594C, _D695C, and E726C single cysteine mutants 
were labeled with fluorescent dyes (Alexa488 and Alexa546) as described (section 2.16.1). 
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The temperature of the microscope objective was not controlled; therefore the incubation 
temperature was estimated as 25°C. FRET efficiencies were calculated from fluorescence 
bursts of diffusing particles and corrected for photophysical properties of the dyes attached to 
the protein using correction parameters listed in table 3.1.  
FRET efficiency histograms of the labeled GyrA mutants K570C and K594C yielded 
unimodal distributions with maxima between 0.2 and 0.3 (Fig. 3.15). While the distribution 
for K594C was very narrow, the one for K570C was less well defined. Distance histograms 
were calculated from FRET efficiencies using the Förster distances determined before 
(section 3.1.14). For both mutants the distance distribution were well defined and could be 
approximated with a Gaussian, yielding mean inter-dye distances of 5.8 and 6.1 nm for 
mutants K570C and K594C, respectively (Fig. 3.15). The GyrA mutants D695C and E726C 
exhibited very low FRET efficiencies with distribution maxima of close to 0 and shoulders 
ranging up to 0.4 (Fig. 3.15), indicating a larger distance between labeling sites than observed 
for positions 570 and 594. For the mutant E726C a minor high-FRET population was 
observed. The corresponding distance histograms showed well defined distributions with 
maxima at approx. 7.5 nm and small shoulders at lower distances that could be correlated to 
the high FRET-efficiency population. The distance histogram for mutant D695C exhibited a 
similar behavior; thus, both histograms were described with a double Gaussian (Fig. 3.15). 
Each of the four mutants exhibited one major FRET-efficiency distribution, indicating a well-
defined position of both CTDs in a symmetrical arrangement. With the presented data set it 
was not possible to locate the domains with respect to the GyrA body. Nevertheless the 
position close to the connection points of GyrA body and CTDs could be excluded given a 
distance of approx. 90 nm (Fig. 3.13 A: C-terminus of GyrA body). 
 
Fig. 3.15: Description see following page. 
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Fig. 3.15: SmFRET histograms (top) and corresponding distance histograms (bottom) for GyrA homo-
dimers labeled at equivalent sites on the CTDs. FRET efficiency histograms for ligand-free GyrA 
mutants K570C and K594C exhibited FRET efficiency maxima at 0.3 and 0.2, respectively, which 
converted to inter-dye distances of 5.8 and 6.1 nm as determined from Gaussian fits of the distance 
histograms. FRET histograms for mutants D695C and E726C showed maxima at approx. 0 and 0.1 
FRET efficiency, respectively, with a small high-FRET peak visible for the latter. Corresponding 
distance histograms exhibited bi-modal behavior and were thus fitted with a double Gaussian, yielding 
major and minor maxima at 7.5 and 4.0 nm for D695C as well as 7.5 and 4.0 nm for E726C. The 
major FRET efficiency populations corresponded to the major distance distribution, indicating a larger 
distance between distant CTD ends than for the N-terminal ends. 
FRET efficiency data were corrected with parameters determined for corresponding homo-dimeric 
GyrA protein consisting of single cysteine mutant subunits. Distances were calculated using 
corresponding Förster parameters. 
 
3.1.16 Localization of the GyrA CTDs with smFRET measurements of hetero-dimeric 
GyrA 
As the CTDs could not be localized by means of smFRET data from single-cysteine mutants, 
hetero-dimeric GyrA with a wt and a mutant subunit with two labeling positions were used for 
single-molecule measurements. This allowed to measure FRET between a label on the GyrA 
body and one the CTD, avoiding high inter-dye distances.  
SmFRET experiments for the localization of GyrA CTD were performed with the hetero-
dimeric constructs GyrA* / GyrA*_T140C_K570C, _T140C_K594C, _E211C_K570C, _ 
E211C_K594C, _E250C_K570C, and _ E250C_K594C. These mutants exhibited labeling 
efficiencies of close to 100 % for the dyes A488 and A546 and showed wild-type-like activity 
(section 3.1.12; Fig. 3.14). Correction parameters and Förster distances had been determined 
for these proteins (tables 3.2 and 3.3). Corrections were done using parameters for both 
possible dye arrangements (A488 on GyrA body and A546 on the CTD and vice versa). 
Experiments with all mutants yielded well-defined and uni-modal FRET efficiency 
distributions, indicating one defined conformation of the labeled CTD (Fig. 3.16 – 3.17). For 
proteins labeled at position 140 and 570 or 594 medium FRET efficiencies with values 
between 0.3 and 0.5 were determined (Fig. 3.16). FRET efficiencies involving positions 211 
and 250 in the tower domain (GyrA body) were generally higher, ranging from 0.7 to 0.9 
(Fig. 3.17). Differences between histograms corrected for different dye arrangements were 
generally lower than 0.1 FRET efficiency. 
Distance histograms were determined from the corresponding FRET efficiencies using the 
Förster distances listed in table 3.2, and mean inter-dye distances calculated by a Gaussian fit. 
Distances between the reference points on the CTD and on the tower domain were 5.3 to 6.3 
nm, while they were generally lower for GyrA labeled on the tower domain and the CTD (4.1 
to 5.1 nm). This indicated that the N-terminal region of the CTD, represented by labeled 
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positions 570 and 594, is located closer to the tower domain than to the DNA-gate. The 
distance distributions for the hetero-dimeric constructs were more narrow than the ones for 
homo-dimeric (single-cysteine) proteins (Fig. 3.15). This finding reports on the degree of 
conformational freedom of the fluorescently labeled domains relative to each other: In the 
hetero-dimeric constructs, we observe potential flexibility between two connected domains 
(GyrA body and CTD), while in homo-dimeric constructs the two labeled domains are only 
indirectly linked (via the GyrA body) and possess a higher degree of conformational freedom 
relative to each other. 
This data suggests a position of the N-terminal part of the CTD (represented by residues 570 
and 594) in proximity to the DNA-gate and the tower domain. 
 
 
 
 
 
 
Fig. 3.16: SmFRET efficiency and distance histograms for ligand-free GyrA as observed using hetero-
dimeric GyrA constructs bearing one double-cysteine mutant subunit. Labeling sites were at the DNA-
gate (T140C) and on the CTD (K570C or K594C). Left: FRET efficiencies for mutant T140C_K570C 
were uni-modal, with maxima between 0.2 and 0.4, depending on the correction-parameter set applied; 
Gaussian fits of corresponding distance histograms yielded inter-dye distances of 5.7 to 6.3 nm. Right: 
FRET histograms for mutant T140C_K594C were also uni-modal, with better defined maxima at 0.5 
and 0.6 and corresponding inter-dye distances of 5.6 to 5.3 nm. 
Histograms were corrected with photophysical parameters and Förster distances for the corresponding 
mutants, acquired in the absence of ligands, with donor and acceptor dyes attached to GyrA body and 
the CTD (top row) and vice versa (bottom row). 
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Fig. 3.17: SmFRET efficiency and distance histograms for ligand-free GyrA in hetero-dimeric GyrA 
constructs labeled in the tower domain (E211C or E250C) and on the CTD (K570C or K594C) of one 
subunit. Sections left (top to bottom): FRET efficiency and distance histograms for mutants 
E211C_K570C and E250C_K570C, exhibiting uni-modal distributions with FRET efficiency maxima 
between 0.8 and 0.9. Corresponding inter-dye distances were calculated by Gaussian fitting of the 
distance histograms, yielding values of 4.2 and 4.1 nm for the first and 4.6 and 4.4 nm for the second 
mutant, depending on corrections applied. Sections right (top to bottom): FRET efficiency and 
distance histograms for mutants E211C_K594C and E250C_K594C. FRET-efficiency distributions 
were uni-modal with maxima at approx. 0.8 and between 0.6 and 0.75 for the two mutants, 
respectively. Corresponding inter-dye distances were 4.4 and 4.5 nm in E211C_K594C and 5.0 and 
5.1 nm in E250C_K594C, depending on the corrections applied. For all mutants distance distributions 
were asymmetrically with a larger shoulder towards higher distances. 
Histograms were corrected with photophysical parameters and Förster distances for the corresponding 
mutants, acquired in the absence of ligands, with donor and acceptor dyes attached to GyrA body and 
the CTD (section top rows) and vice versa (section bottom rows). 
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Two additional positions in the GyrA tower domain were considered for the localization of 
the CTD: T299 close to the DNA-gate and N314 at the periphery of the tower (Fig. 3.13 A). 
GyrA hetero-dimers containing either a T299C_K570C or a N314C_K594C double-Cys 
mutant subunit were labeled with A488 and A546 and subjected to single-molecule FRET 
measurements. Histograms were corrected using averaged photophysical parameters (Tab. 
3.2). 
Both mutants exhibited a high FRET efficiency, suggesting a small distance (i.e. 3 – 5 nm) 
between the dyes and confirming the results of GyrA proteins combining mutations E211C or 
E250C with K570C or K594C (Fig. 3.18). 
 
 
 
Fig. 3.18: SmFRET histograms for additional hetero-dimeric GyrA constructs labeled in the tower 
domain (T299C or N314C) and on the CTD (K570C or K594C) of one subunit. FRET efficiencies 
were approx. 0.8 for mutants T299C_K570C (left) and N314C_K594C.  
Due to the lack of site-specific correction parameters, histograms were corrected with averaged 
photophysical parameters with values 0.67, 0.0104 and 3.08 for α’, β’ and γ’, respectively. 
 
3.1.17 Localization of the GyrA CTDs in the gyrase-DNA complex 
It has been proposed that the CTDs adopt a different conformations in ligand-free GyrA and 
gyrase bound to DNA [57]. To address this problem, single-molecule measurements with 
GyrA in the presence of saturating concentrations of GyrB (8 µM) and neg. supercoiled 
pUC18 (15 nM) were performed. The same double-labeled GyrA hetero-dimers were used as 
for the localization of the CTDs in the absence of ligands (section 3.1.16). 
FRET efficiencies and the corresponding inter-dye distances were determined using the 
correction parameters for GyrA in the presence of GyrB and DNA (Table 3.3). For all six 
arrangements of fluorescent labels, little difference was found between FRET efficiency and 
distance histograms calculated with two different sets of correction parameters and Förster 
distances (Fig. 3.19). This indicated that the arrangement of the dyes (donor on the GyrA 
body, acceptor on the CTD, and vice versa) did not significantly influence the detected FRET 
efficiencies and the corresponding distances. FRET efficiency histograms showed a reduction 
in burst number compared to measurements without plasmid DNA for the same measurement 
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time. This might have been due to the higher diffusion time of the labeled protein bound to 
the DNA causing a higher photon count per burst but a reduction of the number of labeled 
protein detected. 
FRET efficiencies for the T140C_K570C and T140C_K594C mutants were close to 0 (Fig. 
3.19), indicating an increase of the inter-dye distance in the gyrase-DNA complex compared 
to GyrA (Fig. 3.10). The distance histograms of T140C_K594C yielded mean inter-dye 
distances of 8.1 and 7.5 nm. The T140C_K570C mutant showed a minor high FRET 
population (EFRET of > 0.8); a double Gaussian fit of the corresponding distance histograms 
resulted in distances of 7.5 and 7.9 nm for the major and 4.1 and 4.4 nm for the minor 
populations, respectively (Fig. 3.19).  
Proteins with one label in the tower domain (E211C, E250C) and on the CTD each (K570C, 
K594C) generally exhibited higher FRET efficiencies than proteins carrying FRET pairs 
involving position T140C (Fig. 3.19). Mutants E211C_K594C and E250C_K570C showed 
uni-modal FRET efficiency distributions at a value of approx. 0.5 and 0.7, respectively. The 
corresponding distances distribution were fitted with a single Gaussian, yielding mean inter-
dye distances of 5.5 to 5.9 and 5.1 nm, respectively. FRET efficiencies of mutants 
E211C_K570C, E250C_K594C exhibited bimodal behavior. Therefore the corresponding 
distance distributions were fitted with a double Gaussian. The distributions for the higher 
distances were of broader width and larger area, signifying the main population; mean 
distances were 6.0 to 6.4 nm. The minor distributions showed 2.7-, 1.3- and 3.2-fold smaller 
integral and lower mean distances of 4.3, 4.5 and 4.8 nm for mutants T140C_K570C, 
E211C_K570C and E250C_K594C, respectively (Fig. 3.19). The meaning of the bi-modal 
behavior of the distance distributions could not be elucidated but will be discussed in section 
4.1.3. 
Taken together, for all dye arrangements an increase in FRET efficiency could be observed 
upon formation of the gyrase-DNA complex, indicating higher inter-dye distances and thus a 
higher distance between the CTD and the GyrA body than in ligand-free GyrA. In a next step, 
distance information from six different dye arrangements was used for the localization of the 
CTD with respect to the GyrA body. For this purpose, the maxima of distributions with the 
higher integral were considered (Table 3.5). 
 
 
 
 
 77 
 
 
Fig. 3.19: SmFRET efficiency and distance histograms for gyrase in the presence of neg. supercoiled 
plasmid, using hetero-dimeric GyrA constructs labeled on the GyrA body (T140C, E211C or E250C) 
and on the CTD (K570C or K594C) of one subunit. Double mutants are denominated in the section 
heads. FRET efficiency histograms for mutants T140C_K570C, E211C_K570C and E250C_K594C 
exhibited two populations; thus corresponding distance histograms were fitted with double Gaussians. 
Distributions with maxima at higher distances exhibited the larger integrals and were considered to be 
the main distributions. Minor distributions exhibited maxima at between 4.1 and 4.9 nm. 
Continued on following page. 
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Double mutants labeled at the DNA-gate (T140C) generally showed very low FRET efficiencies 
(approx. 0) and higher inter-dye distances (7.5 – 8.1 nm) than mutants labeled in the tower domain 
(E211C, E250C) with inter-dye distances (maxima of major distributions) between 5.1 and 6.4 nm. 
Calculated values are listed in table 3.5. 
Histograms were corrected with photophysical parameters and Förster distances for the corresponding 
mutants, acquired in the presence of DNA and GyrB, with donor and acceptor dyes attached to GyrA 
body and the CTD (section top rows) and vice versa (section bottom rows). 
 
 
3.1.18 Quantification of the conformational change in the CTDs upon formation of the 
gyrase-DNA complex 
A study employing small-angle X-ray diffraction elucidated a first full-length structure of 
GyrA in complex with GyrB and a linear DNA fragment of 140bp length [58]. The position 
determined for the CTD was close to the C-gate, below the proposed exit site of the T-DNA 
segment [95]. The present study localized the CTD in ligand-free GyrA and gyrase in 
complex with neg. supercoiled plasmid DNA by means of single-molecule FRET data 
described above. FRET data from a pair of labeling positions were corrected for either dye 
arrangement, yielding two inter-dye distances per FRET pair: This averaged distance was 
used for triangulation (Tables 3.4 and 3.5). The distance between positions on the GyrA body 
(T140C, E211C, and E250C) and on the CTD (K570C and K594C) increased for all FRET 
pairs from the free to the complexed GyrA, indicating a movement of the CTD. 
 
 
 
Table 3.4: Calculated inter-dye distances in ligand-free GyrA, corrected for dye arrangements with 
donor on the GyrA body and acceptor on the CTD (top row) and vice versa (middle row). Averaged 
distances used for triangulations of CTD positions are listed in the bottom row. Distances are given in 
nm. 
 
GyrA body mutation T140C E211C E250C 
GyrA CTD mutation K570C K594C K570C K594C K570C K594C 
D: body ; A: CTD 6.29 5.58 4.25 4.43 4.59 4.97 
A: CTD; D: body 5.57 5.26 4.08 4.48 4.41 5.11 
Average distance 5.93 5.42 4.16 4.45 4.50 5.04 
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Table 3.5: Calculated inter-dye distances for gyrase in complex with neg. supercoiled plasmid, 
corrected for dye arrangements with donor on the GyrA body and acceptor on the CTD (top row) and 
vice versa (middle row). Averaged distances used for triangulations of CTD positions are listed in the 
bottom row. Distances are given in nm. 
 
GyrA body mutation T140C E211C E250C 
GyrA CTD mutation K570C K594C K570C K594C K570C K594C 
D: body ; A: CTD 7.93 8.14 6.38 5.85 5.13 6.26 
A: CTD; D: body 7.53 7.47 5.97 5.53 5.10 6.13 
Average distance 7.73 7.81 6.17 5.69 5.11 6.19 
 
 
 
 
 
The position of mutated residues K570C and K594C on the CTD were triangulated using 
average inter-dye distances. Due to the lack of information about the position of the 
fluorescent labels relative to the protein, the center of the dyes were assumed to collocate with 
the thiols of the labeled cysteine residues. Triangulation was done manually, with adjusted 
distances not deviating more than 0.05 nm with respect to calculated values.  
Structural models including the calculated positions of amino acid residues K570C and 
K594C are depicted in figure 3.20, both for the situations in ligand-free GyrA and in gyrase 
bound to DNA. Distance changes between the two situations were approx. 2.6 and 2.5 nm for 
K570C and K594C, respectively. The distance between these two positions as measured from 
the model were 1.2 and 2.8 nm in the ligand-free GyrA and in gyrase bound to DNA, 
respectively. These data clearly document for the first time a conformational change of the 
GyrA CTDs when GyrA binds to GyrB and DNA, supporting previous suggestions [57]. 
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Fig. 3.20: Homology models of the dimeric GyrA body from B. subtilis with calculate positions of 
mutated residues K570C and K594C located on the CTD. Residues on the GyrA body used for 
triangulation are depicted in yellow, CTD residue position are depicted in green (K570C) and red 
spheres (K594C).  
A: Side (left) and front (right) view of GyrA body with CTD positions triangulated for the situation in 
ligand-free GyrA, using averaged inter-dye distances for each FRET pair.  
B: Side (left) and front (right) view of GyrA body with CTD positions in the gyrase-DNA complex, 
using averaged inter-dye distances. 
C: 45°-rotated view of GyrA with CTD positions indicated for situations in free GyrA (arrow starts) 
and in the gyrase-DNA complex (arrow ends). Both positions move away from the body domain upon 
complex formation, indicating a movement of the CTD from a rather contracted to an extended 
conformation. 
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3.1.19 Domain localization from other FRET pairs 
The previous sections documented the localization of the upper region of the GyrA CTD with 
respect to the DNA-gate and tower regions of the enzyme body, both in the free GyrA dimer 
and in the complex of GyrA, GyrB and DNA. Additional FRET mutants were used to 
determine the CTD position with respect to the C-gate and to localize the lower part of the 
CTD. None of the cysteine mutations mentioned in this section affected the supercoiling 
activity of gyrase. Correction parameters and Förster distances were not determined for these 
labeling positions; instead FRET efficiencies were corrected using averaged parameters 
(Table 3.2). Distances between labels were not determined. 
The FRET histogram of a hetero-dimeric GyrA with one subunit labeled at the C-gate 
(N399C) and on blade 2 of the CTD (K594C) shows a FRET efficiencies of approx. 0.1 for 
the ligand-free protein (Fig. 3.21A), indicating an inter-dye distance of approx. 8 nm, which 
corresponds well with the distance of 7.8 nm calculated for the FRET model. Upon addition 
of GyrB and DNA (for this measurement relaxed pUC18 was used), the FRET efficiency 
maximum dropped to approx. 0 with the shape of the main distribution remaining similar, 
suggesting an increase of the inter-dye distance, which is in agreement with the model 
(approx. 10 nm). 
The lower part of the CTD was tracked by combined labeling of positions 695 or 726 on the 
CTD and the DNA- (T140C) and C-gate (T408C). The FRET efficiency of T408C_D695C 
and T408C_E726C were close to 0 with considerable shoulders towards higher values, 
indicating a high mean distance of more than 8 nm with potentially high local fluctuations 
(Fig. 3.21A – 3.21B). For mutant T408C_D695C in complex with GyrB and DNA, the FRET 
efficiency remained high, thus change of the inter-dye distance be detected. 
A GyrA mutant carrying labels on positions T140 (DNA-gate) and C695 (CTD) did not show 
a well-defined FRET-efficiency distribution (Fig. 3.21A). In the presence of GyrB and 
supercoiled pUC18 DNA, the distribution slightly shifted to higher FRET-efficiency values, 
but remained broad. Due to the non-linear scaling of FRET efficiency and corresponding 
inter-dye distance (Eq. 2.24), the latter was expected to be distributed around medium values, 
i.e. around the Förster distance (approx. 5.5 nm for this dye pair), both in the absence and 
presence of ligands. Experiments were reproducible, and the broad distributions should be 
trusted. These results and the ones obtained for the mutant T408C_D695C (see above) 
suggest a position of the CTD lateral to the GyrA body, closer to the DNA-gate than the C-
gate. They also indicated that the distant part of the CTD is more flexible with respect to 
GyrA body than the upper part linked to the body. 
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The main FRET efficiencies for the single-cysteine mutants K594C, D695C, E726C were 
close to 0 in the presence of GyrB and neg. supercoiled plasmid (Fig. 3. 21C and 3.22). For 
mutants K594C and E726C this marked a decrease in FRET efficiency of 0.2 and 0.1 
compared to the ones in ligand-free GyrA (Fig. 3.15), respectively, indicating an increase of 
the inter-dye distance between labels on both CTDs. The width of the FRET efficiency 
distributions both in GyrA and in the gyrase-DNA complex, exhibiting shoulders up to 
medium FRET values, suggested fluctuation of the inter-dye distance and thus increased local 
flexibility of the distant end of the CTDs.  
 
 
 
Fig. 3.21: SmFRET efficiency histograms for different FRET constructs, in free GyrA and gyrase 
bound to neg. supercoiled DNA.  
A: FRET efficiency histograms for hetero-dimeric GyrA proteins with one double-cysteine mutant 
subunit (from left to right): N399C_K594C, T408C_D695C, and T140C_D695C. Top: for ligand-free 
GyrA; bottom: for the gyrase-DNA complex. FRET efficiencies were very low for the first two 
constructs labeled on the C-gate and the N-terminal or the distant end of the CTD, respectively, with a 
small decrease in FRET efficiency upon complex formation for the first and a small increase for the 
second. The third construct labeled at the DNA-gate and on the distant end of the CTD exhibited a 
very broad FRET efficiency distribution, indicating high local flexibility of the lower CTD. The 
distribution was shifted to slightly higher values in the gyrase-DNA complex. The first two mutants 
showed high-FRET populations in the gyrase-DNA complex.  
Continued on following page. 
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B: SmFRET histogram for a hetero-dimeric GyrA construct labeled at positions 408 (C-gate) and 726 
(distant CTD end), exhibiting a value close to 0, indicating a large inter-dye distance.  
C: FRET efficiency distributions of single-cysteine mutants D695C and E726C (both labeled on 
equivalent positions at the distant ends of each CTD) in the gyrase-DNA complex. FRET efficiencies 
were close to 0, with high-FRET populations of different intensities for both mutants. 
FRET data for hetero-dimeric GyrA proteins were corrected with averaged photophysical parameters 
(0.67, 0.0104 and 3.08 for α’, β’ and γ’, respectively). SmFRET histograms for homo-dimeric proteins 
were corrected with parameters obtained for corresponding mutants in the absence of ligands. 
 
 
3.1.20 CTD conformations during complex assembly 
As demonstrated in the previous sections, the CTD is located laterally with respect to the 
GyrA-body dimer and describes a movement to a more extended conformation when gyrase is 
complexed with supercoiled DNA. In order to understand the conformational changes during 
the assembly of the complex, single-molecule measurements in the presence of individual 
ligands were performed with hetero-dimeric GyrA constructs containing either a 
T140C_K594C or a T140C_K570C subunit, and with the homo-dimeric single-cysteine 
mutant K594C. Experiments with the latter protein were performed at room temperature and 
should be compared to all other measurements only qualitatively (performed at 37°C). 
Complexation of GyrA by different ligands was monitored qualitatively by following changes 
in the autocorrelation of the donor fluorescence signal (Fig. 3.23A): Fluorescently labeled 
GyrA and its complex with GyrB exhibited dwell times of approx. 1 ms (corresponding to the 
inflection point of the autocorrelation curve). Addition of plasmid DNA to GyrA in the 
absence or presence of GyrB resulted in a 10-fold increase in diffusion time; this indicated a 
drastic increase in molecular weight of the complex bearing the labeled species, consistent 
with the expected binding of the plasmid. Nucleotide addition to GyrA in complex with GyrB 
and plasmid DNA resulted in a slightly flattened autocorrelation curve, but not in a change of 
diffusion time, indicating that the gyrase-DNA complex remains intact. 
 
3.1.21 Effect of GyrB on the GyrA CTD position 
Having documented the conformational change of the GyrA CTDs from free GyrA to the 
gyrase-DNA complex, contributions of the individual complexation partners needed to be 
determined. First, the influence of GyrB binding on the conformation of the GyrA CTD was 
tested. 
GyrB binds weakly to the GyrA dimer; a Kd was not published so far. Addition of 8 µM GyrB 
induced a shift to lower FRET efficiencies in the following three observation systems: In the 
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homo-dimeric mutant (K594C) the distribution maximum decreased from 0.2 to 0.1, while the 
peak width increased. In the hetero-dimeric proteins the FRET efficiency decreased from 0.5 
to 0.2 for the T140C_K594C mutant and from 0.3 to almost 0 for T140C_K570C. In 
T140C_K594C increasing the GyrB concentration to 20 µM did not result in a change of 
FRET efficiency or distribution shape, indicating saturation of both binding sites for GyrB at 
the DNA-gate using 8 µM GyrB (Fig. 3.22B). 
The combination of data from different mutants suggests that the change in FRET efficiencies 
was not caused by changes in the photophysical behavior of the labels, since the shifts were 
observed with substitution of all individual labeling positions. Thus, the change in energy 
transfer should originate from a conformational change in the CTDs. This finding was 
surprising, as there had not been any report of an interaction between GyrB and the CTDs. 
However, from this data alone the cause for the conformational change in the CTDs could not 
be explained. 
 
3.1.22 Complexation of DNA by GyrA induces conformational freedom to the CTDs 
Next, the influence of DNA on the CTD conformation in the absence of GyrB was tested, 
using 20 nM supercoiled pUC18 plasmid. Less events per time were detected than in 
measurements with GyrA and gyrase due to slower diffusion time. 
FRET efficiency distributions of hetero-dimeric constructs T140C_K594C and 
T140C_K570C as well as of homo-dimeric mutant K594C were clearly different from the 
ones in the free GyrA dimer and in the presence of DNA and GyrB, indicating a 
conformational change in the CTDs upon subsequent additions of DNA and GyrB (Fig. 
3.22C). All histograms showed broadened distributions compared to GyrA, indicating 
increased flexibility of the CTDs or conformational heterogeneity. For mutant 
T140C_K594C, the FRET efficiency exhibited bimodal behavior, with the high-FRET 
shoulder at a value of 0.6, corresponding to the distribution for free GyrA,  and the low-FRET 
side closer to the FRET value for GyrA in complex with GyrB and supercoiled plasmid DNA. 
Thermodynamic population of the DNA-free state could be excluded, as increasing the DNA 
concentration by 5-fold to 100 nM did not influence the FRET distributions, i.e. the 
population of the two states. Kinetic characterization of the system was not possible, as the 
interconversion of the two states was a rare (i.e. not statistically relevant) event as judged 
from analysis of FRET traces of individual events. 
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These results show that addition of neg. supercoiled plasmid to GyrA causes conformational 
flexibility in the CTDs. it is also clear, that presence of DNA alone is not sufficient to 
introduce the extended CTD conformation.  
 
 
 
 
 
Fig. 3.22: SmFRET histograms of the gyrase-DNA complex formation for GyrA mutants with 
different dye attachment sites (from left to right): Hetero-dimeric GyrA double cysteine mutants 
T140C_K594C and T140C_K570C, homo-dimeric single cysteine mutant K594C.  
A: Histograms for ligand-free GyrA.  
B: Histograms for GyrA in complex with GyrB (i.e. gyrase).  
C: Histograms for GyrA in complex with neg. supercoiled plasmid.  
D: Gyrase in complex with neg. supercoiled plasmid.  
E: Histograms for complex D with ADPNP added. 
Continued on following page. 
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All three mutants exhibited FRET efficiencies between 0.2 and 0.5 for free GyrA. Formation of gyrase 
(upon addition of GyrB) reduced the FRET efficiency for all constructs. Addition of neg. supercoiled 
plasmid to GyrA resulted in a broadening of the FRET efficiency distributions (in the case of 
T140C_K594C to bi-modality with contributions of FRET 0.6 and approx. 0), indicating 
conformational flexibility in the CTDs. The gyrase-DNA complex showed FRET efficiencies of 0 in 
all mutants, corresponding to the extended conformation established above (Fig. 3.19, 20). Addition of 
ADPNP, a non-hydrolysable ATP-analogue, did not result in further FRET efficiency changes. 
FRET data for double cysteine mutants T140C_K570C and T140C_K594C were corrected with 
averaged photophysical parameters for corresponding mutants acquired in the absence (A; C) and 
presence (B; D; E) of DNA and GyrB. FRET efficiencies for the single cysteine mutant K594C were 
corrected with parameters acquired in the absence of ligands. 
Cartoons represent the GyrA dimer with one subunit in blue (GyrA body) and green (CTD) and the 
other in grey. GyrB subunits, neg. supercoiled DNA and ADPNP are shown in white, by a black line 
and black ellipses. 
 
 
3.1.23 Addition of ADPNP to the gyrase-DNA complex does not induce further 
conformational changes 
The addition of ADPNP to a GyrA_GyrB fusion construct has been shown to induce 
dimerization of the nucleotide domains of GyrB (N-gate) and a pre-closure in the presence of 
plasmid DNA [42]. Here, we tested the influence of a partially closed N-gate on the 
conformation of the GyrA CTDs. 
Addition of 2 mM ADPNP to GyrA and GyrB in complex with supercoiled plasmid DNA 
resulted in FRET efficiency distribution similar to the gyrase-DNA complex, indicating no 
major conformational change of the CTDs (Fig. 3.22D – E). For both hetero-dimeric GyrA 
FRET systems and the homo-dimeric GyrA mutant the FRET efficiencies remained close to 0 
as it was the case in the absence of nucleotide. A rapid change in FRET efficiency due to a 
conformational change connected to potential strand passage was not observed in traces of 
single-molecule events. 
This data suggests that partial closure of the ATPase gate does not influence the CTD 
conformation. A potential movement of the CTDs upon strand passage might be to fast to be 
detected in single-molecule studies using a confocal microscope. 
 
 
3.1.24 GyrA-ligand complex formation does not depend on the order of ligand addition 
For the GyrA-GyrB fusion protein it had been shown that dimerization of the nucleotide-
binding domains, i.e. the closure of the N-gate, impedes binding of a DNA to the DNA-gate 
[42]. To simulate this situation in the gyrase hetero-tetramer supercoiled plasmid was added 
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to gyrase pre-saturated with ADPNP. The FRET system used was a hetero-dimeric GyrA 
mutant with one subunit labeled at positions 140 (DNA-gate) and 570 (CTD). 
In gyrase saturated with ADPNP the FRET efficiency dropped to approx. 0.1 (Fig. 3.23B), 
compared to the value of approx. 0.35 for GyrA (Fig. 3.22A). The shape of the distribution is 
similar to the one in GyrA bound to GyrB (Fig. 3.22B). Addition of DNA reduced the FRET 
efficiency to 0, indicating binding of the DNA and concomitant movement of the CTDs. This 
finding was supported by the increase of the diffusion time (as judged from the 
autocorrelation data (Fig. 3.23B) and the decrease of the number of burst within similar 
exposure time, which was both due to the increase in MW of upon binding of plasmid to the 
gyrase. 
As the sequence of ligand addition did not influence the conformation of the CTDs, the 
resulting complex should not depend on the order of ligand addition. This finding indicated 
that gyrase is a dynamic complex. Even the potential stabilization of gyrase with the non-
hydrolysable nucleotide ADPNP did not inhibit the formation of the gyrase-DNA complex. 
 
 
 
Fig. 3.23: Autocorrelation curves and reverse order smFRET measurements for gyrase-DNA complex 
assembly, using GyrA mutant T140C_K570C.  
A: Autocorrelation curve for the donor fluorescence signal from measurements involving GyrA 
(black), gyrase (blue), GyrA in complex with neg. supercoiled plasmid (green), with GyrB (red) and 
ADPNP added (pink). GyrA and gyrase exhibited a similar diffusion time (corresponding to the 
inflection point at approx. 10-3 s), while all complexes with DNA showed a 10-fold higher diffusion 
time (approx. 10-2 s).  
B: (from left to right): SmFRET histograms for gyrase in the presence of ADPNP; with neg. 
supercoiled plasmid added; autocorrelation curves of the donor fluorescence signal for both 
measurements (blue and pink, respectively), compared to the one for ligand-free GyrA. The FRET 
efficiency for gyrase in the presence of ADPNP showed a peak at approx. 0.1, similar to the one for 
gyrase in the absence of nucleotide (Fig. 3.22B); the FRET efficiency was further reduced by the 
addition of plasmid. Plasmid complex formation was monitored with FCS, exhibiting a higher 
diffusion time than gyrase in the presence of ADPNP. FRET data were corrected with averaged 
photophysical parameters determined for the mutant T140C_K570C in the absence (B: left) and 
presence of DNA and GyrB (B: middle). 
Cartoons represent the GyrA dimer with one subunit in blue (GyrA body) and green (CTD) and the 
other in grey. GyrB subunits, neg. supercoiled DNA and ADPNP are shown in white, by a black line 
and black ellipses. Red and green dots represent the fluorescent dyes. 
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3.1.25 Relaxed and pos. supercoiled DNA induce similar conformational changes 
Single molecule data shown so far were obtained using neg. supercoiled plasmid DNA, which 
is the product of the supercoiling reaction by gyrase [96]. The influence of the reaction 
substrate, i.e. relaxed plasmid DNA, on the CTD conformation should be also elucidated.  
The FRET histogram for hetero-dimeric GyrA bearing the mutant subunit T140C_K594C 
supplied with 20 nM relaxed pUC18 exhibited a broad bi- or tri-modal distribution. Both the 
maxima at 0.65 and 0 FRET efficiencies were similar to the ones found in the histogram for 
GyrA in complex with neg. supercoiled plasmid (Fig. 3.24A; compared to Fig. 3.22C). A 
third small maximum is observed at 0.3, which could be due to insufficient data statistics. Due 
to high fluorescent background originating from low DNA quality and concentration, the 
number of events recorded was approx. 3-fold lower than in measurements of similar duration 
involving supercoiled plasmid. 
The addition of 8 µM GyrB resulted in a sharp decrease in FRET efficiency close to 0, with a 
shoulder towards higher values, as seen for gyrase bound to neg. supercoiled plasmid. The 
distance histograms for data calculated with the averaged set of site-specific correction 
parameters and Förster distance exhibited a bimodal distribution (Fig. 3.24B), similar to 
histograms of experiments involving GyrA in complex with neg. supercoiled plasmid DNA. 
Integrals for the two maxima were not determined due to the low number of detected events. 
The peak corresponding to the low-FRET species showed an averaged inter-dye distance of 
approx. 8.0 nm, which was in agreement with the results for GyrA bound to neg. supercoiled 
plasmid DNA. The second distribution probably corresponded to the medium FRET 
efficiency shoulder, the origin of which could not be explained so far. 
Addition of ADPNP to gyrase in complex with relaxed plasmid did not influence the FRET-
efficiency distribution, with the maximum remaining close to 0 (Fig. 3.24C). 
The results suggest that binding of GyrA to relaxed and neg. supercoiled plasmid DNA of the 
same nucleotide sequence, i.e. educt and product of the supercoiling reaction, induce similar 
conformational change in the CTD; this indicates no or a very low dependence on the 
topology of the DNA ligand.  
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Fig. 3.24: SmFRET and distance histograms for complexes of relaxed plasmid DNA with the GyrA 
mutant T140C_K594C.  
A: GyrA in the presence of relaxed DNA.  
B: FRET and corresponding distance histograms of gyrase in the presence of relaxed DNA.  
C: B with ADPNP added. 
GyrA in complex with relaxed DNA exhibits a bi-modal FRET-efficiency distribution. The higher-
FRET species disappeared completely upon addition of GyrB, indicating the CTDs swinging away 
from the GyrA body; addition of ADPNP did not further influence the histogram. All histograms 
resemble closely the ones for complexes with neg. supercoiled plasmid (Fig. 3.22C – E). FRET data 
were corrected with averaged photophysical parameters for mutant T140C_K594C acquired in the 
absence (A) and presence of DNA and GyrB (B, C). 
Cartoons represent the GyrA dimer with one subunit in blue (GyrA body) and green (CTD) and the 
other in grey. GyrB subunits, relaxed DNA and ADPNP are shown in white, by a black line and black 
ellipses. Red and green dots represent the fluorescent dyes. 
 
 
 
3.1.26 Linear DNA ligands induce CTD movement depending on DNA length 
The previous sections documented the conformational change of GyrA CTD into an extended 
position in gyrase bound to plasmid of different topology (relaxed or neg. supercoiled). By 
employing non-modified DNA fragments of 37 to 110 base-pairs (bp) in length we wanted to 
elucidate whether the CTD movement could likewise be induced by linear oligonucleotides. 
Measurements were performed in the presence of GyrB, with concentrations of 2 µM for the 
37bp or 48bp DNAs and 500 nM for the 60bp, 90bp or 110bp DNAs. This ensured that more 
than 75 and 90% of the protein molecules were saturated with 37bp DNA and DNAs of 
≥48bp length, respectively (section 3.1.9). 
For hetero-dimeric GyrA labeled at amino-acids 140 (DNA-gate) and 594 (CTD) complexes 
with DNA ligands of ≥48bp length the FRET efficiency dropped from 0.5 for the ligand-free 
protein (Fig. 3.22A) to close to 0 (Fig. 3.25B). This value corresponds to the one found for 
gyrase in complex with plasmid, indicating that linear DNAs of ≥48bp were sufficient to 
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promote CTD movement to an extended conformation. At least for the shorter DNAs of 48 
and 60 bp in length this finding was surprising as the number of contacts between the DNA 
molecule and the CTD should be reduced compared to the ones in complexes with longer 
DNAs. 
In contrast to results involving longer DNA ligands, the FRET efficiency distribution for the 
complex of gyrase and a 37bp DNA fragment yielded a maximum at approx. 0.4. (Fig. 
3.25A). This finding is indicative for a conformation different from the ones found in ligand-
free GyrA, in gyrase and in gyrase complexed with plasmid or longer linear DNA, 
characterized by FRET efficiencies of approx. 0.5, 0.25 and close to 0, respectively (Fig. 
3.22A – C; Fig. 3.25B). The FRET efficiency value for the gyrase-37bp DNA complex 
indicated a CTD position between those found in GyrA and gyrase. Due to the high 
fluorescence background of the 37bp DNA stock solution and the concomitant increase in 
fluorescence noise, the burst number was reduced compared to experiments with 48bp DNA 
of the same concentration and the same exposure time. Measurements with different batches 
of 37bp DNA could not increase the quality of the data, but the FRET efficiency distribution 
was reproducible.  
 
 
Fig. 3.25: SmFRET histograms for gyrase in complex with linear DNA ligands of different length, 
using the GyrA double mutant T140C_K594C.  
A: Gyrase in complex with 37bp DNA. The FRET efficiency maximum was at 0.4, indicating a CTD 
position between those in GyrA and the one in gyrase.  
B: Gyrase in complex with 48bp (top left), 60bp (top right), 90bp (bottom left), and 110bp DNAs 
(bottom right). For all complexes with DNA of 48bp and more, the FRET efficiency was approx. 0, 
indicating that the CTDs adopted the extended conformation.  
FRET data were corrected with averaged photophysical parameters for mutant T140C_K594C 
acquired in the presence of DNA and GyrB. 
Cartoons represent the GyrA dimer with one subunit in blue (GyrA body) and green (CTD) and the 
other in grey. GyrB subunits and linear DNAs are shown in white and by a black lines. Red and green 
dots represent the fluorescent dyes. 
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3.1.27 Conformational change of the CTDs in the cleavage-deficient mutant Y123F 
DNA bound to the DNA gate of gyrase adopts a distorted conformation; the degree of 
distortion depends on DNA cleavage by the catalytic Tyr residues located at the GyrA 
dimerization interface [33]. As the CTDs bind the DNA which protrudes from the DNA-gate, 
it is reasonable to assume that distortion of the DNA might influence the CTD position. Thus, 
we tested whether the degree of distortion influences the CTD affinity for DNA and the CTD 
conformational upon complex formation by using the DNA-cleavage deficient GyrA mutant 
Y123F. 
B. subtilis GyrA_Y123F had been purified ahead of this work and shown to be deficient in 
DNA cleavage, plasmid DNA relaxation and supercoiling [33]. The DNA affinity of the 
mutant was determined in fluorescence anisotropy titrations using a 60bp DNA internally 
labeled with A546 (Fig. 3.7). Experiments were performed under the same conditions as 
described for GyrA wt (sections 2.15.1 and 3.1.6). The measured Kd value for GyrA_Y123F 
was 1.5 ± 0.1 µM. In the presence of 4 µM GyrB the Kd decreased to 13 ± 1 nM, indicating a 
100-fold increase in affinity in the presence of GyrB (Fig. 3.26A – B). The same effect was 
observed for GyrA wt and ΔCTD (section 3.1.8). The Kd values measured for GyrA_Y123F 
were approx. 1.5 and 4 times smaller in the absence and the presence of GyrB, respectively, 
than the ones determined for the wild-type protein, indicating a higher DNA affinity with 
prevented DNA cleavage.  
To test the influence of DNA-cleavage deficiency on CTD conformations, a hetero-dimeric 
GyrA*_Y123F FRET construct was produced, of which only one subunit carried the 
mutations T140C and K594C (GyrA*_Y123F / GyrA*_Y123F_T140C_K594C; abbreviated 
GyrA**_Y123F). The protein was expressed and purified as described (sections 2.10.2) 
yielding 8.5 mg of protein with purity similar to other hetero-dimeric GyrA constructs. 
Single-molecule FRET experiments were performed as described (sections 2.18). 
The FRET efficiency distribution for ligand-free GyrA**_Y123F was uni-modal with a 
maximum between 0.5 and 0.6 (Fig. 3.26A). The shape of the distribution was very similar to 
wild-type like GyrA, indicating a similar CTD conformation. Addition of neg. supercoiled 
plasmid induced conformational flexibility to the domains, judged by the very broad FRET 
efficiency distribution. Again, no difference could be detected between wild-type and 
cleavage-deficient mutant (Fig. 3.26A and 3.22C). 
Addition of GyrB to GyrA**_Y123F and DNA was accompanied by a strong drop in FRET 
efficiency to less than 0.1, indicative of the formation of the gyrase-DNA complex and 
induction of the extended conformation of the CTDs (Fig. 3.26A). As expected from previous 
experiments, addition of ADPNP did not further influence the FRET efficiency distribution. 
 92 
Also, using a linear 60bp DNA instead of plasmid resulted in a similarly low FRET efficiency 
of approx. 0.1 (Fig. 3.26D). These results indicate that the CTDs adopt a similarly extended 
conformation in GyrA**_Y123F for all experiments involving DNA and GyrB. Compared to 
the GyrA mutant T140C_K594C the FRET efficiency distributions showed peaks at slightly 
higher values (Fig. 3.26A, compared to Fig. 3.22D – E, Fig. 3.25B); this could be an 
indication of a slightly different position of the CTDs in the complex of cleavage-deficient 
gyrase with DNA, following depopulation of the covalent DNA-tyrosyl intermediate state. 
Nevertheless, no major conformational differences could be detected between CTD 
conformations in wild-type like GyrA and the cleavage-deficient mutant. 
 
 
 
 
Fig. 3.26: SmFRET histograms and fluorescence anisotropy titrations for the cleavage-deficient GyrA 
mutant Y123F, with one subunit labeled at position 140 and 594.  
A (from left to right): Histograms for measurements in the absence of ligands; in the presence of neg. 
supercoiled plasmid; gyrase in the presence of neg. supercoiled plasmid; with ADPNP added.  
B: Titrations of 60bp DNA with GyrA wt (black), GyrA_Y123F (blue), and GyrA_ΔCTD (grey) with 
Kd values of 2.3 ± 0.2 and 1.5 ± 0.1 µM for the first two, respectively.  
C: Titrations of 60bp DNA in the presence of 4 µM GyrB, using GyrA wt (black), GyrA_Y123F 
(blue), and GyrA_ΔCTD (grey) with Kd values of 63 ± 5 , 13 ± 1 and 299 ± 20 nM, respectively.  
D: SmFRET histogram for gyrase in the presence of 60bp DNA.  
FRET data were corrected with averaged photophysical parameters for mutant T140C_K594C 
acquired in the absence (A: 1, 2) and presence (A: 3, 4; D) of DNA and GyrB. 
Cartoons represent the cleavage-deficient GyrA dimer with one subunit in blue (GyrA body) and green 
(CTD) and the other in grey. GyrB subunits, supercoiled or linear DNA and ADPNP are shown in 
white, by a black line and black ellipses. Red and green dots represent the fluorescent dyes. 
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3.1.28 The GyrA-box is required for the supercoiling activity 
One of the most conserved amino-acid sequences in the GyrA CTD is the GyrA-box, a highly 
positively charged hepta-peptide located on a loop in blade 1, that closes the gap to blade 6. In 
E. coli GyrA, alterations of the GyrA-box including the change of the sequence to alanines 
and the deletion resulted in complete DNA supercoiling deficiency, but did not show a strong 
influence on nucleotide-independent DNA relaxation [55]. In order to elucitate the 
mechanism behind these observations, several B. subtilis GyrA mutants were produced and 
tested for their DNA supercoiling and relaxation activities, DNA affinities, and their 
conformational behavior with respect to the CTDs. 
Judged from amino-acid sequence alignments for different species, the GyrA-box in B. 
subtilis GyrA comprises residues 527 – 533 with the amino-acid sequence QKRGGKG, 
featuring three positively charged residues (Fig. 3.27A). GyrA constructs lacking the A-box 
(GyrA_ΔAbox) or having it exchanged to alanines (GyrA_AboxA) were produced and 
purified as described (section 2.10.2). Yields were approx. 25 mg of pure protein per liter 
bacterial culture, marking a two-fold increase compared to Gyr wt and single cysteine mutants 
(section 3.1.1). As expected, GyrA_ΔAbox exhibited wild-type like nucleotide-independent 
plasmid-relaxation activity, but no detectable supercoiling activity (Fig. 3.27B). Both 
activities were similar for GyrA_AboxA, but were only tested ones in comparison with 
GyrA_ΔAbox (Fig. 3.27C). 
 
 
Fig. 3.27: Deletion or substitution of the GyrA-box.  
A: Cartoon representation of a homology model of B. subtilis GyrA CTD, based on the template of X. 
campestris GyrA CTD (PDB entry: 3L6V, chain A [38]). The GyrA-box is depicted in red sticks; the 
N-terminus in blue.  
B and C: Plasmid relaxation and supercoiling reactions. Incubation times were 30 and 2 min for 
nucleotide-independent plasmid relaxation and ATP-dependent plasmid supercoiling reactions, 
respectively. Buffer used was gyrase activity buffer (section 2.12.1). 
B: Plasmid relaxation (lanes 2 – 6) and supercoiling (lanes 8 – 12) by GyrA wt (2, 8), GyrA_ΔAbox 
(3, 9), non-labeled GyrA**_ΔAbox (4, 10), GyrA**_ΔAbox fully labeled with A488 (5, 11) and A546 
(6, 12). Substrates for the relaxation and supercoiling reaction were neg. supercoiled (1) and relaxed 
pUC18 plasmid (7), respectively. Nucleotide-independent DNA relaxation reactions were performed 
with 200 nM GyrA proteins, 800 nM GyrB, and 15 nM relaxed plasmid. ATP-dependent supercoiling 
reactions were performed using 50 nM GyrA proteins, 800 nM GyrB, 50 nM relaxed plasmid, and 2 
mM ATP. 
Continued on following page. 
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C: Relaxation (1, 3) and supercoiling reactions (2, 4) by GyrA_ΔAbox (del) and GyrA_AboxA (A). 
Plasmid substrates were identical with the ones in B. Concentrations used were 200, 800, and 15 nM 
GyrA proteins, GyrB, and plasmid, respectively. Supercoiling reactions were supplied with 2 mM 
ATP.  
Under these conditions, plasmid relaxation was complete after 30 min for both GyrA-box mutants. 
However, no supercoiling activity could be detected. 
 
3.1.29 Effect of the GyrA-box on DNA binding 
Proteins interacting with nucleic acids often mediate contact with highly positively charged 
patches by forming salt bridges to the negatively charged phosphate backbone. The GyrA 
CTD exhibits this kind of positively charged regions at the periphery of the domain, stretching 
two thirds of the outer edge, which is supposed to bind DNA [49]. The GyrA-box being one 
of them [38], GyrA_ΔAbox was tested for changes in DNA affinity compared to GyrA wt. 
GyrA_ΔAbox was titrated to an internally fluorescently labeled 60bp DNA (Fig. 3.7), using 
10 nM DNA and up to 10 µM of protein. The measured Kd was 1.9 ± 0.2 µM, which was very 
similar to the value measured for wild-type GyrA (2.3 µM), but much lower than the one for 
the CTD-deletion mutant (Fig. 3.28A). In order to test the affinity of plasmid DNA to GyrA 
proteins, displacement titrations were performed using the labeled 60bp DNA and non-
modified neg. supercoiled pUC18 plasmid as described (section 2.15.1). Titrations of 1 GyrA 
wt and GyrA_ΔAbox bound to 60bp DNA with neg. supercoiled plasmid resulted in partial 
displacement of the 60bp DNA, as the 60bp DNA the starting anisotropy was 0.090 to 0.094, 
and the anisotropy for the free DNA was not reached even at high plasmid concentrations 
(0.075 compared to the expected value of approx. 0.070) (Fig. 3.28B). No Kd values for the 
plasmid DNA were obtained, as the data could not be described quantitatively. Judged from 
visual inspection of the anisotropy plots, plasmid-DNA affinity for GyrA wt and ΔAbox did 
not significantly differ. 
Titration of 60bp DNA with GyrA_ΔAbox in the presence of 4 µM GyrB yielded a Kd value 
of 50 ± 2 nM. The DNA affinity was very similar (Fig. 3.28C), but the calculated maximal 
anisotropy differed between experiments with GyrA wt and ΔAbox (approx. 0.27 and 0.30, 
respectively). The reason for this difference is not known, but it should neither be due to 
differences in concentration of the present molecules nor due to a different binding mode (in 
presence of GyrB, DNAs bind to the DNA-gate region of GyrA; Fig. 3.6, 3.8). Again, 
displacement titrations were performed, adding neg. supercoiled plasmid to 10 nM 60bp DNA 
and 250 nM GyrA in the presence of 4 µM GyrB. Anisotropy starting values of GyrA wt or 
ΔAbox complexes reflected the difference in end values obtained from titrations of the 60bp 
DNA in the presence of GyrB. Addition of plasmid up to 10 nM resulted in reduction of the 
anisotropy signal to 0.14 for both GyrA complexes, indicating only partial release of linear 
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DNA fragment, which was expected to have an anisotropy of approx. 0.070 in its non-
complexed form (Fig. 3.28D). Due to the complexity of the system consisting of four 
complex-forming species (GyrA dimer, GyrB, 60bp DNA, plasmid), even more possible 
complexes and potential enzymatic activity (nucleotide-independent plasmid relaxation) the 
displacement titrations were not analyzed quantitatively. Interpretation of the data was very 
difficult due to the difference in starting anisotropies for the complexes with GyrA wt and 
ΔAbox (see above). Still, as judged from the high similarity in plot curvature and end point 
values, the DNA binding properties of complexes with GyrA wt and ΔAbox are unlikely to 
differ substantially. 
The results obtained from fluorescence anisotropy gave evidence that affinities of GyrA wt 
and ΔAbox for DNA were similar, both on addition of a linear 60bp DNA fragment or of 
circular DNA (neg. supercoiled plasmid); this finding suggested that the difference in 
enzymatic activity was not due to altered DNA affinity. As the deletion of the GyrA-box did 
not result in a change of DNA affinity, the GyrA-box did not seem to be involved in DNA 
binding. 
 
  
 
 
 
 
Fig. 3.28: Fluorescence anisotropy titrations with GyrA_ΔAbox.  
A: Titration of the fluorescently labeled 60bp DNA with GyrA wt (black), GyrA_ΔAbox (red), and 
GyrA_ΔCTD (grey). Kd values were 2.3 ± 0.2 and 1.9 ± 0.2 µM for the first two proteins, respectively.  
B: Displacement titrations with neg. supercoiled plasmid DNA. Proteins used were GyrA wt (black) 
and GyrA_ΔAbox (red).  
C: Titrations of a 60bp DNA with GyrA wt (black), GyrA_ΔAbox (red), and GyrA_ΔCTD (grey) in 
the presence of 4 µM GyrB. Kd values were 63 ± 5 , 50 ± 2 and 299 ± 20 nM, respectively.  
D: Displacement titrations with neg. supercoiled plasmid DNA in the presence of GyrB. Proteins used 
were GyrA wt (black) and GyrA_ΔAbox (red). 
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3.1.30 SmFRET with a ΔAbox mutant 
It was shown that the conformational change of the GyrA CTDs is connected to complex 
formation of the domain with DNA (sections 3.1.6 and 3.1.22). Although the affinity for 
DNA was not changed upon deletion of the GyrA-box and differences in conformational 
changes between the mutant and the wild-type enzyme could not be expected, single-molecule 
FRET measurements were performed to follow the conformational changes in the mutant. 
A hetero-dimeric FRET construct was produced lacking both GyrA-box regions. The well-
characterized positions 140 at the DNA-gate and 594 on the CTD were chosen as labeling 
sites. GyrA*_ΔAbox / GyrA*_ΔAbox_T140C_K594C (abbreviated GyrA**_ΔAbox) was 
expressed and produced as described (sections 2.10.2) to similar yields (3.5 mg of protein per 
liter of bacterial culture) and purity as the other hetero-dimeric proteins. DNA-relaxation and 
supercoiling activities for the non-modified and labeled GyrA**_ΔAbox were similar to the 
ones for GyrA_ΔAbox (Fig. 3.27B). Single-molecule experiments were performed as 
described (section 2.18). 
The FRET efficiency distribution for the ligand-free enzyme showed one maximum between 
0.5 and 0.6 (Fig. 3.29A). It did not differ from the one for the wild-type like FRET mutant 
(Fig. 3.22A), indicating the same conformation for the ΔAbox mutant. Surprisingly, addition 
of neg. supercoiled plasmid DNA did not result in broadening of the FRET efficiency 
distribution: In contrast to the wild-type like GyrA the FRET efficiency remained uni-modal 
with the same maximum as for the ligand-free GyrA**_ΔAbox (Fig. 3.29A, compared to Fig. 
3.22C), despite similar affinities for plasmid DNA. This effect was not due to a lack of 
complex formation, as the autocorrelation curve clearly shows a shift to higher diffusion time 
compared to the free protein, confirming DNA binding under those conditions (Fig. 3.22B). 
The result was reproduced three times, thus excluding an experimental error. 
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Fig. 3.29: SmFRET histograms for the GyrA**_ΔAbox mutant.  
A (from left to right): In the absence of ligands; in the presence of neg. supercoiled plasmid; gyrase in 
the presence of neg. supercoiled plasmid; with ADPNP added.  
B: Autocorrelation curves for the donor signal of smFRET measurements with GyrA (black) and its 
complexes with neg. supercoiled plasmid (blue), GyrB (green), and ADPNP (red) (correspond to 
measurements for histograms in A). Addition of DNA increases the diffusion time, as does further 
addition of GyrB. The diffusion time is not further influenced by the addition of ADPNP.  
C: SmFRET histogram for gyrase in complex with 60bp DNA. 
FRET data were corrected with averaged photophysical parameters for mutant T140C_K594C 
acquired in the absence (A: 1, 2) and presence (A: 3, 4; C) of DNA and GyrB. 
Cartoons represent the GyrA_ΔAbox dimer with one subunit in blue (GyrA body) and green (CTD) 
and the other in grey. GyrB subunits, supercoiled or linear DNA and ADPNP are shown in white, by a 
black line and black ellipses. Red and green dots represent the fluorescent dyes. 
 
 
 
Addition of GyrB to GyrA**_ΔAbox and plasmid DNA resulted in a strong decrease in 
FRET efficiency to approx. 0 (Fig. 3.29A). The histogram was similar in shape and position 
as for the wild-type like FRET mutant, suggesting that the CTDs adopted the extended 
conformation (Fig. 3.22D). Also similarly, the addition of ADPNP did not show a major 
influence on the distribution. For both situations, the diffusion time was slightly longer than 
for GyrA in complex with DNA (Fig. 3.29B), suggesting a change of complex mass or shape, 
which was not observed for the wild-type like FRET mutant. The low-FRET state was also 
observed for gyrase_ΔAbox in the presence of the 60bp DNA (Fig. 3.29C). 
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The cause of supercoiling deficiency in gyrase lacking the GyrA-box could not be elucidated 
by the presented smFRET and fluorescence anisotropy data. No significant change in 
behavior could be detected between GyrA wt and ΔAbox, apart from a slightly altered CTD 
conformation for the GyrA**_ΔAbox-DNA complex, indicating that the loss of DNA 
supercoiling activity in gyrase lacking the GyrA-box is not connected to DNA binding or 
conformational change in the CTDs. 
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3.2 Part II: Topoisomerase VI from M. mazei 
3.2.1 Co-expression and co-purification of M. mazei topoisomerase VI A and B 
Biochemical and biophysical data for the archaeal topoisomerase VI (TopoVI) is scarce. In 
order to characterize the DNA relaxation and ATP hydrolysis activities and the 
conformational behavior of M. mazei TopoVI, the two subunits A and B were co-expressed 
and co-purified using a bi-cistronic expression vector derived from a pET system (kind gift 
from James Berger, University of California, Berkeley, CA); the construct had been purified 
before [61]. Here we present a slightly modified purification protocol.  
TopoVI A and B were co-expressed in E. coli BL21(DE3) Rosetta cells, with the B subunit 
being produced as an N-terminal His6-tag fusion protein cleavable with TEV protease (His6-
TEV-B, abbreviated His6-TopoVI-B). Over-expression of TopoVI yielded approx. 50 % of 
the total protein with subunits A and His6-TEV-B visible on a polyacrylamide gel at apparent 
molecular weight of 40 and 70 kDa, respectively (Fig. 3.30A), corresponding well with the 
calculated MWs of 42.1 and 71.1 kDa for the A subunit and the His6-TEV-B fusion protein, 
respectively. TopoVI-A exhibited a higher expression level than the B subunit. 
After cell disruption, a large fraction of TopoVI proteins were found to be insoluble (Fig. 
3.30B). The crude extract containing soluble proteins was passed over a Ni2+-NTA column; 
the TopoVI A + His6-TEV-B complex was adsorbed to the resin via the His6-tagged B 
subunits, indicating a stable subunit association. The co-purified TopoVI complex was 
incubated with TEV protease for the enzymatic removal of the His6-tag from the B subunits, 
giving rise to processed B subunits with a calculated MW of 69.0 kDa (hereafter denominated 
B). The cleaved protein was separated from non-cleaved by a second IMAC step, where the 
former was found in the flow-through (Fig. 3.30B). The eluted TopoVI was applied to an SP 
sepharose column: The complex was not adsorbed to the resin and found in the flow-through, 
in contrast to non-complexed B subunits and a major protein contamination with an apparent 
MW of approx. 55 kDa, reported to be a fragment of TopoVI-B [61]. In an anion-exchange 
chromatography step using a Q sepharose column the protein was separated from co-
precipitated nucleic acids in an NaCl gradient. The fraction containing TopoVI A and B 
showed only minor protein contaminations (Fig. 3.30C). The last purification step consisted 
of a SEC run, where the major fraction of TopoVI complex eluted in a peak at approx. 54 ml 
retention volume, corresponding to a calculated MW of approx. 295 kDa (Fig. 3.30D), which 
roughly corresponds to the theoretical MW of approx. 222 kDa for the hetero-tetrameric 
complex. The purified TopoVI was virtually free of foreign protein and nucleic acid 
contaminations, as judged by polyacrylamide gel and UV absorption (Fig. 3.30C and E). The 
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A280nm / A260nm ratio was 2.0. Protein yields were between 2 and 3.5 mg per liter of bacterial 
culture. 
 
 
 
 
Fig. 3.30: Co-production and co-purification of wild-type topoisomerase VI subunits A and B from M. 
mazei. 
A – C: SDS polyacrylamide gels of different purification stages with protein marker (M) and 
corresponding MW indicated in kDa. Samples were taken at different purification steps of TopoVI 
A+B; the subunits are annotated with letters A and B, respectively.  
A: Lane 1: Co-expression from E. coli BL21(DE3) Rosetta cells. Subunits A and His6-TEV-B show 
MWs of approx. 40 and 70 kDa, respectively. Lanes 2 and 3: Soluble and insoluble fraction of crude 
extract, respectively. Lanes 4 and 5: Flow-through and elution from the first Ni2+-NTA column: The 
TopoVI A + His6-TEV-B complex was pulled down via the N-terminally His6-tagged B-subunits. 
B: Lanes 1 and 2: Flow-through and elution from the second Ni2+-NTA column: TopoVI A+B without 
His6-tag (cleaved with TEV protease) was not adsorbed to the nickel resin. Lanes 3 and 4: Flow-
through and elution from an SP sepharose cation-exchange column: Separation of the TopoVI 
complex (not adsorbed: lane 3) and free full-length B subunits and a major contamination with a MW 
of approx. 55 kDa. 5: Flow-through from a Q sepharose anion-exchange column: The TopoVI 
complex did not bind to the column resin. 
C: Lane 1: Elution from a Q sepharose column by increasing concentration of NaCl. Pooled fractions 
containing purified TopoVI complex. Lane 2: Pooled fractions containing protein as eluted from a 
Sephadex S200 size-exclusion column. 
D: Elution chromatogram of the SEC step for TopoVI A+B, monitored by the UV absorption at 280 
nm. Fractions from main peak containing TopoVI A+B were pooled and concentrated (horizontal bar). 
E: UV absorption spectrum of co-purified TopoVI A+B in storage buffer at approx. 5 µM monomer 
concentrations. The absorption maximum was at 278 nm; the A280nm / A260nm ratio was 2.0. 
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3.2.2 Optimization of TopoVI activity buffer conditions 
M. mazei TopoVI was shown to possess ATP-dependent DNA relaxation activity [61]. Buffer 
conditions for the assay were optimized in relaxation reactions containing 1 µM of TopoVI 
(monomeric concentrations for subunits A and B), 15 nM neg. supercoiled pUC18 and 1 mM 
ATP using varying concentrations of buffer components (Fig. 3.31A – D). Incubation times 
and temperatures were chosen as described (section 2.12.2). In absence of ATP, no plasmid 
relaxation was visible.  
For initial experiments the pH was set to 6.5 as reported [61] using MOPS instead of Bis-Tris-
Propane (BTP) as a buffering agent. Concentrations of components were 20 mM MOPS, 100 
mM potassium glutamate (Kglu), 10 mM MgCl2, and 1 mM DTT. 
Screening for the optimal concentration of MOPS (20, 50, and 100 mM) resulted in best 
relaxation with 50 mM buffering agent concentration and almost equal relaxation extend at 20 
mM (Fig. 3.31A). A parallel screen of the salts consisting of monovalent cations and anions 
was performed in presence of 100 mM NaCl, KCl or Kglu. TopoVI showed highest activity in 
buffer containing Kglu. The use of KCl resulted in a slightly reduced activity, indicating a 
slightly inhibitory effect of Cl- anions. Plasmid relaxation activity was completely abolished 
in the reaction performed using NaCl, suggesting a very strong inhibitory effect on the 
enzymatic activity of TopoVI by the Na+ cations (Fig. 3.31A). Kglu was chosen as the 
primary salt for the activity buffer. 
The of Kglu on plasmid relaxation activity was tested in a concentration range between 0 and 
300 mM, using a slightly unfavorable MOPS concentration of 20 mM. The extent of plasmid 
relaxation was maximal in the reaction containing 150 mM Kglu. The relaxation activity was 
slightly reduced between 100 and 200 mM of Kglu, but almost completely abolished in the 
absence of salt or at 300 mM (Fig. 3.31B). 
DNA cleavage and religation by TopoVI as well as ATP hydrolysis strictly depend on MgCl2 
[59, 62]. The relaxation activity was tested as a function of MgCl2 concentration in a range 
between 0 and 100 mM. The enzymatic activity was maximal in 10 mM of MgCl2; no 
relaxation was visible for concentrations of 0, 2 and 100 mM (Fig. 3.31C). 
Plasmid relaxation by M. mazei TopoVI documented in literature was performed using Bis-
Tris propane (BTP) as a buffering agent [61]. The compound was tested at concentrations 
between 0 and 70 mM. Relaxation occurred in a concentration range of 0 to 50 mM, but was 
most efficient at 40 mM BTP. The reaction containing 70 mM BTP showed no product 
formation (Fig. 3.31D). Compared to the MOPS buffer system, BTP resulted in higher 
TopoVI DNA relaxation activity. 
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Thus, optimized buffer conditions were 40 mM BTP (pH 6.5), 150 mM Kglu and 20 mM 
MgCl2, with higher concentrations of buffer components compared to the ones mentioned 
before (20 mM BTP (pH 6.5), 100 mM Kglu and 10 mM MgCl2) [61]. 
 
 
 
 
Fig. 3.31: Optimization of buffer components and concentrations for activity measurements. Depicted 
are agarose gels of plasmid relaxation products by TopoVI. Concentrations of TopoVI, substrate 
plasmid and ATP were 1 µM, 15nM and 1 mM, respectively. Bands corresponding to neg. supercoiled 
and relaxed pUC18 plasmid are denominated –sc and rel, respectively. 
A: Screening of different concentration of the buffering agent MOPS and different salts of monovalent 
cations and anions. Lanes 1, 2, 3: 20, 50, 100 mM of MOPS. Lane 4: Incubation of TopoVI and 
supercoiled plasmid in absence of ATP, using a buffer containing 20 mM MOPS and 100 mM Kglu. 
Lanes 5, 6, 7: Relaxation in buffers containing 100 mM Kglu, KCl, or NaCl. 
B: Screening of different concentrations of Kglu, using 20 mM of MOPS pH 6.5 and 10 mM MgCl2. 
Lane 1: Reaction in absence of ATP, using 100 mM of Kglu: No relaxation is visible. Lanes 2 – 9: 
Relaxation in presence of 0, 50, 80, 100, 150, 200, 250, and 300 mM of Kglu. 
C: Screening of different concentrations of MgCl2, using 20 mM of MOPS pH 6.5 and 150 mM Kglu. 
Lanes 1 – 7: Relaxation in presence of 0, 2, 5, 10, 20, 50, and 100 mM of MgCl2. 
D: Screening of different concentrations of buffer agent BTP; the pH was adjusted to 6.5. 
Concentrations for Kglu and MgCl2 used were 150 and 10 mM, respectively. Lanes 1 and 2: Control 
reactions performed using 20 mM MOPS, pH 6.5, in the absence and the presence of ATP. Lanes 3 – 
9: Relaxation in buffers containing 0, 10, 20, 30, 40, 50, and 70 mM BTP.  
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3.2.3 TopoVI from M. mazei is an ATP-dependent DNA relaxase 
Having optimized the buffer conditions for the DNA relaxation activity of TopoVI, the 
enzymatic activity could be quantified. A DNA relaxation assay was performed in presence of 
1 mM ATP using 15 nM neg. supercoiled plasmid DNA substrate and varying concentrations 
of TopoVI enzyme. 
No relaxation activity was visible in absence of TopoVI. While at 20 nM a distribution of 
relaxed and supercoiled plasmid topoisomers was visible, at 50 to 100 nM enzyme 
concentration the substrate was fully relaxed indicating that maximal relaxation activity was 
reached at 50 nM (Fig. 3.32A). Reactions performed at higher enzyme concentrations (i.e. 
200 – 1000 nM) resulted in partially relaxed plasmid, suggesting that the relaxation activity 
depends on the enzyme :  plasmid ratio. The calculated optimal ratio would be between 3 and 
7 (50 - 100 nM enzyme : 15 nM plasmid). The control reaction performed in absence of ATP 
at 1 µM enzyme concentration clearly showed no plasmid relaxation, which gives evidence 
that the reaction is ATP-dependent. The control also shows that no ATP-independent 
topoisomerase contaminant was co-purified with TopoVI. This result confirmed previous 
findings for TopoVI from S. shibatae and M. mazei [25, 61]. 
The relaxation activity of TopoVI was further tested in presence of different nucleotides, 
using ATP, ADP, and the structural ATP analog ADPNP. Reactions were incubated for 30 or 
60 min. At 50 nM concentration of the enzyme, the plasmid substrate was fully relaxed in 
presence of ATP. As expected, no relaxation was visible for reactions performed in the 
presence of ADP or ADPNP, demonstrating that DNA relaxation by TopoVI depends on ATP 
hydrolysis (Fig. 3.32B). The reaction performed in presence of ATP was completed after 30 
min. 
 
Fig. 3.32: Plasmid DNA relaxation activity by M. mazei TopoVI. Plasmid and nucleotide 
concentrations were 15 nM and 1 mM, respectively. Bands corresponding to neg. supercoiled and 
relaxed pUC18 plasmid are denominated –sc and rel, respectively. Reactions were performed in 
TopoVI activity buffer (section. 3.2.2). 
A: Relaxation using different TopoVI concentrations. Lanes 1 – 7: 0, 20, 50, 100, 200, 500, 1000 nM 
TopoVI, respectively. Lane 8: Reaction in absence of ATP. Reactions showing the highest TopoVI 
activities are denominated with corresponding TopoVI concentrations (lanes 3 and 4). 
B: Incubation of supercoiled plasmid with 50 nM TopoVI and different nucleotides. Incubation times 
were 30 or 60 min (as indicated). Reactions were performed in absence of nucleotide (lane 1), in 
presence of ATP (lanes 2, 3), ADP (lanes 4, 5), or ADPNP (lanes 6, 7; abbrev: ANP). 
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3.2.4 DNA relaxation by TopoVI is inhibited in presence of NaCl 
In section 3.2.2 it was demonstrated, that the relaxation activity of TopoVI is abolished in 
presence of 100 mM NaCl; responsible for this loss of activity is mainly the presence of Na+ 
cations. For different experiments TopoVI was diluted from storage conditions resulting in a 
systematic contamination with NaCl due to the storage buffer conditions (300 mM NaCl); 
thus it was of great importance to determine the inhibitory concentration of Na+. 
DNA relaxation was performed under optimized buffer conditions using 50 nM of TopoVI, 
15 nM of neg. supercoiled plasmid DNA and 1 mM of ATP in presence of varying 
concentrations (0 – 200 mM) of NaCl. At salt concentrations below 10 mM the relaxation 
activity was not affected, whereas addition of 20 mM of NaCl already resulted in the presence 
of supercoiled and partially relaxed plasmid. At salt concentrations of 50 mM and above the 
relaxation activity of TopoVI was completely inhibited (Fig. 3.33A). 
These results suggest that a maximal NaCl concentration of approx. 10 to 15 mM is tolerated 
by TopoVI. The concentrations of NaCl in all experiments described hereafter were lower 
than 15 mM. 
 
 
Fig. 3.33: For legend see following page. 
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Fig. 3.33: Inhibition of TopoVI DNA relaxation activity by salts and specific topoisomerase poisons. 
Concentrations of TopoVI, neg. supercoiled plasmid and ATP were 50 nM, 15 nM and 1 mM, 
respectively. Bands corresponding to neg. supercoiled and relaxed pUC18 plasmid are denominated –
sc and rel, respectively. Reactions were performed in TopoVI activity buffer (section. 3.2.2). 
A: Relaxation reactions by TopoVI in absence of ATP (lane1) and presence of 0, 2, 5, 10, 20, 50, 100, 
and 200 mM NaCl (lanes 2 – 9). 
B: Relaxation reactions by TopoVI in presence of 0, 100, 150, 200, 250, 300, 350, 400, and 500 µM of 
Na2SO3 (lanes 1 – 9). 
C: Relaxation reactions in absence of TopoVI (lane 1), in absence of ATP (lane 2), in presence of 
TopoVI and ATP (lane 3), and with 50 µM of topoisomerase inhibitors added (lanes 4 – 7): oxolinic 
acid, ciprofloxacin, nalidixic acid, and sparfloxacin. 
D: Relaxation reactions in absence of TopoVI (lane 1), in absence of ATP (lane 2), in presence of 
TopoVI and ATP (lane 3), and with varying concentrations of ciprofloxacin added (lanes 4 – 9): 50, 
100, 150, 250, 300, and 350 µM, respectively. 
E: Relaxation reactions in absence of TopoVI (lane 1), in absence of ATP (lane 2), in presence of 
TopoVI and ATP (3), with 100 and 200 µM of etoposide (lanes 4 and 5) or 2.1 and 4.2 % (v/v) DMSO 
added (lanes 6 and 7), respectively. 
 
 
3.2.5 Screening potential DNA cleavage and religation inhibitors 
Only one specific inhibitor of TopoVI is known today: The drug radicicol completely inhibits 
DNA relaxation by S. shibatae TopoVI at concentrations higher than 125 µM [97], occupying 
the ATP binding site of the B subunits [98]. With a view to experiments addressing the DNA 
cleavage and religation site of M. mazei TopoVI, located on subunit A, several compounds 
known for their inhibitory effect in type IIA topoisomerases were tested on TopoVI. 
Inorganic selenite was shown to induce complexation of DNA and human topoisomerases I 
and II in vitro [99]. Na2SO3 was added to DNA relaxation reactions up to 500 µM. Above a 
concentration of approx. 250 µM, TopoVI was completely inhibited (Fig. 3.33B). The 
corresponding concentration of Na+ cations was around 500 µM, which is not in the inhibitory 
range. Thus selenite acts as an inhibitor to TopoVI. 
Compounds tested next belong to the class of quinolones which are potent antibacterial drugs 
targeting the Gyrase-DNA complex [100]. Oxolinic acid, ciprofloxacin (CFX), nalidixic acid 
and sparfloxacin were added to DNA relaxation reactions in concentrations of 50 µM. No 
inhibitory effect could be observed for either of them (Fig. 3.33C). CFX was tested in a 
concentration-dependent manner up to 350 µM. The DNA relaxation activity of TopoVI was 
slightly lowered at concentrations above 250 µM, but complete inhibition was not achieved 
(Fig. 3.33D). 
The last compound to be tested was etoposide, a topoisomerase II poison, and used as a 
chemotherapeutic agent [101]. It also was shown to inhibit S. shibatae TopoVI (personal 
communication by D. Gadelle, Group Forterre, Paris). Etoposide, dissolved in DMSO was 
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added to the relaxation reaction at concentrations of 100 and 200 µM, exhibiting a slight 
inhibitory effect. However, this effect was due to DMSO, as shown in control reactions (Fig. 
3.33E). 
Compounds found to inhibit M. mazei TopoVI were the salt Na2SO3 and the fluoroquinolone 
drug CFX, with inhibition observable at concentrations above 250 µM for either of them. 
Both drugs need to be tested in DNA cleavage reactions (section 3.2.8). 
 
 
3.2.6 A fluorescently labeled 50bp DNA to monitor DNA-gate dynamics in TopoVI 
One of the main objectives of this work was to monitor gate dynamics in TopoVI. One way to 
do so is to detect conformational changes and cleavage events in a DNA bound to the DNA-
gate. A fluorescently double-labeled 50bp DNA (abbrev. 50bp FRET DNA) was devised to 
serve as ligand for TopoVI in smFRET studies. It contained a putative binding site for S. 
shibatae TopoVI [59]. Different non-labeled and single-dye labeled versions of the 50bp 
DNA bearing the same nucleotide sequence were used for binding and cleavage studies.  
 
3.2.7 Binding of the 50bp DNA to TopoVI wt and Y106F 
In order to characterize the influence of the fluorescent dyes on binding of the 50bp FRET 
DNA to TopoVI, single-dye labeled 50bp DNAs (50bp-A488, 50bp-A546) were titrated with 
TopoVI and compared to a 50bp DNA of the same sequence end-labeled with fluorescein 
(50bp-Fluor). Binding was monitored by fluorescence anisotropy. 
Anisotropy signals of the non-complexed DNAs were in a range between 0.05 (A488) and 
0.082 (A546), differing slightly due to the differences in mobility and attachment points of 
the dyes. The anisotropy signal increased for all three DNAs upon addition of protein, 
indicating complex formation. A 1:1-binding model was fitted to the data yielding Kd values 
of 3.2 ± 0.6, 1.9 ± 0.1 and 0.36 ± 0.03 µM for 50bp-Fluor, -A488 and –A546, respectively 
(Fig. 3.34C). Anisotropy values for saturating conditions were calculated as 0.133, 0.179 and 
0.335, respectively. The large differences in binding affinity (up to 6.5-fold) and end 
anisotropies among the three DNAs suggested a considerable influence of the identity and 
position of the fluorescent labels on the binding behavior towards TopoVI. 
In the course of the validation of the 50bp DNA as a model substrate, the influence of the 
Y106F mutation in the TopoVI-A subunit on DNA binding was tested. The protein was 
deficient in DNA-cleavage activity, as indicated by the lack of plasmid relaxation (Fig. 
3.34B) and sequence comparison with homologues proteins. Titration of 50bp-A546 with 
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TopoVI Y106F yielded a Kd value of 4.1 ± 0.2 µM, marking an approx. 10-fold decrease in 
affinity compared to the wt protein. A possible explanation for this result is the potential lack 
of formation of a covalent tyrosyl-DNA intermediate. 
Titration of the double-labeled 50bp DNA with TopoVI Y106F showed a Kd value of 1.4 ± 
0.1 µM. The increase in affinity for TopoVI was due to the presence of a second dye, 
suggesting an additive effect of the two labels on the binding. This finding questions the 
validation of the 50bp DNA for FRET experiments. 
 
 
3.2.8 Cleavage of the 50bp DNA by TopoVI 
After showing the formation of the DNA-protein complex it was important to test whether wt 
TopoVI was able to cleave the substrate, and if this would be at the expected position of the 
preferred cleavage site. For this purpose a 50bp DNA was annealed from a non-modified and 
a 32P-labeled strand incubated with TopoVI in absence or presence of 2 mM nucleotide (ATP 
or ADPNP) and 500 µM inhibitors (ciprofloxacin or inorganic selenite) to induce the 
formation of a DNA-protein complex, i.e. DNA cleavage (section 2.13). DNA products were 
separated by gelelectrophoresis and visualized by a phosphorimager. Despite the high 
sensitivity of the method, cleaved DNA product was observed in none of the reactions (Fig. 
3.34A). This finding was somewhat surprising, as from differences in DNA affinity between 
wt TopoVI and the cleavage-deficient mutant one would expect the population of the covalent 
DNA-protein intermediate: It was not clear, if DNA cleavage did not occur or if the cleavage 
complex could not be trapped by the method used. 
 
3.2.9 SmFRET experiments with the double-labeled 50bp DNA 
It could be demonstrated that the fluorescent labels alter the binding properties of the 50bp 
DNA towards TopoVI. In addition no cleavage product could be detected. Nevertheless, the 
double-labeled 50bp DNA was used in smFRET measurements to detect potential 
conformational changes in the DNA upon binding to TopoVI and different nucleotides. 
Concentrations for the DNA, protein and nucleotides were 40 pM, 2.5 µM and 1 mM, 
respectively. Experiments were performed at room temperature. FRET efficiencies were 
corrected using parameters determined with single-dye labeled 50bp DNA, in the absence and 
the presence of TopoVI. Correction parameteres for ligand-free and TopoVI-bound DNA 
were determined as described (section 2.18.2); values for α’, β’, and γ’ were (A) 0.53, 0.014, 
2.00 and (B) 0.64, 0.11, 3.41 in absence and presence of TopoVI, respectively. SmFRET 
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measurements of ligand-free DNA were corrected with parameter set A, while all 
measurements involving TopoVI were corrected with parameter set B. 
FRET histograms of the free DNA showed a narrow distribution with a maximum at approx. 
0.6 (Fig. 3.34D). Upon addition of wt TopoVI the FRET efficiency distribution shifted to a 
mean value of 0.4 and adopted a broader shape, suggesting a conformational change of the 
DNA or a change of the environment of the dyes. Addition of ADPNP or ATP to the DNA-
protein complex (which might result in a conformational rearrangement of the ATPase-gate) 
did not further influence the position of the FRET efficiency distribution, suggesting no 
rearrangement of the complex in the region of the DNA-gate (Fig. 3.34D, F). Judged from 
anisotropy titration data, the fluorescent labels alter the binding of the 50bp DNA to TopoVI 
and might therefore be restricted in motion; thus it is possible that the change in FRET 
efficiency is due to physical contact of one or both dyes with the protein. 
The single-molecule experiments were also performed with the cleavage-deficient TopoVI 
Y106F mutant. Addition of the protein to the labeled 50bp DNA resulted in a shift of the 
FRET efficiency very similar to the one induced by the wt protein. The FRET efficiency 
distribution also remained constant upon addition of ADPNP (Fig. 3.34E). Thus, no 
difference in FRET efficiency of the DNA bound to wt and mutant TopoVI could be detected, 
indicating similar DNA conformations and complex formation for both proteins.  
In DNA cleavage experiments with TopoVI, no cleaved DNA products were observed. It is 
not clear whether the cleavage complex was formed. As a result, the lack of difference in 
DNA conformation in the complex with wt TopoVI and the cleavage-deficient mutant could 
be either because cleavage in the wt enzyme did not occur or because the conformation of the 
DNA does not change upon cleavage by TopoVI. 
 
From the presented results it is not clear if the 50bp DNA can be used as G-segment for 
TopoVI: No cleavage product could be detected, and the fluorescent labels attached to the 
DNA influenced the affinity for the enzyme. Due to this uncertainty, this project was not 
further developed. 
 109 
 
 
Fig. 3.34: A 50bp DNA ligand for TopoVI: Binding, cleavage, and smFRET experiments. 
A: DNA cleavage assay using a 32P-labeled 50bp DNA. 1, K: Labeled control DNAs of 50 and 25 bp 
in length. Reactions denominated with + were incubated with TopoVI wt. Reactions 2 – 4 were 
performed in absence of nucleotide; reactions 5 – 7 in presence of ATP; and reactions 8 – 10 in 
presence of ADPNP. Inhibitors ciprofloxacin (C) and sodium selenite (S) were added to reactions 3, 6, 
9 and 4, 7, 10, respectively. In neither of the reactions was a cleavage product observed. 
B: DNA relaxation assay with the cleavage-deficient mutant TopoVI Y106F (YF). Relaxation 
reactions by TopoVI Y106F in the presence of ATP (lane 1) and by TopoVI wt in the absence (lane 2) 
and the presence of ATP (lane 3). 
Continued on following page. 
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C: Fluorescence anisotropy titrations of 50bp DNA. Left: Titration of the DNA labeled at one end 
with fluorescein (black) or internally labeled with A488 (green) with TopoVI wt. Kd values were 3.2 ± 
0.6 and 1.9 ± 0.1 µM, respectively. Middle: Titrations of the DNA labeled internally with A546 with 
TopoVI wt (red) and Y106F (blue; abbrev: YF). Measured Kd values were 0.36 ± 0.03 and 4.1 ± 0.2 
µM, respectively. Right: Titration of the double labeled 50bp DNA (FRET construct) with TopoVI 
Y106F, yielding a Kd value of 1.4 ± 0.1 µM. Bands corresponding to neg. supercoiled and relaxed 
pUC18 plasmid are denominated –sc and rel, respectively.  
D – F: SmFRET histograms for the double-labeled 50bp DNA, corrected with parameters listed in 
section 3.2.9. 
D (left to right): Histograms for free DNA, DNA bound to TopoVI wt, and with ADPNP added.  
E (left to right): Histograms for free DNA, DNA bound to cleavage-deficient mutant TopoVI Y106F, 
and with ADPNP added.  
F: Histogram for the 50bp DNA in complex with TopoVI wt in presence of ATP. FRET efficiencies 
for free DNA were corrected with parameters determined from single-fluorophore labeled DNA; all 
other FRET efficiencies were corrected with parameters determined in presence of TopoVI wt. 
 
3.2.10 Mutation of solvent-accessible cysteine residues in TopoVI 
Observation of conformational changes in TopoVI via a fluorescently labeled DNA was not 
successful, as described above. Another possibility was to couple fluorescent dyes to the 
protein surface, making use of the specific modification of thiols (present in side-chains of 
cysteine residues) by maleimide groups. Site-specific labeling of proteins requires the 
removal of solvent-accessible cysteines and the introduction of cysteines in the desired 
positions. 
M. mazei TopoVI contains one and six cysteine residues in subunits A and B, respectively 
(Fig. 3.35A). In order to determine the residues which are accessible to the solvent, the 
protein was fluorescently labeled with Alexa546-C5-maleimide, using 30 µM protein and a 
ten-fold excess of fluorescent dye (300 µM). The reaction was incubated at 25°C for 2 h, the 
protein separated from non-reacted dye by SEC and subsequently analyzed on an SDS-
polyacrylamide gel. The labeling degree was calculated as described (section 2.16.3), yielding 
a value of 140 % (120 – 160 % in repeated experiments) of dye with respect to available A 
and B subunits. Fluorescent labeling was restricted to the B subunit, while the A protein was 
not modified (Fig. 3.35C). As judged from the X-ray structure of the TopoVI holoenzyme 
[61], cysteine residues C267, C278, C316 (all located in the ATPase domain) and C550 (on 
the C-terminal domain of TopoVI-B) were considered potentially solvent-accessible. 
The number of cysteine residues in the TopoVI-B subunit was reduced in a step-wise fashion, 
and each mutant was fluorescently labeled to test for remaining solvent-accessible thiols. The 
mutants were purified after the protocol developed for the wt protein (section 2.10.3). C550 
was the first to be exchanged to alanine, reducing the labeling efficiency of TopoVI-B with 
A546 to approx. 110 % (Fig. 3.35C). Next proteins tested for fluorescence labeling were the 
double mutants C267S_C550A and C278A_C550A. Both proteins were purified by IMAC 
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using His SpinTrap microcolumns and labeled with A546, using micromolar protein 
concentrations and 50 dye concentrations in the low micromolar range and 50 µM of 
fluorescent dye. The wild-type protein showed a labeling degree of approx. 120 %, while the 
labeling efficiencies of the mutants were reduced to 75 and 110 % for the protein 
preparations, assuming pure TopoVI mutants. These values indicate C267 to be solvent-
accessible, while C278 was barely labeled with A546 (Fig. 3.35D). The modification of C267 
was confirmed by mass spectrometry of tryptic fragments of labeled wild-type protein (Lab of 
Bernhard Schmidt, University of Göttingen, Germany). C316 was exchanged next: The 
labeled triple cysteine mutant C267S_C316S_C550A (SSA) showed a further reduced 
labeling degree of 24 % compared to the one of 110 % of the wild-type under labeling 
conditions described above (Fig. 3.35E). Considering that a contaminating protein present in 
the preparation of TopoVI SSA was labeled to a much higher degree than the mutant B 
subunit, the labeling efficiency for the remaining cysteine residues was considered low 
enough to further reduce it using a modified labeling procedure. TopoVI SSA was used as a 
basis to introduce cysteine residues for labeling and subsequent smFRET experiments. 
 
 
 
Fig. 3.35: Determination and removal of solvent-accessible cysteine residues and influence of 
mutations on the ATPase activity. 
Continued on following page. 
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A: X-ray structure of the M. mazei TopoVI hetero-tetrameric holoenzyme with cysteine residues 
depicted in sphere representation. Cysteines represented in yellow and blue spheres were found to be 
solvent-accessible or less accessible in labeling experiments, respectively. 
B: Steady-state ATP hydrolysis assays with TopoVI wt (black), double mutant C267S C550A (green; 
SCA) and triple mutants C267S C316S C550A (blue; SSA), C267S C316A C550A (blue; SAA) and 
C267S C316G C550A (blue; SGA), using 4 µM and varying concentrations of ATP. Values for KM 
and kcat are given in section 3.2.11. 
C – E: SDS-polyacrylamide gels of TopoVI proteins labeled with A546 in fluorescence view (right) 
and after coommassie staining (left). The protein size marker is denominated M, and corresponding 
MW are indicated in kDa. TopoVI subunits are annotated with letters A and B, respectively. Non-
reacted dye is annotated with D.  
C: Fluorescently labeled TopoVI wt (lanes 1, 3) and C550A (lanes 2, 4).  
D: Fluorescently labeled TopoVI wt (lanes 1, 4) with mutants C267S C550A (lanes 2, 5) and C278A 
C550A (lanes 3, 6).  
E: Fluorescently labeled TopoVI wt (lanes 1, 3) and mutant C267S C316S C550A (lanes 2, 4). 
 
 
3.2.11 ATP hydrolysis and DNA relaxation assays with TopoVI mutants 
As the modification of an enzyme by mutagenesis often leads to a change in the catalytic 
properties, the TopoVI mutants C267S_C550A (SCA) and C267S_C316S_C550A (SSA) 
were tested for potential activity loss. 
First, the ATPase activity of the wild-type protein was determined under steady-state 
conditions and monitored spectrophotometrically, using 4 µM of enzyme and varying 
concentrations of ATP. ATP hydrolysis rates could be described according to the Michaelis-
Menten formalism, yielding values for KM and kcat of 0.50 ± 0.14 mM and (1.4 ± 0.1) · 10-3 
per second (Fig. 3.35B). The plasmid relaxation activity was determined before: The maximal 
relaxation was observed at a protein concentration of 50 – 100 nM (Fig. 3.32A). The test was 
performed in presence of 15 nM neg. supercoiled pUC18 plasmid and 1 mM ATP. 
The ATPase and DNA relaxation activities of TopoVI mutants SCA and SSA were 
determined under the same conditions as for the wt protein. While the KM values remained 
similar (difference in the range of the error), the turn-over number kcat was increased to (2.8  ± 
0.4) and (3.9 ± 0.4) · 10-3 per second for mutants SCA and SSA (Fig. 3.35B). The DNA 
relaxation activity of SCA remained unchanged compared to the wt, showing maximal 
plasmid relaxation at a protein concentration of approx. 100 nM (Fig. 3.36A). In SSA 
however, maximal relaxation was achieved only between 500 and 1000 nM of enzyme, 
indicating a change in the enzymatic behavior by the mutation of C316 to serine (Fig. 3.36B). 
In order to reduce the loss in plasmid relaxation activity for the C316 mutant, the residue was 
exchanged to alanine and glycine. The triple mutants C267S_C316A_C550A (SAA) and 
C267S_C316G_C550A (SGA) exhibited wild-type like KM values, but higher turn-over 
numbers of (4.1 ± 0.3) and (2.9 ± 0.2) · 10-3 per second. Plasmid relaxations activities were 
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similar to the one for SSA, namely at enzyme concentrations of approx. 500 nM (Fig. 3.35B 
and Fig. 3.36C, D).  
It is evident, that the exchange of C316 to S, A or G only moderately affects the ATP turn-
over number (2 – 3-fold increase), but results in an approx. 5- to 10-fold decrease of plasmid 
relaxation activity compared to wt. This finding suggests that mutation of C316 partially 
uncouples DNA relaxation and ATP hydrolysis. Still, the TopoVI mutant SSA was used as a 
basis for the introduction of cysteines for smFRET measurements: The plasmid relaxation 
activity might be reduced, but at least the protein retains ATP-dependent topoisomerase 
activity. 
 
 
 
 
 
Fig. 3.36: Plasmid DNA relaxation activity by M. mazei TopoVI mutants. Plasmid and nucleotide 
concentrations were 15 nM and 1 mM, respectively. Bands corresponding to neg. supercoiled and 
relaxed pUC18 plasmid are denominated –sc and rel, respectively. Protein concentrations resulting in 
maximal plasmid relaxation are mentioned (red). Reactions were performed in TopoVI activity buffer 
(section 3.2.2). 
A: Plasmid relaxation by TopoVI SCA. Lanes 1 – 9: 0, 0.02, 0.05, 0.1, 0.2, 0.5, 1.0, 2.0, and 5.0 µM. 
B: Plasmid relaxation by TopoVI SSA. Lanes 1 – 9: 0, 0.05, 0.1, 0.2, 0.5, 1.0, 2.0, 5.0 and 10.0 µM.  
C: Plasmid relaxation by TopoVI SAA. Lane 1: Relaxation by 50 nM TopoVI wt as a control. 2 – 9: 
0.02, 0.05, 0.1, 0.2, 0.5, 1.0, 2.0, and 5.0 µM. 
D: Plasmid relaxation by TopoVI SGA. Lane 1: Relaxation by 50 nM TopoVI wt as a control. 2 – 9:  
0.02, 0.05, 0.1, 0.2, 0.5, 1.0, 2.0, and 5.0 µM. 
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3.2.12 Construction and validation of FRET mutants 
The TopoVI triple mutant C267S_C316S_C550A (SSA) was hardly labeled under extreme 
reaction conditions, i.e. using high dye concentrations of 300 µM and long incubation times 
of 2 h. Several mutants for labeling of positions in the upper (R87C, D159C, E164C) and 
lower ATPase-gate (P408C) were constructed by introducing cysteine residues to the SSA 
triple mutant (Fig. 3.37A). Production and purification of these mutants were performed as 
for the wild-type, resulting in protein of similar purity (as judged from SDS polyacrylamid 
gels and UV absorption), but with lower yields of 3 – 5 mg per liter bacterial culture. 
Labeling of the FRET mutants was performed using 30 µM protein and 24 and 36 µM of 
A488 and A546, respectively, and reducing the incubation time to 10 min. Initial labeling 
reactions were performed in parallel on FRET mutants and TopoVI SSA to monitor the 
labeling of residual native cysteines. Total labeling degrees were 60 – 100 % (relative to 
introduced cysteine residues) for the FRET mutants, but maximally 5 % for the SSA mutant 
(Fig. 3.37B). 
The enzymatic activities of the FRET mutants were determined in plasmid relaxation assays. 
The mutants R87C, E164C and P408C reached exhibited maximal relaxation activity at 
concentrations of approx. 500 µM, i.e. at the same concentration as the SSA mutant, 
indicating no loss of activity due to exchange of certain residues to cysteine (Fig. 3.37D, E 
and G). The mutant D159C showed maximal plasmid relaxation at an enzyme concentration 
of 5 µM, marking a 10-fold reduction in activity compared to the SSA mutant (Fig. 3.37C); 
this was probably due to the proximity of the mutation site to the dimerization interface of the 
ATPase-gate (Fig. 3.37A). Only for the FRET mutant E164C, the relaxation activity was 
tested using the labeled enzyme. Maximal plasmid relaxation was exhibited at approx. 1 µM 
protein concentration, indicating a small loss of activity due to fluorescent labeling (Fig. 
3.37F). 
All of the four above-mentioned TopoVI SSA FRET mutants were shown to retain the 
relaxation activity of the SSA mutant (with the exception of the mutant D159C) and could be 
fluorescently labeled in a site-specific manner. Thus single molecule measurements could be 
performed with all mutants. 
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Fig. 3.37: Labeling positions and validation of TopoVI FRET mutants.  
A: X-ray structure of the M. mazei TopoVI hetero-tetrameric holoenzyme, with cysteines introduced 
for site-specific labeling depicted in spheres. Exchanged residues in the upper ATPase-gate region are 
colored in red (R87C), blue (D159C) and yellow (E164C), while the one in the transducer region is 
depicted in green (P408C).  
B: Fluorescence view (right) and coomassie staining (left) of an SDS-polyacrylamide gel of TopoVI 
mutants double-labeled with A488 and A546. The protein standard is denominated M, and 
corresponding MW are indicated in kDa. Proteins depicted are TopoVI FRET mutants E164C (1) and 
D159C (2) together with TopoVI SSA triple mutant (3). TopoVI subunits are denominated with A and 
B. No free dye was observed (D). 
Continued on following page. 
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C – G: Plasmid DNA relaxation activity by TopoVI FRET mutants. Plasmid and nucleotide 
concentrations were 15 nM and 1 mM, respectively. Bands corresponding to neg. supercoiled and 
relaxed pUC18 plasmid are denominated –sc and rel, respectively. Protein concentrations resulting in 
maximal plasmid relaxation are mentioned (red). Reactions were performed in TopoVI activity buffer 
(section 3.2.2). 
C, D and F: Plasmid relaxation by FRET mutants D159C, E164C and double labeled E164C, 
respectively. Lane 1: Relaxation by 50 nM TopoVI wt as a control. Lanes 2 – 9:  Relaxation with 
TopoVI mutants at concentrations of 0.02, 0.05, 0.1, 0.2, 0.5, 1.0, 2.0, and 5.0 µM. 
E, G: Plasmid relaxation by FRET mutants P408C and R87C, respectively. Lane 1 and 2: Reactions in 
absence and presence of 50 nM TopoVI wt as a control. Lanes 3 – 9:  Relaxation with TopoVI 
mutants at concentrations of 0.1, 0.2, 0.5, 1.0, 2.0, 5.0, and 10.0 µM. 
 
3.2.13 Conformational changes in the ATPase-gate of TopoVI revealed by smFRET 
TopoVI FRET mutants R87C, E164C and P408C have been validated for smFRET 
experiments. Although mutant D159C exhibited a decreased plasmid relaxation activity, it 
was also considered for smFRET measurements. Experiments were performed at 37°C in 
activity buffer lacking DTT. FRET efficiencies were corrected with average correction 
parameters for the dye pair A488 / A546 (Tab. 3.2, section 3.1.13). 
 
3.2.14 Nucleotide-induced locking of the ATPase domains 
First, experiments were performed with double-labeled TopoVI free from ligands with the 
concentration of the donor dye fixed to 50 pM. Mutants E164C and D159C showed medium 
FRET efficiencies and broad distributions, indicating high flexibility of the inter-dye distance 
(Fig. 3.38A, B). This finding was supported by the data from mutant R87C, which showed a 
FRET efficiency distributed between 0.1 and 0.9 with two small maxima at 0.3 and 0.9 FRET 
efficiency (Fig. 3.38B). These results suggest significant conformational freedom of the 
ATPase domains in the ligand-free state.  
Addition of 4 mM ADPNP to mutant E164C did not shift the FRET peak, but resulted in a 
narrowed FRET efficiency distribution compared to the free enzyme, indicating the restriction 
of the inter-dye distance and thus of the ATPase domains. For mutant R87C, population of a 
high-FRET state with a maximum of approx. 0.85 was observed in presence of 4 mM 
ADPNP, suggesting a decrease of the inter-dye distance well below the Förster distance of 5.5 
nm (Fig. 3.38C). As ADPNP was proposed to promote dimerization in the ATPase domains 
[62], this state should reflect the closed gate. Addition of 4 mM ATP to mutant E164C did not 
yield a defined FRET efficiency distribution, but the mean efficiency seemed to remain 
unchanged compared to the free enzyme (Fig. 3.38D). A reason for this behavior could be 
ATP-hydrolysis dependent opening and closing of the domain.  
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In contrast to FRET from labels located in the upper ATPase-gate region, the FRET 
efficiency for dyes coupled to the mutant P408C showed a narrow distribution with a defined 
maximum at approx. 0.1, indicating a rather fixed inter-dye distance of more than 7 nm (Fig. 
3.38B). No change in FRET efficiency was observed upon addition of up to 10 mM ADPNP 
or ATP to the enzyme, suggesting a constant distance between the lower ATPase regions even 
upon potential dimerization of the upper ATPase domains (Fig. 3.38C, D). 
 
3.2.15 Opening of the ATPase gate in presence of supercoiled plasmid 
Data presented in the previous section suggest dynamic opening and closing of the ATPase 
domains in absence of nucleotides. We wanted to know whether this conformational 
flexibility was influenced by binding of a large DNA, in this case neg. supercoiled pUC18 
plasmid. Plasmid DNA was added in concentrations between 30 and 40 nM. Interestingly, the 
mutant E164C exhibited a strong FRET efficiency shift from medium values in the ligand-
free state to almost 0 for the protein-DNA complex. A similar effect, albeit less pronounced, 
was observed for the R87C mutant: The FRET efficiency was still distributed between values 
of 0 and 0.95, but with a clear shift toward lower FRET efficiencies. These results indicate an 
opening of the ATPase-gate upon binding of supercoiled plasmid, but also considerable 
conformational freedom in the ATPase domains, similar to the one seen in ligand-free 
enzyme. 
In mutant P408C, addition of 50 nM DNA resulted in broadening of the histogram and a 
slight shift of the peak to 0.2 FRET efficiency. Also a small high-FRET population was 
observed. Both could be due to steric hindrance of the DNA with the fluorescent labels, as the 
latter should face the central cavity that is thought to be occupied by the bound DNA. 
In mutant D159C addition of 50 nM plasmid DNA resulted in a shift of the FRET efficiency 
to approx. 0.7, suggestive of a decrease of the inter-dye distance. This result disagrees with 
the findings for mutants E164C and R87C, but could be due to the altered enzymatic activity 
of mutant D159C. 
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Fig. 3.38: SmFRET histograms for TopoVI mutants labeled in the ATPase gate region and their 
complexes with neg. supercoiled DNA and the nucleotides ADPNP and ATP. 
A: Histograms for TopoVI D159C in the ligand-free state (left) and bound to DNA (right). 
B – F: FRET efficiency histograms of complex formation for TopoVI mutants fluorescently labeled at 
different positions in the ATPase domains (left to right): Mutants E164C and R87C with labeling sites 
in the upper region of the ATPase domains, and P408C labeled in the lower ATPase domains. 
B: Histograms for the ligand-free TopoVI proteins; C and D: Histograms for TopoVI in presence of 
ADPNP or ATP; E: Histograms for TopoVI in complex with neg. supercoiled plasmid; F: Histograms 
for the protein-DNA complex in presence of ADPNP. 
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3.2.16 ADPNP induces a fixed ATPase gate conformation in presence of plasmid DNA 
Addition of ADPNP to the protein-plasmid complex lead to well-defined FRET efficiency 
peaks both in the E164C and R87C mutants. Maxima were found at values of approx. 0.2 and 
0.6, respectively, which were clearly different from the ones found for the protein in presence 
of ADPNP, but without DNA, indicating a locked but open conformation of the ATPase 
domains. In case of E164C the low-FRET distribution for the complex in absence of 
nucleotide completely disappeared, while for R87C the low-FRET state was still populated. 
This could be due to the different ADPNP concentrations used (10 and 4 mM, respectively).  
The fixed conformation of the ATPase gate in the tripartite complex of TopoVI with 
supercoiled plasmid and ADPNP was independent of the order of addition (DNA first, 
ADPNP second, or vice versa), indicating only transient closure of the ATPase gate by 
ADPNP to allow binding of the plasmid to TopoVI. 
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4. Discussion 
4.1 Part I: Conformational changes in the C-terminal domain of GyrA 
from B. subtilis 
4.1.1 The C-terminal domain of B. subtilis GyrA confers supercoiling activity 
One major goal of this work was to monitor conformational changes in the C-terminal domain 
of GyrA and characterize the influence of the CTD on the DNA-binding properties of GyrA. 
Full-length GyrA from B. subtilis and a truncated version lacking the C-terminal domain 
(GyrA_ΔCTD) were expressed as N-terminal His6-tag fusion constructs cleavable by TEV 
protease and purified by immobilized-metal affinity chromatography. This purification 
strategy was recently reported for GyrA from A. aeolicus and previously attempted but not 
achieved for the full-length B. subtilis enzyme [102, 103]. Gyrase from B. subtilis, constituted 
from the subunits GyrA and GyrB, exhibits nucleotide-independent DNA relaxation as well as 
ATP-dependent DNA supercoiling activity, similar to its counterpart from E. coli [18, 36, 
104]. Deletion of the CTD of B. subtilis GyrA abolishes the DNA supercoiling activity and 
strongly reduces the nucleotide-independent DNA relaxation activity. However, GyrA_ΔCTD 
exhibits an ATP-dependent DNA relaxation activity which is approx. 5 times faster than the 
relaxation activity of the full-length enzyme, showing a comparable final topoisomer 
distribution (sections 3.1.3 and 3.1.5). These findings give evidence that the GyrA CTD is 
indispensable for the supercoiling activity gyrase in B. subtilis. The behavior is also found in 
E. coli gyrase: Deletion of the GyrA CTD results in the above-mentioned activity change. 
Additionally, it strongly enhances decatenase activity in an ATP-dependent manner, 
indicating a similar enzymatic activity for GyrA_ΔCTD as found in topoisomerase II and IV 
[105, 106].  
 
4.1.2 Fluorescently labeled GyrA constructs to monitor conformational changes in the 
CTDs 
Type IIA topoisomerases transport a double-stranded DNA through a transiently cleaved 
second DNA duplex bound to a region termed DNA-gate, thereby exhibiting tightly 
controlled sequential opening and closing of three gates. Conformational changes in the 
ATPase-gate and the DNA-gate of gyrase and TopoII have been monitored by smFRET 
techniques [33, 42, 43] and were proposed also for the C-gate of gyrase and topoisomerase II 
[44, 95]. Apart from gate dynamics typical for all type IIA topoisomerases, gyrase was 
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proposed to exhibit movements of the GyrA CTDs in response to DNA binding, resulting in 
the delivery of the T-segment for transport through the transiently cleaved G-segment [57, 
107]. To monitor potential conformational changes in the GyrA CTD two approaches were 
used: (1) B. subtilis GyrA with a single cysteine mutation in the C-terminal domain was 
expressed and produced as described before [46]. The mutants can be readily labeled with 
fluorescent dyes and exhibits wild-type like DNA supercoiling and relaxation activity both in 
their non-modified and labeled states, validating them for smFRET studies (section 3.1.11). 
As GyrA is a constitutive dimer [108], the isolated protein complex contains two equivalent 
free thiols symmetrically arranged in the CTDs. One limitation is the large distance between 
the CTDs (illustrated by the distance of the attachment points of the CTDs on the GyrA body 
of ≥ 9 nm) almost beyond the dynamic range of fluorescence resonance energy transfer, 
making the reliable determination of inter-dye distances difficult. Indeed, FRET efficiencies 
for labeled single-cysteine mutants in the free GyrA dimer are 0.3 and 0.2 for GyrA mutants 
K570C and K594C, respectively, and even close to 0 for D695C and E726C (Fig. 3.15). A 
second disadvantage of the symmetrical GyrA FRET constructs is the simultaneous 
observation of the movements of two CTDs. It is not possible to assign potential shifts in 
FRET efficiency and corresponding conformational changes to one domain, and FRET 
efficiency histograms could exhibit increased complexity due asymmetric behavior of the 
complex. 
(2) To avoid the drawbacks of the GyrA with equivalent labeling sites, asymmetric GyrA 
dimers were developed. Two different versions of GyrA were co-expressed in E. coli, 
randomly assembling to homo-dimeric complexes of either species or to hetero-dimeric 
complexes containing one GyrA subunit of each version. Wild-type like GyrA was expressed 
as an N-terminal His6-tag fusion protein, while the other GyrA version was non-tagged, but 
contained two cysteines, one on the GyrA body and one on the CTD. By means of Ni2+-
affinity chromatography homo-dimeric wild-type like and hetero-dimeric proteins were 
separated from homo-dimeric non-tagged proteins. SmFRET measurements of labeled hetero-
dimeric GyrA resulted in unimodal well-defined FRET efficiency distributions, giving 
evidence that homo-dimeric protein consisting from mutant subunits is efficiently removed. 
Fluorescent labeling of the co-expression product shows nominal labeling degrees of approx. 
100 % (i.e. approx. 2 dye molecules per GyrA dimer), indicating a low fraction of homo-
dimeric wt GyrA.  
GyrA hetero-dimeric proteins containing mutant subunits T140C_K570C, T140C_K594C, 
E211C_K570C, E211C_K594C, E250C_K570C, and E250C_K594C were validated for 
smFRET experiments. All of them exhibit wild-type like DNA supercoiling and relaxation 
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activities both in their non-modified and labeled states. In principle the test does not give 
evidence that the mutant subunit confers wild-type like activity, as the wild-type CTD might 
compensate for a potential loss of function of the modified, mutant partner CTD (e.g. loss of 
wrapping, sterical clashes between the DNA and the fluorophores). However, all homo-
dimeric single-cysteine mutants show unaltered DNA supercoiling and relaxation activities, 
thus validating the use of the hetero-dimeric GyrA proteins for smFRET experiments. 
 
 
4.1.3 Localization of the GyrA CTDs by molecular triangulation 
To localize the GyrA CTDs relative to the cleavage-religation domain („GyrA body“) 
different GyrA constructs were fluorescently labeled with A488 and A546 dyes and the inter-
dye distances calculated from single molecule FRET data, a procedure performed previously 
in a localization study with YxiN helicase [66]. By triangulation of distances between three 
reference points on the GyrA body and two on the CTD it was possible to localize the N-
terminal part of  the CTD in the ligand-free state and in the DNA-gyrase complex. 
In the free GyrA dimer positions 570 and 594 on the second sector (blade) of the CTD are 
located close to the extended α-helices linking the C-gate to the G-segment-binding part of the 
enzyme, consisting of the cleavage-reunion domain and the tower domain (Fig. 3.20A) [108]. 
Uni-modal FRET efficiency distributions indicate a well-defined position of the CTDs. 
Positioning of the residue 695 on the CTD could give a hint to where the lower part (blades 4 
and 5) of the CTD could reside: As estimated from smFRET data the inter-dye distances from 
labeling positions 140_695 (DNA-gate_CTD) and 408_695 (C-gate_CTD) are approx. 5.5 
and more 7.5 nm, respectively (Fig. 3.21A); the distance between positions 594 (as 
determined by triangulation) and 695 on the CTD should be around 3 nm (after [50]), placing 
residue 695 lateral of the DNA-gate (Fig. 4.1A). Our model localizes the CTD in a similar 
position as a model derived from SAXS data [57] (Fig. 4.1C). 
In gyrase bound to plasmid, the N-terminal part of the CTDs is located further away from all 
reference points on GyrA body used for triangulation: Distance changes of the reference 
points 570 and 594 upon formation of the gyrase-DNA complex are calculated as 2.6 and 2.5 
nm, respectively (Fig. 3.20B, Fig. 4.1B). This finding indicates a ligand-induced 
conformational change of the CTD to a more extended position with respect to the GyrA body 
compared to non-complexed GyrA. Additional evidence for a movement of the CTDs is given 
by the reduction in FRET efficiency between labels attached to the C-gate (N399C) and the 
CTD (K594C) (Fig. 3.21A) and between two labels attached to the both CTDs in position 594 
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(Fig. 3.22A, D), indicating distance increase between the C-gate and the CTDs as well as 
between the two CTDs upon formation of the gyrase-DNA complex. A number of FRET 
efficiency distributions from measurements of GyrA in complex with GyrB and plasmid DNA 
exhibit bi-modal behavior, which could be interpreted in a sense that the CTDs can occupy 
two different positions; however, this effect is not systematically observed for all GyrA 
constructs, indicating that the CTDs rather adopt one defined conformation. The cause for bi-
modal FRET efficiency distributions is not known. 
FRET histograms for mutants T140C_D695C and T408C_D695C do not exhibit a large 
change (Fig. 3.21A), indicating only minor movement of blade 4 of the CTD (represented by 
residue 695) relative to the GyrA body, placing it in position similar to the one in ligand-free 
GyrA (Fig. 4.1). This model places the CTD such that the loops from blades 1, 4, 5, and 6 are 
facing away from the GyrA body (Fig. 4.1D). This part of the circular rim of the CTD is 
proposed to bind DNA due to its negative charge, thus introducing a sharp turn into the 
double helix [49]. The model derived from our smFRET data seems to fit the suggested path 
of the DNA: The G-segment extending from the binding site at the DNA-gate is wrapped 
around the CTD in a turn of approx. 180° and delivered as a T-segment to the upper cavity, 
spanned by the ATPase- and the DNA-gate of gyrase. 
The conformational change of the GyrA CTDs upon formation of the gyrase-DNA complex 
was proposed previously [43, 49, 57], but has not been observed so far in gyrase. The CTD 
was suggested to adopt a conformation extended along the axis connecting the tower domains, 
resulting in the lower part of the CTD facing away from GyrA body. However, smFRET data 
from the mutant T140C_D695C argue against such a conformation, suggesting a position of 
the lower CTD region within a distance of 4 – 6 nm from the DNA-gate. 
A recent structural model of gyrase in complex with a 140bp DNA, based on SAXS data, 
places the CTDs close to the C-gate, away from the catalytic core [58]. Our smFRET data 
clearly argue against such a conformation, placing both the upper and the lower part of the 
CTDs in (1) proximity of the DNA-gate and (2) at a distance of more than 7 nm from the C-
gate.  
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Fig. 4.1: Localization of the GyrA CTD (in color) relative to GyrA core (grey). Presented B. subtilis 
GyrA core and CTD structures are homology models of structures of individual subunits of E. coli 
GyrA (PDB entries: 2Y3P and 1ZI0 [50, 94]). 
A and B: Side (left) and front views (right) with CTD positions placed relative to GyrA according to 
smFRET data. In the uncomplexed GyrA, the CTD adopts a contracted conformation lateral to  the 
catalytic core domain (A). In the gyrase-DNA complex (GyrB and DNA not shown) it swings away 
from the GyrA core domain to a slightly extended conformation (B). 
C: Structural alignments of models for full-length GyrA, derived from smFRET (yellow CTD) and 
SAXS data of E. coli GyrA (green CTD) [57]; GyrA cores are aligned. The proposed CTD 
conformations are in good agreement, as both models place the domain lateral to GyrA core. However, 
the FRET-model shows a slight rotation of the CTD relative to the SAXS model. 
D: Cartoon representation of full-length GyrA as in gyrase-DNA complex (equivalent to B, right). 
CTD blades 2 and 3 (red) face the GyrA core domain, while 1, 6, 5, and 4 (blue) are positioned to 
wrap DNA. This CTD position is supported by structural data: This region is highly negatively charge 
and was therefore suggested to constitute the main DNA interaction site on the CTD [49]. 
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4.1.4 Potential errors in the determination of spatial arrangements of GyrA subunits 
by smFRET 
The accuracy of positioning the mutated amino acid residues K570C and K594C by means of 
measuring energy transfer between fluorescent labels attached to the thiols is limited by 
factors of structural and photophysical nature of the fluorescent dyes:  
(1) In FRET measurements we determined several inter-dye distances. For the localization of 
labeled residues, the position of the dye and its attachments point on the thiol were assumed to 
colocalize (in reality the fluorophore is thought to tumble in proximity of its attachment 
point). This simplification results in localization error that should be in the range of the linker 
length of the fluorescent dye (approx. 1 nm). However, the change in FRET efficiency 
observed for all the mutants involved in triangulation of positions 570 and 594 on the CTD is 
trustworthy, as the labeling positions on the protein were chosen such that the position of the 
dyes relative to the attachment sites on the protein should be the same in the ligand-free GyrA 
and the in the gyrase-DNA complex. Thus FRET efficiency changes should just depend on 
the relative orientation of the GyrA core and C-terminal domains. 
(2) Following statistical double-labeling (i.e. labeling with two different dyes at the same 
time), hetero-dimeric GyrA constructs containing two different labeling sites are assumed to 
exhibit statistical labeling distributions of the two cysteines. Out of technical reasons, labeling 
with two dye molecules of the same species results either in a FRET efficiency below 0 (for 
protein labeled with donor only) or in a peak of FRET 1 (for protein labeled with acceptor 
only) that is often not detected. The relevant protein species labeled with one donor and one 
acceptor dye each exhibit two different dye arrangements. SmFRET data are corrected for 
photophysical properties of either one or the other dye arrangement, resulting in slightly 
different histograms, corresponding to two different apparent inter-dye distances (Fig. 3.16, 
3.17, 3.19). The two values indicate a possible distance range, within which the real mean 
distance of the dyes should fall. In the ligand-free state and the gyrase-DNA complex, 
differences in inter-dye distances calculated for either dye arrangement do not exceed 0.4 nm, 
with the exception of the mutant T140C_K570C in free GyrA and T140C_K594C in the 
gyrase-DNA complex of 0.7 nm each. This variation can be taken as a systematic error in the 
determined inter-dye distances, resulting in a decreased positioning accuracy. As the distance 
variations are small (less than 10 %), the qualitative description of the CTD movement should 
be trustworthy. 
(3) The Förster distance used to calculate the inter-dye distance from the corresponding FRET 
efficiency is a function of the orientation factor κ and the diffraction index n (among other 
parameters: eq. 2.25), describing the local flexibility of the transition dipoles of the 
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fluorescent dyes and the diffraction index of the medium between them, respectively. They 
were not determined, but set to idealized values: (a) κ2 could be determined in anisotropy 
decay measurements, but was set to 2/3, assuming complete motional freedom and thus 
random orientation of the dyes [86]. Theoretically, κ2 can adopt values between 0 and 4 
(corresponding to perpendicular and parallel arrangement of the dipoles), but the assumption 
of rotational averaging of the dipole alignments is reasonable as already rotational flexibility 
of one dye should minimize the error in the Förster distance to less than 10 % [109]. (b) The 
refractive index of the medium between the fluorescent dyes was approximated to with the 
one for water (n = 1.33), not taking into account the potential presence of peptide structure 
between the dyes [87]; however, as a large fraction of the transition dipole field should 
occupy an aqueous environment, this simplification should be reasonable. 
The uncertainty of the dye position relative to the protein, statistical labeling of non-equal 
cysteine positions and difficulties in the determination of the Förster distance for a given dye 
pair affect the accuracy of the absolute positioning of the domain, but not the conclusion that 
the GyrA CTDs adopt an extended conformation upon binding of plasmid DNA and GyrB to 
GyrA. 
 
4.1.5 Assembly of the gyrase-DNA complex 
In the previous sections the conformational change of the CTDs from a rather contracted state 
in the ligand-free protein to an extended state in the gyrase-DNA complex has been discussed. 
The effect of DNA or GyrB binding to GyrA on the conformation of the CTD was addressed 
in anisotropy experiments and smFRET measurements. 
As demonstrated in DNA anisotropy titrations of full-length GyrA and GyrA_ΔCTD to a 
linear 60bp DNA clearly show the contribution of the CTDs to DNA binding (Fig. 3.5A): 
While binding of the DNA to the GyrA body is only weak, the DNA-GyrA complex is 
drastically stabilized in the full-length GyrA, indicated by the 20- to 35-fold increase in 
affinity. This finding agrees with previous observations [91]. However, from these 
experiments it is not clear whether the DNA almost exclusively binds to one CTD or 
complexes simultaneously several binding sites, i.e. one CTD and the DNA gate, or both 
CTDs and the DNA gate. Binding of two DNAs to the individual CTDs in one GyrA dimer 
could be possible, but is rather unlikely due to the concentration ratio DNA : GyrA of up to 
1000. The findings indicate that the CTDs are the main DNA binding sites in GyrA. 
The effect of DNA binding to GyrA on the CTD conformation was determined using neg. 
supercoiled plasmid. Three different GyrA constructs showed a broadening of the FRET 
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efficiency distributions upon formation of the GyrA-DNA complex, indicating a 
conformational change of the CTDs (Fig. 3.22C). Saturating conditions were confirmed, as 5-
fold increase of the DNA concentration did not result in a change of the FRET efficiency 
distribution for mutant T140C_K594C. The broadening of the distribution is an indication for 
conformational dynamics: T140C_K594C shows a bimodal FRET efficiency distribution with 
maxima similar to the ones found in non-complexed GyrA and in the gyrase-DNA complex, 
clearly indicative of some CTDs adopting an extended conformation. Together with the 
anisotropy results, this finding suggests that the conformational change is due to simultaneous 
binding of the DNA to the CTD and core domain of GyrA. As the DNA-affinity of the GyrA 
core is small, this bridging interaction might be transient, causing the CTDs to swing back in 
the contracted conformation. From these data it is not clear, if the observed heterogeneity 
CTD conformation is due to asymmetric behavior of the two CTDs in one complex, or if it is 
caused by conformational change in all CTDs. 
However, it is clear from these results that DNA binding to GyrA induces conformational 
change in the CTDs, but is not sufficient for the completely extended conformation found in 
the gyrase-DNA complex. This finding again indicates that GyrB is necessary to induce a 
stable extended CTD conformation. 
The formation  of the gyrase complex in absence of DNA has not been extensively studied so 
far. Our smFRET data of GyrB binding to labeled GyrA (Fig. 3.22B) indicate a partial release 
of the CTDs resulting in a slightly less contracted conformation than in GyrA, but clearly 
different from the one in the gyrase-DNA complex (Fig. 3.22A, C). There has been no report 
of direct physical interaction between the GyrA CTDs and GyrB, leaving only speculation 
what the cause for the conformational change might be. (1) Structural rearrangement of GyrA 
in the DNA gate leading indirectly to higher distances between the fluorescent labels cannot 
be excluded, but is not very probable: Gate opening has not been observed under 
physiological conditions [33], indicating that the open state is barely populated. In addition, 
X-ray structures of the GyrA-body dimer in the absence and presence of GyrB-TOPRIM 
domain do not show structural rearrangement in GyrA, indicating a very rigid and stable fold 
[28, 108]. (2) More likely seems a non-specific interaction between the GyrA CTDs and GyrB 
bound to GyrA. GyrB subunits bind to GyrA DNA-gate region via the TOPRIM domains, 
which occupy the sides of the heart-shaped GyrA dimer. In our model of ligand-free GyrA 
(Fig. 4.1A), the CTDs are located at some distance of the GyrA body. However, considering 
the significant conformational flexibility of the lower part of the CTDs with respect to the 
GyrA core and potential inaccuracies in domain localization, the structural space of the CTDs 
might overlap with the location of the TOPRIM domains on GyrB and result in sterical clash 
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between the CTD and GyrB upon complex formation. As a result, GyrB would displace the 
GyrA-CTD by pushing them into a slightly extended conformation. 
Formation of the gyrase-DNA complex from the individual components is thermodynamically 
favored, as shown by the 35-fold affinity increase of GyrA to the 60bp DNA in the presence 
GyrB compared to the DNA only. A similar effect is observed for GyrA_ΔCTD (25-fold 
affinity increase), giving two important hints: (1) In gyrase, the 60bp DNA clearly binds to 
the DNA-gate and stabilizes the gyrase complex. (2) The 60bp DNA simultaneously contacts 
the GyrA CTDs. A longer circular DNA should thus also contact both CTDs. This hypothesis 
is supported by measured FRET efficiencies of close to 0 for all three constructs mentioned 
above (Fig. 3.22D). For some hetero-dimeric constructs (e.g. for mutant T140C_K570C: Fig. 
3.19), bi-modal distance distributions were observed, which could indicate conformational 
heterogeneity of the CTDs and possible asymmetric behavior of the two CTDs in one gyrase-
DNA complex, as mentioned in section 4.1.3. As the effect is not systematically observed, it 
is save to state that both CTDs in the gyrase-DNA complex adopt an extended conformation. 
The highly dynamic (and potentially asymmetric) state of the CTDs observed for the GyrA-
DNA complex is mostly abolished in the presence of GyrB. 
 
4.1.6 Influence of the conformation, topology and length of DNA substrates on the 
CTD conformation  
Gyrase is a DNA manipulating enzyme, introducing neg. superhelicity to (circular) DNA in 
an ATP-dependent manner.  Before the actual supercoiling reaction, characterized by the 
DNA strand passage, the CTD binds and wraps DNA extending from the DNA-gate [110], 
thereby undergoing a conformational change to present the T-segment to the cavity between 
the ATPase- and the DNA-gate. SmFRET experiments elucidate the links between movement 
of the CTDs and events up- and down-stream in the supercoiling cycle. 
The DNA bound to the DNA-gate of gyrase (G-segment) exhibits different levels of 
distortion, depending on cleavage of the DNA double strand and the formation of the covalent 
tyrosyl-DNA intermediate [33]. The cleavage-deficient mutant Y123F clearly shows 
movement of the CTDs to an extended conformation upon binding of plasmid DNA and 
GyrB, supported by the observation of simultaneous binding of the DNA to the DNA-gate and 
the CTDs (Fig. 3.26A, C). However, conformational differences in the DNA extending from 
the DNA gate should result in a different direction of the DNA relative to the enzyme, which 
in turn should influence the position of the CTD upon gyrase-DNA complex formation. 
Indeed, the FRET efficiency maximum for the cleavage-deficient GyrA mutant (Y123F) in 
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complex with GyrB and supercoiled plasmid exhibits a slight, but reproducible shift of 
approx. 0.05 compared to wt GyrA, indicating a small conformational difference of the CTDs 
in the absence of DNA cleavage and distortion. 
In a further step, the influence of the topology of a plasmid substrate on the CTD position was 
tested. The CTD conformations are the same for all complexes of GyrA with negatively 
supercoiled and relaxed plasmid (Fig. 3.22, in comparison with Fig. 3.2). The CTDs have 
been proposed not to bind to supercoiled DNA and to remain in the contracted conformation, 
potentially resulting in a CTD- and thus wrapping-independent DNA relaxation mode [57]. 
Our data argues against this model as neg. supercoiled DNA induces a similar extended 
conformation of the CTDs as relaxed DNA. However, smFRET measurements addressing the 
ATPase-gate dynamics in gyrase showed that DNA wrapping and presentation of the T-
segment to the enzymatic core by the CTD is less efficient for neg. supercoiled than for 
relaxed DNA [42]. This raises the question, if the conformational change observed for the 
CTDs is due to wrapping of the DNA around the domain or mere simultaneous contact of the 
DNA to the DNA-gate and the CTDs. 
In order to understand the link between CTD movement and events like DNA wrapping and 
T-segment presentation, linear double-stranded DNAs were used as substrates for gyrase. In 
presence of GyrB a DNA of 37 bp length binds to the DNA-gate without contacting the 
CTDs. In contrast a 48bp DNA is long enough to simultaneously offer binding sites to the 
DNA-gate and the CTDs (Fig. 3.8). This finding is supported by data from hydroxyl-radical 
footprinting using a 147bp DNA that clearly show protection of a central 40bp region by 
GyrA, which is supposed to be excluded from the solvent [107]. Moreover, binding of a 37bp 
DNA to gyrase does not influence the conformation of the CTD, indicating that the FRET 
efficiency shift is caused by binding of GyrB only (Fig. 3.25). This finding indicates, that (1) 
GyrB is not responsible for the extended conformation of the CTDs, but only for the 
stabilization of the gyrase-DNA complex; (2) simultaneous contact of DNA to the DNA-gate 
and the CTDs is necessary to induce the extended conformation of the CTDs. 
Surprisingly, in the presence of GyrB the 48bp DNA induces the CTDs to adopt the extended 
conformation, indicating that only a very small DNA-CTD interface is necessary to induce 
CTD movement. SmFRET studies of the ATPase-gate have shown, that linear DNAs of 110 
bp and longer completely wrap around the CTDs and possibly present a T-segment to the 
GyrB cavity, whereas shorter DNAs do not serve as T-DNAs. Apparently the movement of 
the CTD does not require extensive wrapping of the DNA and is independent of potential T-
segment presentation. 
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Taken together, in the gyrase-DNA complex the CTDs adopt an extended conformation 
independent of the conformation or the topology of the double-strand bound to the DNA-gate, 
the DNA length, the extent of wrapping and potential T-segment presentation. Thus, the role 
of the CTDs can be reduced to binding of DNA and facilitating the geometry of an arbitrary 
DNA substrate in order to present a T-segment. 
 
 
4.1.7 The role of the CTDs during strand passage 
A very important point in understanding the supercoiling activity of gyrase would be the 
observation of strand passage. Binding of ATP to type II topoisomerases induces dimerization 
of the ATP-domains, while the hydrolysis and phosphate release of the first and the second 
nucleotide is supposed to induce strand passage and resetting of the enzyme for another 
supercoiling cycle, respectively [45, 47]. Somewhat contradictory, binding of the non-
hydrolysable ATP analog ADPNP to gyrase has been found to allow one strand transfer step; 
as phosphate release cannot take place, the enzyme should be stalled with a closed ATPase-
gate [111]. Binding of ADPNP to the gyrase-DNA complex results in a loss of DNA 
wrapping, which was taken as an indication for a loss of interaction between DNA and CTD 
[48]. A potential release of the CTDs should result in a contracted conformation similar to the 
one in the complex of gyrase with the 37bp DNA. However, addition of ADPNP to the 
gyrase-plasmid complex does not result in a FRET-efficiency change: In all tested mutants 
(Fig. 3.22E), using supercoiled or relaxed plasmid DNA, the CTDs remain in the extended 
conformation. Two explanations could be given for the fact, that no release of the CTDs is 
observed: (1) Conformational change of the CTDs connected to strand transfer is not detected, 
because gate opening and connected to this CTD movement is a transient and very rare event. 
(2) Or the CTDs do not follow the passage of the T-segment towards the C-gate of the GyrA 
body, remaining in the extended conformation during strand passage.  
Not surprisingly, the CTDs in the cleavage-deficient gyrase bound to DNA do not move in 
presence of ADPNP, proving that the extended conformation of the CTDs is not affected by 
ATPase-gate movements upon nucleotide binding. However, CTD movement at later stages 
of the supercoiling cycle cannot be excluded as discussed above. 
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4.1.8 Deletion of the GyrA-box abolishes the supercoiling activity by gyrase despite 
only minor changes in the DNA-binding of the CTDs and its conformations 
The GyrA CTD contains a highly conserved and positively charged heptapeptide sequence 
known as the GyrA-box. The region is part of a peripheral loop bridging the gap between the 
first and the sixth blade of the β-pinwheel fold, probably stabilizing a spiral assembly of the 
blades [38]. Deletion or substitution of the GyrA-box in B. subtilis gyrase results in a 
completely changed enzymatic profile unique among type II topoisomerases: The mutants 
exhibit wild-type like nucleotide-independent DNA relaxation activity, but no residual ATP-
dependent DNA supercoiling [55]. Binding of a 60bp DNA and neg. supercoiled plasmid to 
the A-box deletion mutant in absence of GyrB do not show a significant difference to wild-
type GyrA. However, in contrast to wt GyrA no conformational change of the CTDs is 
observed upon binding of neg. supercoiled plasmid to GyrA, indicating that no bridging 
interaction of the DNA between DNA-gate and CTD takes place in the A-box-deletion 
mutant. A possible explanation would be that the GyrA-box introduces a kink into DNA to 
contact both GyrA core and CTD, as proposed before [112]. Considering the small difference 
in DNA affinity compared to the wt protein, we can conclude that, in the absence of GyrB, 
GyrA binds to DNA mainly via the CTDs, and that the GyrA-box might be involved in DNA-
bridging interactions to the DNA-gate. 
In presence of GyrB, however, the binding to linear or circular DNA and the resulting CTD 
conformation are the same for GyrA wt and the A-box deletion mutant. This finding argues 
against the hypothesis, that the primary function of the GyrA-box might be the complexation 
of DNA. A possible function, as already proposed, could be the stabilization of the spiral β-
pinwheel fold and guidance of the DNA to serve as a T-segment [38], indicated by the loss of 
inducing positive supercoils into DNA upon deletion of the GyrA-box. 
 
4.1.9 The role of the GyrA CTDs in DNA supercoiling catalyzed by gyrase 
The present work contributes to the understanding of the events during the ATP-dependent 
DNA supercoiling cycle in gyrase, a unique bacterial type II topoisomerase. Formation of the 
active enzyme complex is initiated either by binding of the GyrA dimer to the DNA, with the 
CTDs being the main interaction sites, and the subsequent binding of two GyrB subunits to 
form a high-affinity complex; or by binding of GyrB to GyrA and later simultaneous binding 
of a DNA to the DNA-gate and the CTDs. The conformation of the GyrA-CTDs is influenced 
by both DNA and GyrB. While bridging of the GyrA body domains and CTD by the DNA is 
the main driving force for the movement of the CTDs to an extended conformation, GyrB 
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only slightly displaces the CTDs in the gyrase and mainly stabilizes the complex with DNA 
(Fig. 4.2; A). 
A small contact of the DNA to the CTD of only several nucleotides length initiates the 
conformational change of the CTDs, which, as a result, wrap the DNA around their periphery 
in a turn of 180° and deliver the extending strand, i.e. the T-segment, to the cavity formed by 
the two GyrB-ATPase domains. Upon nucleotide binding, GyrB dimerizes, thereby closing 
the ATPase-gate over the T-segment and stabilizing the hetero-tetrameric protein complex. 
The G-DNA bound to the DNA-gate exhibits different states of distortion, being cleaved and 
re-ligated by the active site tyrosines located on GyrA; DNA cleavage and distortion results in 
small changes in the extended conformations of the CTDs. Simultaneous closure of the 
ATPase-gate and DNA cleavage will eventually lead to sequential opening of the DNA- and 
the C-gate and concomitant transport of the T-segment through the gap of the cleaved G-DNA 
segment, followed by the hydrolysis of ATP, which resets the enzyme for another 
supercoiling cycle [42]. The transport was shown to be a very rare event [33], as gate 
openings are hardly ever observed. The role of the CTD in strand passage is not clear, but 
could be addressed by measuring FRET from an immobilized protein as a function of time, 
e.g. using TIRF microscopy. The proposed conformations of the CTDs during the catalytic 
cycle are depicted in Fig. 4.2 (S). 
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Fig. 4.2: Model of the CTD movements during the assembly of DNA with gyrase complex (top: A 
with states I – V) and the supercoiling reaction cycle (bottom: S with states V – IX). GyrA body, 
GyrA CTDs, and GyrB are shown in blue, green, and grey, respectively; DNA is depicted as a black 
line, and nucleotide is shown in red. CTD movements are exaggerated for increased clarity.  
I: CTDs are located close to the GyrA body in the free enzyme. II: Upon binding of GyrB, they 
slightly move away from the core. III: Presumably, initial binding of DNA to GyrA takes place on the 
CTDs. IV: Contacts of the DNA with the DNA-gate induces the extended CTD conformation; this 
state should be in equilibrium with (III). V: The active enzyme complex with an extended 
conformation of the CTDs is formed in presence of both DNA and GyrB. 
V, VI: The active enzyme complex can cleave DNA (VI); VI exhibits a slightly more extended CTD 
conformation than V. VII: Nucleotide binding induces ATPase-gate closure, but does not cause a 
significant change of the CTD conformation. VIII, IX: hypothetical CTD movements upon transfer of 
the T-DNA segment through the open DNA-gate (VIII) and C-gate (IX). The CTD bound to the T-
segment may guide or follow the transfer movement and transiently swing towards the C-gate, 
predicting asymmetry with respect to the position of the two CTDs in gyrase. However, no 
asymmetric conformation is detected in experiments involving nucleotide. The supercoiling cycle is 
completed by hydrolysis of ATP and release of ADP and phosphate (V). 
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4.1.10 Outlook 
For the first time the conformational changes in the GyrA CTDs have been monitored. 
Several conformational states during gyrase-DNA complex assembly and supercoiling have 
been identified. The GyrA-DNA complex shows bi-modal behavior, caused either by (1) 
conformational flexibility of the CTDs or (2) asymmetric behavior of the two CTDs in one 
GyrA-DNA complex. In smFRET measurements with a non-symmetrical GyrA dimer with 
one CTD only it should be possible to exclude either of these possibilities: the first should 
result in a similar conformational behavior as found in GyrA with both CTDs, while the 
second should lead to increased level of extended CTD conformation.  
In fact, an asymmetric GyrA dimer containing just one CTD should exhibit a distinct activity 
profile, being an ATP-dependent supercoiling enzyme on one side and an ATP-dependent 
DNA relaxase on the other. Which activity would be prominent could be elucidated in 
supercoiling assays. 
A very important step towards the understanding the supercoiling mechanism of gyrase is 
connected to the observation of T-DNA strand passage: So far we have not detected a 
conformational change in the CTDs which could be attributed to strand transfer. A TIRF 
instrument in combination with immobilization of GyrA directly or via a DNA could extend 
the observation time of one GyrA molecule, allowing to observe a potential movement of the 
CTDs when the attached T-segment is guided towards the GyrA C-gate. The immobilization 
of GyrA could be achieved indirectly by linking DNA to a surface and binding of 
fluorescently labeled GyrA to the DNA. Monitoring the conformational dynamics of the CTD 
in gyrase bound to immobilized plasmid of different topology could provide insight in the 
kinetics of strand passage and the dependence of CTD movements on substrate topology. 
For the present study a hetero-dimeric expression / purification system for GyrA with 
different subunits was developed. The method could be extended to GyrB-GyrA fusion 
proteins (compare to [42]): Hetero-dimeric fusion constructs could give evidence about the 
symmetry of certain conformational changes or enzymatic activities during the supercoiling 
reaction, e.g. conformational changes connected to ATP-hydrolysis, T-segment delivery 
(monitored with a fusion enzyme lacking one CTD), and intra-subunit conformational 
dynamics (as shown in the present work by monitoring FRET between the GyrA body and 
CTD). 
In the present study attempts have been made to characterize the molecular properties of the 
highly conserved GyrA-box which confer supercoiling activity to gyrase. However, the GyrA-
box deletion mutant (ΔAbox) exhibited wild-type like DNA affinity and CTD movements; 
thus no hint to explain the change in activity was obtained. Possible differences between wt 
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and ΔAbox might be found in internal conformations of the CTD [55] or in DNA wrapping 
and T-segment presentation. Potential opening of  a cleft between blades 1 and 6 of the CTD 
which are connected by a loop containing the GyrA-box might lead to a different 
conformation or increased internal flexibility of the domain in the ΔAbox mutant; this could 
be tested using an isolated fluorescently double-labeled CTD. Alterations in T-segment 
presentation might be detected by monitoring the conformational change of the ATPase-gate, 
using a GyrB-GyrA fusion construct [42]: The wild-type like construct exhibits a half-closed 
ATPase-gate in the presence of a 140bp DNA or relaxed plasmid and ADPNP, indicative of 
the presence of a T-segment in the upper cavity of the enzymatic core. Potential deficiency of 
T-segment presentation in the ΔAbox mutant might result in a fully closed ATPase-gate in the 
presence of the same substrates. 
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4.2 Part II: Conformational changes in topoisomerase VI from M. mazei 
 
Topoisomerase VI (abbrev. TopoVI) is a type IIB topoisomerases. In an ATP-dependent 
mechanism, it relaxes supercoiled DNA and decatenates circular daughter chromosomes prior 
to cell division by transient cleavage of a double-stranded DNA and transport of a second 
DNA duplex through the gap before resealing it. In the present work the gate conformations 
in TopoVI from M. mazei were addressed by measuring FRET in a double fluorescently 
labeled 50bp DNA, which acts as a ligand of TopoVI, and in fluorescently labeled TopoVI. 
An important part of this work was the validation of a mutant protein which could not be 
labeled at native cysteine residues to serve as a basis for the introduction of cysteine residues. 
 
4.2.1 Formation of the TopoVI-DNA complex: Validation of a 50bp DNA ligand as a 
binding and cleavage substrate 
In order to characterize DNA binding to TopoVI and to monitor conformational changes in 
the double helix following binding and cleavage, a 50bp DNA containing a preferred binding 
site for TopoVI from S. shibatae was used to serve as a G-DNA segment [59], similar to 
experiments performed with gyrase and TopoII [33, 43]. The 50bp DNA binds TopoVI with a 
Kd value of 3.2 µM (Fig. 3.34C), indicating an at least 15-fold higher affinity of the DNA-
gate than the one found for a 60bp DNA in GyrA lacking the CTDs (43 µM, Fig. 3.5A). This 
is not surprising as in TopoVI the DNA-gate is the main DNA-binding site, while GyrA 
comprises several DNA-binding sites, namely the DNA-gate and the CTDs. However, 
compared to the GyrA-GyrB complex the DNA affinity of TopoVI has to be judged as rather 
weak: In presence of GyrB a 48bp DNA exhibits Kd values of 378 and 189 nM for GyrA 
ΔCTD and wt, corresponding to a 8.5- and 17-fold higher DNA affinity than found for 
TopoVI. 
The DNA devised for smFRET measurements contained two internal fluorescent labels (A488 
and A546) with one dye attached to each of the strands. While the presence of the A488 dye 
did not strongly influence the affinity of the 50bp DNA for TopoVI, the presence of A546 
resulted in a almost 10-fold affinity increase, posing limits to the suitability of the double-
labeled DNA as a ligand for TopoVI.  
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A radioactively labeled version of the 50bp DNA was used in a cleavage assay. Despite the 
high sensitivity of the method no cleaved product could be detected in reactions performed in 
the absence and presence of nucleotides and / or inhibitory compounds like ciprofloxacin and 
inorganic selenite. The cause for this finding is debatable: The preferred binding site for S. 
shibatae TopoVI might not be preferentially cleaved by the M. mazei enzyme or the cleavage 
complex not trapped by the method used. A problem arising from the lack of cleavage product 
formation is that no information about the position of the DNA on the DNA-gate is provided; 
from the length of potential products the approximate location on the DNA-gate could have 
been deduced. As a result potential conformational change of the DNA monitored by 
smFRET could not be interpreted sufficiently well. In an extreme case DNA cleavage and 
gate opening might not be tracked due to an unfavorable dye arrangement away from the 
central cleavage site. 
Nevertheless, smFRET measurements were performed using the fluorescently double-labeled 
DNA. The non-complexed DNA shows a medium FRET efficiency of approx. 0.6. Binding of 
the DNA to TopoVI results in a decrease of the FRET efficiency to approx. 0.4 (Fig. 3.34). 
The cause could be a distortion of the DNA upon association with the enzyme, manifested by 
a change of the inter-dye distance, but could also be due to a change in the Förster distance of 
the two dyes when attached to the DNA or a different arrangement of the dyes relative to each 
other. 
Interestingly, the cleavage-deficient mutant TopoVI-A_Y106F exhibited a 10-fold lower 
DNA-affinity than the wild-type protein, suggesting the formation of the covalently linked 
protein-DNA intermediate upon DNA binding for the wt, which would contribute to a lower 
Kd. The DNA conformation in the complex seems to be independent of DNA cleavage, as 
suggested by the unchanged FRET efficiency for the 50bp DNA in complex with cleavage-
deficient TopoVI. These findings are in strong contrast to the interactions found in the gyrase-
DNA complex: DNA binding is stronger for a cleavage-deficient gyrase mutant, indicating 
fundamental differences between the DNA-gates of type IIA and IIB topoisomerases. Also the 
DNA is mildly and severely distorted upon binding to the DNA-gate and phosphate-backbone 
cleavage, respectively, indicating that cleavage-induced distortion of the DNA accounts for 
the lower affinity for the enzyme [113].  
The ATPase-gate of TopoVI is supposed to adopt a closed conformation in the presence of 
ADPNP (Fig. 3.38 and [62]). Addition of ADPNP to the different DNA-protein complexes 
did not show any influence on the conformation of the DNA bound to the DNA-gate of 
TopoVI. This might be an indication that the conformation of the DNA-protein complex is not 
changed upon closure of the ATPase-gate, at least in the absence of a T-DNA segment. 
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4.2.2 Changes in the enzymatic activity of TopoVI caused by the step-wise removal of 
solvent-accessible cysteine residues 
Conformational changes in the ATPase-gate of M. mazei TopoVI were addressed by smFRET 
measurements, using fluorescently labeled protein with one dye introduced to a cysteine 
residue in each of the ATPase domains. In order to avoid labeling of native cysteines, three 
residues in the B subunits which could be modified with Alexa 546 (C267, C316, and C550) 
were exchanged in a step-wise process. The four remaining cysteines in TopoVI were barely 
labeled by Alexa 488 and 546 (Fig. 3.37B). 
While exchange of C267 and C550 to serine and alanine, respectively, did not influence the 
ATP-dependent relaxation activity of TopoVI, mutation of C316 to either Ser, Ala or Gly 
marked an activity decrease of 5 to 10-fold (Fig. 3.36). Moreover, the substitutions resulted in 
a two- to three-fold increase of the ATP hydrolysis activity (Fig. 3.35B). These findings 
strongly indicate that mutation of C316 causes partial uncoupling of DNA relaxation and ATP 
hydrolysis. Given the location of C316 in the ATP-binding pocket between the ATPase- and 
transducer-domain, this explanation seems plausible. The triple-cysteine mutant 
TopoVI_(B)C267S_C316S_C550A (TopoVI_SSA) was chosen as a basis for the introduction 
of cysteine residues for fluorescent labeling. Despite showing partial un-coupling, it still 
exhibits the characteristic DNA relaxation activity of the wt TopoVI and should therefore be 
suitable for studies of conformational dynamics. 
 
4.2.3 Conformational dynamics in the ATPase-gate of TopoVI: Implications for the 
DNA relaxation cycle 
To monitor conformational changes in the ATPase-gate of TopoVI, four amino-acid residues 
located either on the ATPase domain (R87, D159, E164) or on a loop on the transducer 
domain (P408) were selected for individual mutation to cysteine (Fig. 3.37A). Mutants were 
constructed on the basis of TopoVI_SSA. All proteins exhibit the same DNA relaxation 
activity as the SSA mutant, with the exception of the mutant D159C, which showed 10-fold 
reduced activity compared to SSA at the same enzyme concentrations. Although the residue is 
not conserved among TopoVI proteins of different organisms, the loss in activity could be 
caused by a potential disturbance of the putative dimerization interface of the ATPase 
domains upon the exchange of D159.  
SmFRET measurements with fluorescently labeled TopoVI mutants report on the 
conformational states of the ATPase-gate: Broad FRET efficiency distributions are observed 
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for the mutants labeled in the upper ATPase domain, indicating considerable conformational 
flexibility of the domains in the absence of nucleotide or DNA. In contrast, the  FRET 
efficiency for the P408C mutant is well defined, suggesting low flexibility of the transducer 
domain (Fig. 3.8B). Upon binding of ADPNP, the ATPase domains are fixed in a well-
defined conformation, indicated by the narrow FRET efficiency distributions seen for mutants 
E164C and R87C. The latter protein exhibits high-FRET, suggesting dimerization of the two 
ATPase domains (Fig. 3.8C). Nucleotide-induced dimerization of the ATPase domains has 
been proposed for TopoVI [62, 65] and was demonstrated for other proteins of the GHKL 
family (e.g. GyrB, Hsp90) [42, 114].  
In contrast to the ADPNP-induced closure of the ATPase-gate, binding of neg. supercoiled 
plasmid to TopoVI results in an increased distance between the domains, indicated by the 
clear FRET efficiency shift to almost 0 for the mutants E164C and R87C (Fig. 3.8E). Still the 
distributions are broad, suggesting a high flexibility of the ATPase domains. This behavior 
has been proposed on the basis of high-resolution crystal structures from the ATPase domains 
of S. shibatae TopoVI [65]: The central cavity of TopoVI has the size to just accommodate 
two DNA duplexes, with the G-DNA segment bound to the DNA gate and the T-segment 
residing in the residual space between the DNA-gate and the ATPase-gate [61]. Due to its 
DNA double-strand crossings this is the case for neg. supercoiled plasmid, a native substrate 
of TopoVI [25]. In gyrase, the presence of a T-segment induces a pre-closed state of the 
ATPase-gate[42]; the difference in conformational behavior between topoisomerase VI and 
gyrase must lie in the domains linking the ATPase- and DNA-gate: While for the first one the 
structural organization of the connecting region is known, the architecture of full-length GyrB 
and the orientation of the GHKL domain relative to the DNA-gate is still a matter of 
speculation.  
What happens in the ATPase-gate of TopoVI in presence of both ADPNP and plasmid DNA? 
Data for mutants E164C and R87C show narrow FRET efficiency distributions, indicating a 
well-defined conformation. The values are lower than in the absence of DNA, suggesting a 
higher inter-dye distance than for the dimerized ATPase domains: The ATPase gate seems to 
be stabilized in a half-open conformation, a state which has not been proposed for TopoVI: 
The presence of DNA (presumably of a T-segment) in the central cavity inhibits ADPNP-
induced dimerization, while the ATPase domains could be fixed relative to the transducer 
domains in response to ADPNP binding. This was observed in crystal structures of a fragment 
of the TopoVI-B subunit with ADPNP present in the nucleotide-binding pockets: A conserved 
lysine in the transducer domain contacts the γ-phosphate of the nucleotide, thereby causing 
the rotation of the ATPase domain relative to the transducer domain [62]. At this stage of the 
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reaction cycle (prior to strand passage), TopoVI and gyrase seem to share similarities again: 
As in TopoVI, the fully closed state for the ATPase-gate of gyrase is barely populated in the 
presence of a T-DNA segment and ADPNP, indicating that the gate of both enzymes struggle 
with physical strain induced by DNA [42].  
However, TopoVI as well as gyrase might overcome this half-open state for transient 
dimerization of the ATPase domains: In order to stabilize the DNA-enzyme complex during 
opening of the DNA-gate and passage of the T-segment, the ATPase-gate needs to close. 
Dimerization of the ATPase-gate in presence of two DNAs (G- and T-segment) in the cavity 
might be a short-lived event due to the physical strain such a state might impose on the 
enzyme and should result in passing the T-segment through the DNA-gate, which is proposed 
to be mediated by the hydrolysis of one of the two bound ATP molecules [45]. In both 
enzymes ATPase-gate closure in presence of G- and T-segment has not been observed, 
indicating that strand passage is a very rapid process.  
 
 
 
 
4.2.4 Outlook 
The data presented in this work document conformational changes in the ATPase domains of 
M. mazei TopoVI. Four conformational states can be observed: Dynamic states for the ligand-
free enzyme and in complex with neg. supercoiled plasmid, with the latter exhibiting a higher 
distance between the domains; and fixed states in presence of ADPNP (probably representing 
a closed ATPase-gate) and ADPNP and neg. supercoiled plasmid (half-open). 
It is not clear if the well-defined ATPase-gate conformation in presence of ADPNP 
corresponds to domain dimerization and thus to a closed gate. Determination of photophysical 
correction parameters and the Förster distance for the different TopoVI mutants will allow the 
calculation of inter-dye distances, which can be compared to structural models and might 
either support or argue against the hypothesis of gate closure. 
Binding of neg. supercoiled DNA to TopoVI induces spreading of the ATPase-gate: From the 
data presented it is not clear, if this is due to the presence of a G-DNA or a T-segment. 
SmFRET measurements using linear DNA or relaxed plasmid, both of which should not serve 
as a T-segment, might solve this question. According to docking model of a TopoVI-A dimer 
or the holoenzyme and a G-DNA, the latter should not be in physical contact with the 
domains forming the ATPase-gate (GHKL, transducer) [61, 63]. Hence, we propose that the 
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conformation of the ATPase-gate is not influenced by the G-DNA segment, and that the T-
segment induces spreading of the ATPase domains and locking of the ATPase domains in 
half-open state in the absence and presence of ADPNP, respectively.  
So far only wild-type like TopoVI has been used for smFRET measurements. In order to link 
the conformational changes of the ATPase-gate to catalytic steps, active-site mutants deficient 
in DNA strand cleavage and ATP hydrolysis should be used. Mutants with alterations of the 
invariant lysine in the transducer domain or in the N-terminal lid could give evidence about 
their role in the dimerization of the ATPase domains. 
Presumably all of the conformational states of the ATPase-gate described so far (see above) 
represent stages before the transport of a T-segment. ATPase-gate closure in presence of neg. 
supercoiled plasmid seems to be a reasonable conformational intermediate during the 
relaxation cycle (section 4.2.3). By increasing the observation time of a single complex, it 
might be possible to observe interconversion of different states under relaxation conditions 
using ATP and to detect short-lived states such as closure of the ATPase-gate in the plasmid-
bound complex. This should be achieved by single-molecule experiments using TIRF 
microscopy and immobilized fluorescently labeled TopoVI proteins. A similar experiment has 
been performed for topoisomerase II, where DNA-gate dynamics were detected [43]. The 
immobilization of TopoVI could be achieved by biotinylation of the enzyme and direct 
coupling to a streptavidin-coated surface [115]. However, immobilization via DNA seems to 
be more reasonable as this can be done using synthetic DNA molecules and avoids further 
modification of the protein.  
We have presented smFRET data reporting on conformational changes in the ATPase-gate, 
but not in the DNA-gate. Potential conformational changes in the DNA-gate should be 
detectable using proteins labeled in the TopoVI-A subunits. Gate opening should be a very 
short-lived event and has been proposed to happen only in presence of G- and T-DNAs as 
well as nucleotide [61, 63]. SmFRET measurements on a TIRF microscope as proposed above 
should provide evidence of DNA-gate dynamics, linking them to events like T-segment 
capture and ATPase-gate closure.  
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5. List of abbreviations 
Amino acids are abbreviated in their common three or single letter codes. 
 
A488 Alexa Fluor 488 
A546 Alexa Fluor 546 
AboxA GyrA-box substituted with an alanine heptapeptide 
ADP adenosine 5'-diphosphate 
ADPNP adenosine 5'-(beta,gamma-imido)triphosphate 
ATP adenosine 5'-triphosphate 
B. subtilis Bacillus subtilis 
B. burgdorferi Borellia burgdorferi 
bp base-pairs 
CFX ciprofloxacin 
CTD C-terminal domain 
ΔAbox GyrA-box deletion mutant 
ΔCTD CTD deletion mutant 
DTT 1,4-dithiothreitol 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
FRET Förster resonance energy transfer 
G-DNA / G-segment gate-DNA segment 
GyrA* GyrA_C350L (Cys-free mutant) 
GyrA* NHT His6-TEV-GyrA* with His6-tag cleaved with TEV protease 
GyrA**_Y123F Hetero-dimeric FRET mutant GyrA*_Y123F / 
GyrA*_Y123F_T140C_K594C 
GyrA**_ΔAbox Hetero-dimeric FRET mutant GyrA*_ΔAbox / 
GyrA*_ΔAbox_T140C_K594C 
His6-GyrA* GyrA* with N-terminal His6-tag 
His6(-tag) Hexa-histidine tag 
His6-TEV-GyrA* GyrA* with N-terminal His6-tag cleavable with TEV protease 
His6-TEV-TopoVI-B TopoVI-B with N-terminal His6-tag cleavable with TEV protease 
IEX ion exchange 
IMAC immobilized metal affinity chromatography 
Kd dissociation constant 
M. mazei Methanosarcina mazei 
MW molecular weight 
NADH nicotinamide adenine dinucleotide 
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OD optical density 
ORF open reading frame 
PCR poly-chain reaction 
PEP phosphoenolpyruvate 
S. shibatae Sulfolobus shibatae 
SDS sodium dodecylsulfate 
SEC size-exclusion chromatography 
sm single molecule 
TCEP tris(2-carboxyethyl)phosphine 
T-DNA / T-segment transfer-DNA segment 
TEV Tobacco edge virus 
TIRF total internal reflection fluorescence 
TMR Tetramethyl rhodamine 
TopoVI topoisomerase VI 
TopoVI_SSA Topoisomerase triple-mutant (B)C267S_C316S_C550A 
TopoVI-A topoisomerase subunit A 
TopoVI-B topoisomerase subunit B 
TOPRIM topoisomerase-primase fold 
Tris tris(hydroxymethyl)aminomethane 
WHD winged-helix domain 
wt wild-type  
X. campestris Xanthomonas campestris 
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